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REGULATION OF CONNEXIN40 GAP JUNCTIONS
by
THOMAS V. SHEELA
Under the Direction of Charles F. Louis
ABSTRACT
Gap junctions provide direct electrical and biochemical communication between
cardiomyocytes in the heart. Connexin40 (Cx40) is the major connexin in the atria of the
heart and little is known regarding its regulation. Thus, the goal was to investigate the
regulation of Cx40 in both physiological and pathophysiological conditions. The first
objective of this thesis was to determine whether Cx40 gap junctions were regulated by
β-adrenergic receptor activation. Cx40 has previously been shown to be acutely activated
by cAMP, this cAMP-induced increase in Cx40-mediated cell-to-cell dye transfer has
been shown to be effected through the β-adrenergic receptor-adenylyl cyclase- Protein
Kinase A (PKA) pathway in Cx40-transfected HeLa cells. The second objective of this
thesis was to determine whether Cx40 gap junctions were regulated by intracellular Ca2+
concentration ([Ca2+]i ). [Ca2+]i was increased by addition of the ionophore ionomycin
and elevating extracellular calcium [Ca2+]o from 1.8 mM to 21.8 mM. This resulted in an
elevation of [Ca2+]i and effected an inhibition of Cx40-mediated cell-to-cell dye transfer
(IC50 of 500 ± 0.72 nM) which was Calmodulin-dependent. The third objective of this
thesis was to determine whether Cx40 gap junctions were regulated by ischemia.
Inducing ischemia chemically by inhibiting the electron transport chain with sodium

cyanide and glycolysis with iodoacetate and 2-deoxyglucose effected an inhibition of
Cx40-mediated cell-to-cell dye transfer that was shown to be Calmodulin dependent.
The main conclusions of this thesis were: (1) β-adrenergic receptor activation increases
Cx40-mediated cell-to-cell dye transfer which requires the activation of PKA; (2) A
sustained elevation in [Ca2+]i causes a partial inhibition of Cx40 gap junction-mediated
cell-to-cell dye transfer which was Ca2+-and Calmodulin dependent; (3) Chemical
ischemia causes a partial inhibition of Cx40 gap junction-mediated cell-to-cell dye
transfer which was shown to be Calmodulin-dependent.

Index words: Connexin40, Atria, β-adrenergic receptor, Intracellular calcium, Chemical
ischemia.
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CHAPTER 1

Introduction
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Cell-cell junctions
In the process of building a multicellular organism, cells are organized to form
tissues that adhere to each other by specialized structures or junctions which are critical
for the development and function of these tissues. Through development, and also as
tissues are maintained in a mature organism, cells express informational and junctional
molecules on their surface, so that cells recognize and adhere to like cells. In mammalian
cells these cell-to-cell junctions are classified into three types of junctions: tight
junctions, adherens junctions and gap junctions.
Tight junctions
Epithelial and endothelial cells have junctional complexes on their apical domains
that form seals between adjacent cells called tight junctions. These are important in
tissues such as the bladder, intestines and glands where they form a barrier separating two
fluid compartments and allowing controlled transport of ions and solutes between these
compartments through the paracellular pathway. Freeze fracture studies show that tight
junctions form a network of parallel strands between the lateral faces of two opposing
cells called zonula occludens (Staehelin, 1973).
Tight junctions are composed of membrane proteins that include claudins,
occludins, zonula occludens-1 (ZO-1), ZO-2 and ZO-3. The extracellular loops of
claudins and occludins bind to claudins and occludins from the neighboring cells
(Fig.1.1A). The carboxyl termini of these membrane proteins directly interact with
zonula occludens (ZO-1 and ZO-2) found in the cytoplasm (Furuse et al., 1993;
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Gumbiner, 1987). Occludins are integral membrane proteins with a molecular mass of 65
kDa (Furuse et al., 1993). They contain four transmembrane domains with two
extracellular loops and one intracellular loop, with the amino and carboxy termini in the
cytoplasm. Like occludins, claudins are integral membrane proteins with four
transmembrane domains, two extracellular loops, one intracellular loop, and their N- and
C-termini in the cytoplasm (Furuse et al., 1998). There are 24 members in the claudin
family with molecular masses ranging from 20 – 27 kDa (Gonzalez-Mariscal et al.,
2003). Zonula occludens are peripheral membrane proteins in the vicinity of tight
junctions in the plasma membrane. They bind to the C-termini of occludins and claudins
forming an interface between these proteins and the F-actin filaments (Anderson and
Itallie, 1995). There are three types of zonula occluding proteins ZO-1, ZO-2 and ZO-3
with molecular masses of 200, 160 and 100 kDa respectively.
Adherens junctions
Adherens junctions are protein complexes found at cell-cell junctions of epithelial
cells; their main function is to anchor cells by connecting the actin cytoskeleton of
neighboring cells through direct interaction; they are also responsible for contact
inhibition of cell growth and cell signaling. They can appear as bands encircling the
apical pole of epithelial cells called zonula adherens or as spots of attachment to the
extracellular matrix called adhesion plaques.
Adherens junctions are composed of three major proteins, cadherins, α-catenin
and β-catenin (Fig.1.1B). Cadherins are integral membrane glycoproteins that mediate
intercellular adhesion in a calcium-dependent manner (Takeichi, 1990). They are
composed of a long extracellular region (composed of five domains) where the calcium-

4
binding sites are located, a single transmembrane domain, and a relatively short
cytoplasmic C-terminal tail (two domains) (Fig.1.1B). Cadherins are classified as type I
and type II; Type I includes N- (Neural), E- (Epithelial), P-(placental) and R (Retinal)cadherins to name a few depending on the tissue they are expressed in; type II comprises
cadherin-5 through -12. Cadherins are anchored to the microfilament network of the
cytoskeleton via a complex composed of multiple intracellular proteins including α- and
β-catenin. β-catenin binds directly to the carboxy-terminal cytoplasmic domain of Ecadherin (Nagafuchi and Takeichi, 1988; Nagafuchi and Takeichi, 1989; Ozawa et al.,
1990).
Gap junctions
In tissues, cells are connected to each other by means of intercellular channels
called gap junctions. Gap junctions connect the cytoplasms of neighboring cells allowing
the passage of ions (electrical coupling) and small molecules (biochemical coupling)
between them. Gap junction proteins are classified into three classes: innexins,
pannexins and connexins.
Innexins
In invertebrates, cell-to-cell communication occurs via gap junction proteins
called innexins (Phelan et al., 1998a). Innexins associate to form hexameric subunits
forming a hemichannel in the plasma membrane with hemichannels from adjacent cells
docking to form intercellular channels. Each innexin subunit is comprised of four
transmembrane domains with two extracellular loops, one intracellular loop, with the
carboxy and amino termini in the cytoplasm (Fig.1.2A). 25 C.elegans and 8 Drosophila
innexins have been identified to date. Innexin gap junctions mediate both electrical and
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biochemical coupling. The first innexin to be expressed in Xenopus oocytes was the
Shak-B from Drosophila (Phelan et al., 1998b) and Inx-3 from C.elegans (Landesman et
al., 1999). Innexins are known to form homotypic junctions (both hemichannels
composed of a single type of innexin), heterotypic junctions (each hemichannel is
composed of a unique but different innexin) (Jacobs et al., 2000) and heteromeric
junctions (both hemichannels are composed of mixtures of different innexins) (Stebbings
et al., 2000). Innexins have been shown to form functional intercellular channels that are
voltage (Landesman et al., 1999; Phelan et al., 1998b) and pH sensitive (Landesman et
al., 1999).
Pannexins
Recently, the human genome database was searched for orthologs of the innexin
gene family yielding three members of a new family of vertebrate gap junction proteins
termed pannexins. These proteins appear to be highly conserved in worms, mollusks,
insects and mammals (Panchin et al., 2000), and their sequences show significant
homology to the innexins. Like the innexins, pannexins contain four transmembrane
domains, two extracellular loops, and one intracellular loop with both the N- and Ctermini in the cytoplasm (Fig.1.2B). This suggests that in vertebrates, gap junction
proteins are classified into two families, the well studied connexins and much less studied
pannexins. In mammals, three pannexin genes have been cloned called Panx1, Panx2 and
Panx3 (Baranova et al., 2004). Panx1 and Panx2 mRNAs were found in human adult
brain and other tissues, whereas Panx3 has been found in osteoblasts and synovial
fibroblasts only (Bruzzone et al., 2003). When transfected into Xenopus oocytes, Panx1
but not either Panx2 or Panx3 form functional hemichannels; Panx1 and Panx2 form both

6
homomeric and heteromeric gap junctions (Bruzzone et al., 2003). Panx1 protein has a
molecular mass of ~ 48 kDa. Panx1 hemichannels have been shown to mediate the
release of ATP from erythrocytes during low oxygen conditions (Locovei et al., 2006).
The function of Panx 2 and 3 are not yet understood.
Connexins
Structure:
In mammals, gap junctions are composed of protein subunits called connexins
which form intercellular channels (Fig.1.1C). Connexin gap junctions are composed of
two hemichannels termed a connexon (Musil & Goodenough, 1993; Laird, 1996), with
each connexon hemichannel comprised of six connexin subunits forming a channel with a
central pore (Musil & Goodenough, 1993; Laird, 1996) (Fig.1.1C). Gap junctions formed
from two hemichannels each containing the same connexin protein are called homotypic
gap junctions, while those composed of hemichannels containing different connexins are
called heterotypic gap junctions. When both hemichannels in a gap junction are
composed of a single type of connexin it is called a homomeric gap junction, when
composed of different connexins it is called a heteromeric gap junction. Each connexin
consists of four transmembrane domains with their amino (N-) and carboxy (C-) termini
in the cytoplasm (Fig.1.2C). In most connexins the amino acid sequences in the two
extracellular loops are highly conserved while the sequences of the intracellular loops
vary. The major difference between the different connexins lies in the length and amino
acid sequence of their carboxy termini. Although innexins and pannexins do not have
sequence similarity to the vertebrate gap junction connexin proteins, they share the same
topology (Fig.1.2). Using atomic force microscopy and freeze fracture studies, Hoh et al
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(Hoh et al., 1993) and others (Lal et al., 1995; Revel and Karnovsky, 1967) have shown
that the center-to-center distance of a gap junction is ~ 9-10 nm, the central pore diameter
is 2 nm, a depth of 1 nm and width of 3.8 nm (Hoh et al., 1993; Lal et al., 1995; Revel
and Karnovsky, 1967). Twenty highly related human connexin genes have been
identified (Willecke et al., 2002) with their nomenclature based on their expected
molecular weight in kilodaltons, so that the major connexin (Cx), a protein of 43 kDa, is
referred to as Cx43. A problem with this system is that homologous proteins in different
species may have different molecular weights or different connexin proteins in different
species may have identical molecular weights. An alternative nomenclature to eliminate
this problem was developed based on connexin sequence homology (Kumar and Gilula,
1992) in which connexins are divided into 3 classes α, β and γ, with different members of
each class being given different number eg., α1 for rodent Cx43 and β1 for rodent Cx32
etc.
Formation:
Gap junctions are formed when six connexin subunits oligomerize to form a
connexon, with a connexon from one cell pairing with a connexon of the neighboring cell
to form a gap junction channel. Large numbers of these gap junctions aggregate in the
plasma membrane to form gap junctional plaques. Like other membrane proteins,
connexins are also synthesized on the endoplasmic reticulum (ER). The intracellular
transport of connexins occurs via the secretory pathway, where they are co-translationally
integrated into the ER membrane, transported by successive vesicle budding and fusion
of the ER membrane, through the Golgi stacks to the plasma membrane. Gap junction or
plaque formation is prevented when cells are treated with various inhibitors of the
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secretory pathway, suggesting that gap junction formation occurrs via this pathway (Laird
et al., 1995). Studies in which connexins were synthesized using translation competent
cell lysates supplemented with pancreatic ER-derived microsomes have demonstrated
that connexins are co-translationally integrated into the ER membrane in a signalrecognition particle-dependent manner (Falk et al., 1994; Zhang et al., 1996). The
organization of the connexin topology also occurs in the ER (Falk and Gilula, 1998). A
combination of protease protection assays and antibody binding studies on isolated liver
and heart gap junction membranes established that Cx32 and Cx43 pass through the
membrane four times forming two extracellular loops and a cytoplasmic loop with both
the amino and carboxy termini exposed to the cytoplasm (Milks et al., 1988).
Following their synthesis, connexins oligomerize to form connexons, with the
location of connexin oligomerization known to be connexin-type specific (Diez et al.,
1999; Sarma et al., 2001). Cx32 oligomerization is known to occur in the ER or the
ER/golgi intermediate compartment, Cx43 oligomerization occurs in the trans-golgi
network (Martin et al., 2001; Musil and Goodenough, 1993), and Cx26 oligomerization
occurs in the plasma membrane (integrated directly into the plasma membranes in a
posttranslational manner) (Evans, 2002). In heteromeric connexons (connexons
comprised of two different connexins) an oligomeric intermediate is observed, for
instance in Cx26/Cx32 heteromeric connexons where oligomerization is observed in a
Golgi membrane fraction (Diez et al., 1999).
After oligomerization of the connexons they are transported to the plasma
membrane via the vesicular transport mechanism. Connexons can be inserted into the
plasma membrane either directly into the plaque region (Guerrier et al., 1995), or
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randomly in the membrane and then translocated laterally into the plaque region (Johnson
et al., 1974) where they dock with a connexon from the neighboring cell to form a gap
junction.
Metabolism:
Connexins are short lived as their half-lives are known to be in the range of ~ 1 5 hrs (Fallon and Goodenough, 1981). Pulse chase studies have demonstrated that Cx43
has a half-life of ~ 1-2 hr (Beardslee et al., 1998; Laird DW, 1991). Gap junction
internalization occurs via structures called “annular gap junctions” (Jordan et al., 2001),
double membrane vesicles containing entire gap junctions. Degradation of annular gap
junctions is known to occur either in lysosomes or proteosomes. Indeed Rahman, Carlile
et al. (1993) have demonstrated the presence of Cx32 in lysosomes at levels comparable
to the Golgi apparatus in rat liver (Rahman et al., 1993). It has be demonstrated that
inhibiting lysosomal enzymes results in the intracellular accumulation of Cx43 in BICRM1Rk cells, suggesting that like Cx32, Cx43 gap junctions are also degraded in
lysosomes. Other studies have demonstrated that specific inhibitors of proteosomal
enzymes prolonged the half-life of Cx43 in BWEM cells (Laing and Beyer, 1995),
suggesting that Cx43 gap junctions can be degraded in either lysosomes or proteosomes.
The preference for one degradative pathway over the other may be cell type dependent
and that within the same cell type the degradative pathway chosen might depend on the
metabolic state of the cell.

10
Function:
Gap junctions are regulated by various factors that include transjunctional
voltage, intracellular pH, phosphorylation, intracellular Ca2+, and more recently it has
been recognized that associated proteins may also play this role.
Transjunctional voltage: Gap junctions are known to be regulated by
transjunctional voltage and most gap junctions close when large voltages (~ 60-80 mV)
are applied. Different connexins exhibit voltage gating to different degrees, for example
Cx43, the major connexin ubiquitously expressed in mammals, has a half-maximal
inactivation of ± 60 mV (Moreno et al., 1994); Cx40 which is expressed in the atria,
conduction system and endothelium of the heart has a half maximal inactivation of ± 50
mV (Beblo et al., 1995); Cx45 which is expressed in the cardiac conduction system has a
half-maximal inactivation of ± 20 mV (Moreno et al., 1995).
Intracellular pH: Gap junctions are regulated by intracellular pH and in general
gap junctions close in response to intracellular acidosis. Different connexins have
variable degrees of sensitivity to intracellular acidification, for instance the pKa for Cx43
is 6.71±0.03 (Stergiopoulos et al., 1999), while the pKa for Cx50 is 7.17 ± 0.03 (more
basic than the pKa for Cx32) (Stergiopoulos et al., 1999). It is believed that for Cx43 the
regulatory region for pH gating is within the intracellular loop and carboxy-terminus
domains of the connexin described as “particle-receptor” or “ball and chain” model
(Homma et al., 1998).
Phosphorylation: Connexins are phospho-proteins (except Cx26) whose
phosphorylation is catalyzed by various protein kinases. The C-termini and the
intracellular loop of most connexins contain consensus phosphorylation sites for various
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protein kinases; phosphorylation of connexins is important for gap junction assembly,
trafficking, channel function, and turnover (Herve and Sarrouilhe, 2002). Connexins are
differentially regulated by phosphorylation. For example phosphorylation of Cx32 (Saez
et al., 1990) or Cx40 (Van-Rijen et al., 2000) by c-AMP analog, 8-bromo cAMP resulted
in an increase in gap junction permeability, whereas phosphorylation of Cx43 by PKC
resulted in a decrease in gap junction permeability (Lampe et al., 2000). Lin, WarnCramer et al. (2001) have provided evidence for the interaction of Cx43 with the SH2 and
SH3 domains of v-src, which is associated with the phosphorylation of Cx43 at Y247 and
Y265 residues in the carboxyl terminal domain (Lin et al., 2001). This interaction of
Cx43 with v-src is known to disrupt gap junctional communication.
Intracellular Ca2+: Gap junctions are sensitive to Ca2+ and are known to close at
elevated intracellular [Ca2+] (~ micromolar concentrations) levels. Ca2+ does not appear
to directly bind to connexins but this Ca2+ effect on gap junction gating is mediated by
the Ca2+-binding protein Calmodulin (CaM) (Peracchia, 2004). It has been postulated
that CaM serves as a mediator for this Ca2+- mediated effect on Cx32 (Hertzberg and
Eldik, 1987) and Cx43. Evidence for the direct interaction of CaM with connexins was
provided by immunofluorescence studies, where CaM co-localized with Cx32 in HeLa
cells stably transfected with Cx32 (Peracchia et al., 2000) and with Cx37 and Cx43 in
transfected HeLa cells (Sotkis et al., 2001).
Associated proteins: A number of proteins are known to interact with connexins
to form protein complexes (Duffy et al., 2002). Such protein-protein interactions can
regulate several connexin functions including connexin assembly, trafficking, turnover,
and channel gating. Connexins are known to interact with various proteins including the
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tight junction proteins ZO-1(Toyofuku et al., 1998), cytoskeletal proteins such as the α
and β-tubulins (Giepmans et al., 2001), as well as the adherens junction proteins
cadherin, β-catenin (Ai et al., 2000), and the occludins (Kojima et al., 2001). The Cterminus of Cx43 is known to interact with the second PDZ domain of ZO-1. This
interaction is speculated to have a potential role in the trafficking of Cx43 to the
intercalated discs of the heart, thus facilitating the formation of Cx43 gap junctions
(Toyofuku et al., 1998). GST binding assays and immunolocalization studies have shown
that Cx43 binds to α and β-tubulin, indicating that the connexins interact with the
cytoskeletal proteins α and β-tubulin (Giepmans et al., 2001). Co-immunoprecipitation
and immunofluorescence studies have provided evidence for the direct association of
Cx32 with the occludins and claudin-1 in cultured hepatocytes, indicating that connexins
directly associate with tight junction proteins (Kojima et al., 2001). Finally, there is
evidence that connexins interact with signaling proteins such as src (Lin et al., 2001).

Gap junctions in diseases
Gap junction-mediated communication is important for various cellular functions
such as regulation of cell growth, differentiation, and development. Gap junctions effect
multiple cellular functions including the intercellular movement of ions, metabolites,
transmitting signals such as second messengers between cells to regulate cell growth and
development, the flow of current between cells to maintain electrical communication,
maintenance of a constant internal environment (cellular homeostasis), and transport of
metabolites and products in tissues. Alteration in gap junction number, distribution,
function, and mutations in connexin genes are known to result in various diseases in
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humans. Several studies have demonstrated the role of connexin mutations in a wide
spectrum of human diseases, such as in demyelinating neuropathies/peripheral
neuropathy, various skin disorders, cataracts, deafness, oculodentodigital dysplasia
(ODDD) and cardiac diseases to name a few (Chang et al., 2003; Wei et al., 2004).
Peripheral neuropathies:
Cx32 is expressed in both the peripheral nervous system (located in the paranodal
loops and Schmidt-Lantermann incisures in myelinating Schwann cells) and central
nervous system (oligodendrocytes and its processes) (Scherer et al., 1995). Mutation in
the Cx32 protein is associated with an X-linked form of Charcot-Marie-Tooth (CMTX)
disease (Bergoffen et al., 1993). CMTX is a demyelinating syndrome associated with
progressive degeneration of peripheral nerves brought on by a defect in Schwann cells.
Over 200 unique Cx32 mutations have been identified in CMTX patients (Nelis et al.,
1999).
Skin disorders:
Cx26, Cx30, Cx31 and Cx43 are the major connexins expressed in the epidermis
and hair follicles where their main function is to regulate keratinocyte growth and
differentiation (Choudhry et al., 1997). Cx26 mutations are associated with skin
disorders such as palmoplantar keratoderma, which is a group of disorders characterized
by thickening of the palms and the soles of individuals (Heathcote et al., 2000), and
Vohwinkel sydrome an autosomal-dominant condition with mutilating keratoderma
accompanied by deafness (Maestrini et al., 1999). Cx30.3 and Cx31 mutations are
associated with erythorokeratoderma variabilis (EKV), autosomal dominant
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genodermatosis characterized by persistent plaque-like or generalized hyperkeratosis and
transient red patches of variable size, shape, and location (Richard et al., 2003).
Cataracts:
Cx43, Cx46 and Cx50 are expressed in human eye lens. Cx43 is expressed in the
lens epithelium, while the fiber cells express Cx46 and Cx50. The main function of these
lens connexins is to maintain homeostatis (movement of fluid, ions, nutrients and
metabolites) and lens growth (White, 2002). Point mutations in Cx46 and Cx50 genes
are known to cause zonular pulverulent (dust-like appearance) cataracts (Mackay et al.,
1997; Shiels et al., 1998). Cx50 knockout mice developed microphthalmia (small eyes),
suggesting that Cx50 is responsible for lens growth and development (Rong et al., 2002),
while Cx46 knockout mice developed severe cataracts suggesting that Cx46 is
responsible for the coupling of central fibers to the peripheral cells, and this coupling is
essential for fiber cell homeostasis and maintaining lens clarity (Gong et al., 1998).
Deafness:
Mutations in at least 4 connexin genes are known to be associated with deafness
namely, Cx26, Cx30, Cx30.3, and Cx31 (Kelsell et al., 2001). Cx26 mutations are
known to result in autosomal-recessive (DFNB1) and dominant (DFNA3) forms of
genetic hearing impairment (White, 2000). Knockout mouse studies have also revealed
the role of Cx26 and Cx30 in hearing. Cx26 is responsible for cochlear function and cell
survival in the sensory epithelium of the inner ear (Cohen-Salmon et al., 2002), while
Cx30 is responsible for generating endocochlear potential and mediating survival of the
auditory hair cells after the onset of hearing (Teubner et al., 2003).
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Cardiac gap junctions
Cardiac Morphology and function
The heart is a muscular organ in vertebrates, responsible for pumping blood
through the blood vessels to and from various tissues providing metabolic substrates and
removing metabolic products from tissues in the body by repeated rhythmic contractions.
The heart consists of 4 cavities/chambers; the upper 2 cavities comprise the right and left
atria and the lower 2 cavities the right and left ventricles, each cavity has a valve to
prevent backflow of blood. The atria and ventricles are enclosed by 4 layers, the
pericardium, which is the outermost layer, the epicardium, myocardium and
endocardium. The myocardium forms the bulk of the mass of the heart wall and is
composed of muscular tissue. Energy, nutrients and oxygenated blood are provided to the
working myocardium by blood vessels called coronary arteries. The myocardium is
capable of organized contraction and relaxation propelling blood throughout the body,
delivering metabolic substrates to and transferring metabolic products from each organ.
Contraction occurs when the myocardium is excited by electrical impulses that are
carried through the conduction system. These impulses control heart rate and rhythm.
The electrical impulse originates in the sinus node (SA), which is located at the upper
portion of the right atrium then travels to the atrioventricular node which is located near
the junction of the four chambers of the heart. Impulses from the atrioventricular node are
distributed to the ventricular myocardium via the right bundle branch and the left bundle
branch.
The myocardium is composed of rod-shaped or fiber-like muscle cells called
cardiomyocytes. These cells are striated and contain dense bands called intercalated
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discs that separate individual cells from one another at their ends. Intercalated discs
contain specialized intercellular channels between cardiac muscle cells composed of gap
junctions. Gap junctions allow the cell-to-cell flow of electrical current (electrical
communication) and the movement of small molecules (intercellular communication)
between cardiomyocytes. Propagation of electrical impulses between adjacent
cardiomyocytes is accomplished via gap junctions. Any alteration in gap junction
function affects electrical conduction, thereby affecting heart rate and rhythm indicating
the critical role of gap junctions in cardiac function.
Connexin expression and function in the heart
Cell-to-cell action potential propagation in the heart is mediated through gap
junction channels that are located in regions called “intercalated discs” found at lateral
cell-to-cell borders in cardiomyocytes. The 3 major connexins in the heart are Cx40,
Cx43 and Cx45, with Cx43 expressed at much higher levels in the heart compared to the
other connexins (Van-Kempen et al., 1996). Cx40 is most abundant in the atria (upper
chambers of the heart) and atrioventricular conduction system (conducting link between
the atria and ventricles) (Delorme et al., 1995; Van-Kempen et al., 1996) whereas Cx45 is
restricted to the atrioventricular conduction system.
Connexin40: Cx40 is the major atrial connexin together with Cx43, it is also
expressed in the ventricular conduction system along with Cx45 (Beyer et al., 1992) and
in lower levels in the sinoatrial node (SAN) and atrioventricular nodes (AVN) (Kwong et
al., 1998). During neonatal development Cx40 expression can be observed in the
ventricles but its expression levels declines in adult developmental stages (Kwak et al.,
1999). Cx40 has been shown to be regulated by voltage (Bruzzone R, 1993; Beblo DA,
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1995), intracellular pH (Peracchia et al., 2004) (Stergiopoulos et al., 1999) and cAMPdependent protein kinase (Van-Rijen et al., 2000). Thus, in HeLa cells transfected with
human Cx40, a single open channel conductance of 120 pS, and 2 substates of 30 and 80
pS were observed (Van Rijen HVM, 2000). Furthermore, in oocytes transfected with
mouse Cx40, CO2-induced cytosolic acidification decreased the voltage gating sensitivity
of these junctions (Peracchia et al., 2004), indicating Cx40 is also regulated by
intracellular pH. Cx40 gap junctions are somewhat cation selective and Cx40-transfected
N2A cells are only slightly permeable to 2',7'-dichlorofluorescein and also to the more
polar 6-carboxyfluorescein dye (Beblo et al., 1995). Cx40 is a phospho-protein and
contains potential consensus phosphorylation sites for protein kinases including casein
kinase II, PKA and PKC. The effect of these protein kinases on Cx40 gap junction
conductance or permeability is still unknown and therefore a focus of this study.
Connexin43: Cx43 is the major connexin expressed throughout the heart
including the atria, ventricles and conduction system, except in the sinoatrial and
atrioventricular nodes (Davis et al., 1995). The human Cx43 protein sequence consists of
382 amino acids. Cx43 gap junctions are known to be regulated by transjunctional
voltage, intracellular pH, intracellular Ca2+ and protein kinase catalyzed phosphorylation.
In Cx43-transfected SKHep1 cells, Cx43 channels are regulated by transjunctional
voltage with a half-maximal inactivation at ± 60 mV (Moreno et al., 1994). These
channels have also been shown to be pH sensitive; gap junctional conductance was
decreased by 60 % when intracellular pH was decreased from 7.0 to 6.3 (Hermans et al.,
1995). Cx43 gap junctions exhibit minimal ion selectivity and allow the cell-to-cell
transfer of Lucifer Yellow dye in Cx43-transfected HeLa cells (Elfgang et al., 1995).
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Cx43 is a phospho-protein and its amino acid sequence contains putative phosphorylation
consensus sequences for PKC, PKA, PKG and MAP kinases in its carboxy-terminus
(Kemp and Pearson, 1990). Direct activation of PKC with the phorbol ester TPA is
known to catalyze the phosphorylation of Cx43 on S368, S372 (Shah et al., 2002), and
S262 residues (Doble et al., 2004; Lampe et al., 2000). Activation of PKC with TPA or
PKG with 8-bromo cGMP decreased both electrical (gap junctional conductance) and
biochemical communication (cell-to-cell dye transfer) in Cx43-transfected SKHep1 cells
(Kwak et al., 1995). Activation of PKA with 8-bromo cAMP did not affect Cx43mediated gap junction conductance or dye permeability in these cells (Kwak et al., 1995).
Activation of MAP kinase by epidermal growth factor in rat liver epithelial cells
decreased Cx43-mediated gap junctional conductance that was associated with the
phosphorylation of Cx43 at residues Ser255, 279 and 282 (Lau et al., 1992), indicating
Cx43 gap junctions are regulated by MAP kinase, PKC and PKG but not PKA.
Connexin45: Cx45 is expressed mainly in the ventricular conduction system
(Coppen et al., 1998), in the sinoatrial (Coppen et al., 1999), and atrioventricular nodes; it
is also expressed at very low levels in the atria and ventricles. Cx45 gap junctions are
known to be regulated by transjunctional voltage, intracellular pH, and phosphorylation
catalyzed by various protein kinases (PKA and PKC). Cx45 gap junctions are highly
sensitive to transjunctional voltage with half maximal activation at ±20 mV (Moreno et
al., 1995) and unitary conductances of approximately 20 and 40 pS (van-Veen et al.,
2000). Like Cx40, Cx45 gap junctions are cation selective and allow the cell-to-cell
transfer of 2',7'-dichlorofluorescein but not the more polar dye 6-carboxyfluorescein
between Cx45-transfected N2A cells (Veenstra et al., 1994). SKHep1 cells endogenously
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express Cx45 and gap junctional conductance mediated by Cx45 channels in these cells
was completely inhibited when intracellular pH was decreased from 7.0 to 6.3, indicating
that Cx45 gap junctions like Cx40 and Cx43 are also highly sensitive to intracellular pH
(Hermans et al., 1995). Cx45 is a phospho-protein that contains putative phosphorylation
consensus sequences for PKA and PKC (Kemp and Pearson, 1990; Kennely and Krebs,
1991). The conductance of Cx45 gap junctions in SKHep1 cells increased upon
activation of PKC with TPA and elicited a third conductance state of 16 pS. Although
Cx45 electrical communication was increased by PKC activation, it did not affect Cx45mediated biochemical communication (dye permeability) (Kwak et al., 1995). In
contrast, activation of PKA with 8-bromo cAMP resulted in a decrease in Cx45-mediated
gap junctional conductance (van-Veen et al., 2000) suggesting that Cx45 gap junctions
are regulated by both PKA and PKC.

Gap junction mutations in Cardiac diseases
Gap junctions are responsible for electrical and intercellular communication in the
heart. Studies using connexin knockout mice have revealed the function of the individual
cardiac connexins. Thus, Cx43 knockout mice die shortly after birth (Reaume et al.,
1995). Tissue-specific Cx43 knockout mice (heart) are known to develop normal heart
structure and function, but exhibit sudden cardiac death due to spontaneous ventricular
arrhythmia by ~ 2 months of age (Gutstein et al., 2001). Endothelial cell-specific Cx43
knock out mice developed hypotension and bradycardia (Liao et al., 2001), suggesting
that Cx43 plays an essential role in heart outflow tract morphogenesis and development
of the coronary arteries. Cx43 mutations are associated with oculodentodigital dysplasia,
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a rare autosomal dominant congenital disorder mainly affecting the development of the
face, eyes, skeletal system, heart, dentition (Kelly et al., 2006) and congenital heart
malformation (Chen et al., 2005). Connexin43 mutations are associated with abnormal
heart morphogenesis that includes atrial septal defect (ASD), ventricular septal defect
(VSD) and other cardiac defects (Xie et al., 2005). Cx43 mutations are thought to be
associated with congenital heart malformation. Thus, when fetuses with congenital heart
malformation were examined for Cx43 mutations, several amino acid substitutions were
found that included Arg239Trp, Ser251Thr, Ala253Pro, Pro283Leu and Thr290Asn
(Chen et al., 2005), suggesting that Cx43 mutations are associated with several cardiac
diseases. Reduction in gap junction number or expression is known to be associated with
a number of pathological conditions. For example there is reduction in Cx43 expression
following myocardial ischemia and hypertrophy in the heart, suggesting that this
reduction in Cx43 content may play an important role in the development of hypertrophy
(Peters et al., 1993). During end-stage ischemic heart disease there is a remodeling of
gap junctions, and Cx43 gap junction distribution is altered from the lateral cell-cell
borders (intercalated discs) to the transverse cell-cell borders (Smith et al., 1991a),
suggesting that alteration in gap junction distribution is a response to the development of
cardiac diseases.
In studies with Cx40 knock-out mice (mice lacking Cx40), there is an increased
incidence of death, reduced velocity of impulse conduction in both the atria and
ventricular conductive myocardium (Kirchhoff et al., 1998) (Simon et al., 1998; Verheule
et al., 1999), dysrhythmias (abnormality in the rate, regularity or sequence of cardiac
activation), and various morphological defects in the heart (Kirchhoff et al., 2000). Cx40
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polymorphism is known to be associated with atrial standstill, a rare form of arrhythmia,
where P waves are absent in electrocardiogram suggesting the absence of atrial activity
(Hauer et al., 2006).
Cx45 knockout mice die during embryogenesis due to abnormalities of vascular
development and cardiogenesis (Kruger et al., 2000), suggesting an important role of
Cx45 in the development of these organs.

Significance of Connexin40 in the heart
In the heart, Cx40 is most abundant in the atria and atrioventricular conduction
system, with lower levels of expression in the ventricles (Vozzi et al., 1999a). Cx40
together with Cx43 is expressed in vascular smooth muscle, endothelial cells, and a
subpopulation of cardiomyocytes in the vertebrate cardiovascular system (Little et al.,
1995).
There is evidence that Cx40, together with Cx43 and Cx45 is required for normal
cardiac rhythm (Hagendorff et al., 1999),(Kumai et al., 2000), (Kruger et al., 2000),
(Tamaddon et al., 2000). Thus, studies of Cx40 deficient mice show an increased
incidence of death between embryonic day (ED) 11.5 and embryonic day 13.5, and fewer
than 50% of the mice survive after birth. These mice that do survive show reduced
velocity of impulse conduction in the atria and the ventricular conductive myocardium
(Kirchhoff et al., 1998; Simon et al., 1998; Verheule et al., 1999), together with both
spontaneous as well as inducible dysrhythmias (abnormal rate, regularity or sequence of
cardiac activation). These mice express various morphological defects in the heart which
includes an absence of the mesenchymal cup on the rim of the primary atrial septum,
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myocardial hypertrophy and atrioventricular septal defects between the two bridging
valvar leaflets (Kirchhoff et al., 2000).
Cx40 deficiency in the heart is also associated with disturbances of sinoatrial
electrophysiology, intra-atrial pulse propagation and a prolongation of the PQ interval
and QRS duration. This results in spontaneous atrioventricular block (impaired electrical
conduction in the AV node and His-Purkinje system) indicating a decreased AV
conduction capacity (Hagendorff et al., 1999). These results point to the critical role that
Cx40 plays in electrical conduction in the heart. Any alteration in Cx40 function will
clearly impact normal cardiac muscle performance.
In the atria, gap junctions are mainly comprised of Cx40 and Cx43 proteins.
However, several studies have demonstrated that Cx40 and Cx43 do not form heterotypic
gap junctions (Bruzzone et al., 1993; Elfgang et al., 1995; Haubrich et al., 1996),
suggesting that gap junctions formed by these connexins are regulated independently of
each other in this region of the heart. Cx43 is a well studied connexin and its regulation
has been studied under both physiological and pathophysiological conditions, whereas
Cx40 regulation is still not well characterized.
Although Cx40 has been shown to be regulated by transjunctional voltage
(Bruzzone R, 1993; Beblo DA, 1995), intracellular pH (Peracchia et al., 2004)
(Stergiopoulos et al., 1999) and 8-bromo-cAMP (Van-Rijen et al., 2000), its regulation
by intracellular [Ca2+], purinergic and adrenergic receptor agonists and ischemia as
occurs during pathological conditions in the heart is still unknown and is therefore the
focus of this study. Understanding the biochemical basis and pathways involved in these
conditions should provide insight into the role of Cx40 gap junctions in the progression
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of arrhythmias such as atrial fibrillation, and open the possibility of developing new
therapeutic approaches for their management and treatment.
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Thesis objectives
The goal of this thesis was to examine the regulation of Cx40 gap junctions in
both physiological and pathophysiological conditions. This thesis has four main
objectives: To study the regulation of
1.

Cx40 gap junctions by β-adrenergic receptor activation

2.

Cx40 gap junctions by intracellular [Ca2+]

3.

Cx40 gap junctions by ischemia

4.

Cx43 hemichannels by purinergic receptor activation
Cardiomyocytes express at least three different connexins, namely Cx40, Cx43

and Cx45 and therefore are not an optimal cell type for determining the functional
properties of individual cardiac connexins. Thus, to study the regulation of gap junctions
comprised of Cx40 alone, studies were conducted using this connexin stably transfected
in communication-deficient HeLa cells. Cell-to-cell communication mediated by Cx40
gap junctions was determined by measuring the level of cell-to-cell transfer of the
fluorescent dye Alexa Fluor 594.
Beta-adrenergic regulation of Cx40 gap junctions
Catecholamines play an important role in cardiac physiology and
pathophysiology. Sympathetic nerve activation is known to release the catecholamines
epinephrine and norepinephrine into the blood stream affecting both contraction and
relaxation of the heart through α- and β- adrenergic receptors. The human heart
expresses both α- and β- adrenergic receptors, and Cx40 is the major connexin in the atria
of the heart where the action potential originates. Previous investigators have shown that
cell-permeant analogs of cAMP caused an increase in Cx40-mediated cell-to-cell dye
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transfer in Cx40-transfected SkHep cells. This study will be the first to examine whether
Cx40-mediated cell-to-cell dye transfer can be regulated via β-adrenergic receptordependent activation of Protein Kinase A as would occur in the intact heart. The first
objective of this thesis will be to determine whether Cx40 gap junctions are regulated by
β-adrenergic receptor activation and the signaling pathway/s involved in the β-adrenergic
receptor-mediated effects on Cx40 gap junctions. Cx40-transfected HeLa cells will be
incubated with β- adrenergic receptor agonists for various times and Cx40 gap junction
function detected by measuring the extent of cell-to-cell transfers of Alexa Fluor 594 dye.
Components of the signal transduction pathway and the receptor subtypes will then be
characterized through a pharmacological approach using selective agonists for the
receptor subtypes and inhibitors for various protein kinases.
Regulation of Connexin40 Gap junctions by Intracellular Ca2+
During myocardial ischemia there is accumulation of intracellular Ca2+
concentration [Ca2+]i in cardiomyocytes (Watts et al., 1980) that may be due to the influx
of Ca2+ from the extracellular space via the Na+/Ca2+ exchanger or release from the
sacroplasmic reticulum (during ischemia there is increase in intracellular [H+] along with
[Ca2+] (Lazdunski et al., 1985). This increased [Ca2+]i is known to be associated with a
decrease in gap junction-mediated electrical (gap junction conductance) and biochemical
communication (gap junction permeability) in cardiomyocytes (Burt, 1987a; White et al.,
1990). The major connexins present in cardiomyocytes are Cx40, Cx43 and Cx45, and
Cx43, the major connexin in the heart is known be to inhibited by elevated [Ca2+]i (Crow
et al., 1994). Previously our laboratory has demonstrated that Cx43-mediated cell-to-cell
dye transfer is inhibited by elevated [Ca2+]i with an IC50 of approximately 350 nM in
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transfected HeLa cells. Although Cx40 is most abundantly expressed in the atria, its
regulation by [Ca2+]i is unknown. Therefore the second objective of this thesis will be to
examine the possible effect of [Ca2+]i on Cx40 gap junctions and the mechanisms
underlying any action of [Ca2+]i on Cx40 gap junction permeability. Intracellular Ca2+
will be measured ratiometrically (340 nm /380 nm) with Fura-2. [Ca2+]i will be elevated
in Cx40-transfected HeLa cells by adding ionomycin (2 µM) to permeabilze the plasma
membrane to Ca2+, and then elevating extracellular Ca2+ ([Ca2+]o) from 1.8 to 21.8 mM
by adding CaCl2 to the bathing buffer which elevates [Ca2+]i from nano molar to micro
molar. Cx40 gap junction function will be detected by measuring the level of cell-to-cell
transfer of Alexa Fluor 594 dye. The mechanism/s responsible for the [Ca2+]i-dependent
changes in Cx40 gap junction permeability will be determined using inhibitors of [Ca2+]idependent protein kinases and Ca2+-binding proteins.
Regulation of Connexin40 Gap junctions by Ischemia
Myocardial ischemia is known to cause arrhythmias which lead to sudden cardiac death
(Janse and Wit, 1989). During ischemia there is a significant decrease in cellular ATP and
oxygen concentration that is associated with inhibition of cardiac gap junction-mediated
electrical conduction (Beardslee et al., 2000). One of the important mechanisms responsible for
the myocardial ischemia-induced origin of arrhythmias is the uncoupling of gap junctions (Groot
and Coronel, 2004). Other studies have also shown that gap junction-mediated electrical
conduction was inhibited during ischemia in cardiomyocytes (Beardslee et al., 2000). Since
cardiomyocytes express at least three different connexins, namely Cx40, Cx43 and Cx45,
whether this ischemia-induced inhibition of gap junction-mediated electrical conduction is due to
inhibition of all three connexins, or just one or more connexins is still not clear. Cx43, the major
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connexin in the heart is known to be inhibited in ischemia (Li and Nagy, 2000). Although Cx40
is most abundantly expressed in the atria, it remains to be determined whether it is affected by
ischemia. Therefore the third objective of this thesis will be to determine whether Cx40 gap
junction permeability is affected by ischemia. Chemical ischemia will be induced by inhibiting
the electron transport chain with sodium cyanide and glycolysis with iodoacetate and 2deoxyglucose.
Regulation of Cx43 hemichannels
Hemichannels are “half” gap junctions, composed of 6 connexin subunits that
connect the interior of the cell to its exterior space. Evidence for a physiologic role for
non-junctional connexin hemichannels in vivo was first provided by electrical studies on
horizontal cells of fish retina (DeVries and Schwartz, 1992; Malchow et al., 1993).
Cardiomyocytes are known to express functional hemichannels in the heart (Kondo et al.,
2000) and Kondo and colleagues (John et al., 1999) (Kondo et al., 2000) have examined
the presence of functional hemichannels in isolated cardiomyocytes. In isolated
cardiomyocytes hemichannel-mediated conductance and calcein dye uptake was shown
to be increased in the presence of reduced extracellular Ca2+ concentration or metabolic
inhibition in the presence of normal extracellular Ca2+ concentration (John et al., 1999).
These results suggested that functional hemichannels existed in the heart. The presence
of endogenous hemichannels in cardiac myocytes may have both physiological and
pathophysiological significance, since their activation during ischemia is known to enable
a non-selective current to exchange [K+]i for [Na+]o and [Ca2+]o. The physiological
function of these hemichannels is unclear, although hemichannel activity has been
reported to be gated by [Ca2+]o (Ebihara and Steiner, 1993; Pfahnl and Dahl, 1998;
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Valiunas and Weingart, 2000), metabolic state (Contreras et al., 2002; John et al., 1999),
membrane potential (Trexler et al., 1996; Valiunas and Weingart, 2000), Protein Kinase
C (Li, 1996), and Ca2+-dependent volume regulation (Quist et al., 2000). Many of the
properties of these hemichannels are similar to those of the corresponding gap junction
channels (Trexler et al., 1996).
ATP is released with norepinephrine from sympathetic nerve terminals
(Burnstock, 1995), from endothelial cells during vascular injury (Born and Kratzer,
1984), and from cardiomyocytes during hypoxia (Forrester and Williams, 1977). Little
information is known about the subcellular ionic changes which accompany purinergic
receptor activation (caused by ATP) of cardiac myocytes, even under physiological
conditions. It has been shown previously in our laboratory that Cx43-mediated cell-tocell dye transfer was transiently inhibited by ATP via activation of PKC in Cx43transfected HeLa cells. Since cardiomyocytes are known to express Cx43 hemichannels
(Kondo et al., 2000) it is important to understand the effect of agonists such as ATP on
Cx43 hemichannels. Therefore the fourth objective of this thesis will be to determine
whether like Cx43 gap junctions, Cx43 hemichannels are regulated by agonists such as
ATP that are released during cardiovascular ischemia.
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Fig.1.1: A model of cell-cell junctions. A. The protein complex (occludins, ZO-1, ZO-2
and ZO-3) that is responsible for the formation of tight junctions, B. Protein complex
(cadherins and catenins) that is responsible for the formation of adherens junctions, and
C. Assembly of six gap junction proteins called connexins to form a connexon. Two
connexons from opposing cells dock to form an intercellular gap junction channel.
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Fig.1.2: A model of gap junction proteins with all the proteins with similar topology,
each protein is comprised of 4 transmembrane domains with two extracellular loops, one
intracellular loop, with the carboxy (C) and amino (N) termini in the cytoplasm. A.
Innexins- invertebrate gap junction proteins, B. Pannexins- possible vertebrate gap
junction proteins, and C. Connexins- vertebrate gap junction proteins.
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CHAPTER 2

Beta-adrenergic regulation of Cx40 gap junctions
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Introduction
Cardiomyocytes are tightly interconnected by gap junctions that are found in
every mammalian tissue, except adult skeletal muscle. These junctions are comprised of
connexin proteins that form intercellular channels and are composed of two hemichannels
termed a connexon (Laird, 1996; Musil and Goodenough, 1993) with each hemichannel
comprised of six connexin subunits. Each connexin consists of four transmembrane
domains with the amino (N-) and carboxy (C-) termini in the cytoplasm. Twenty highly
related human connexin genes have been identified with their nomenclature based on
their expected molecular weight in kilodaltons, so that the major known connexin (Cx), a
protein of 43 kDa, is referred to as Cx43. A problem with this system is that homologous
proteins in different species may have different molecular weights or different connexin
proteins in different species may have identical molecular weights. An alternative
nomenclature to eliminate this problem was developed based on connexin sequence
homology (Kumar and Gilula, 1992), in which connexins were divided into 3 classes α, β
and γ, with different members of each class being given different number eg., α1 for
Cx43 and β1 for Cx32 etc. The permeability properties of gap junctions are regulated by
various factors that include voltage, intracellular pH, phosphorylation and intracellular
calcium and more recently it is recognized that associated proteins may play this role; gap
junctions allow the passive cell-to-cell diffusion of small molecules of up to
approximately 1000 Dalton. This form of cell communication is important for the
intercellular movement of metabolites, transmitting signals such as second messengers
between cells to regulate cell growth and development, the flow of current between cells
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to maintain electrical communication, and the maintenance of a constant internal
environment (cellular homeostasis) in cardiomyocytes.
Three major connexins expressed in the heart include connexin 40 (Cx40),
connexin 43 (Cx43) and connexin 45 (Cx45). Cx43 is expressed at much higher levels in
the heart compared to other connexins (Van-Kempen et al., 1996). Cx40 is most
abundant in the atria (upper chambers of the heart) and atrioventricular conduction
system (conducting link between the atria and ventricles) (Delorme et al., 1995), whereas
Cx45 is restricted to the atrioventricular conduction system. Impaired electrical
communication due to alterations in the number, spatial distribution, or function of
myocardial gap junctions have a causative role in the origin of arrhythmias which is
associated with a number of different pathophysiological conditions including acute
ischemia, chronic myocardial infarction, atrial fibrillation, diabetes, hypertension,
valvular dysfunction, heart failure and hyperthyroidism (Cooklin et al., 1997) indicating
the importance of functional gap junctions for maintaining normal functioning of the
heart. In studies with Cx40 knock-out mice (mice lacking Cx40), there is an increased
incidence of death, reduced velocity of impulse conduction in both the atria and
ventricular conductive myocardium (Kirchhoff et al., 1998) (Simon et al., 1998; Verheule
et al., 1999), dysrhythmias (abnormality in the rate, regularity or sequence of cardiac
activation) and various morphological defects in the heart (Kirchhoff et al., 2000). These
several studies demonstrate that Cx40 is critically important for normal cardiac rhythm
(Hagendorff et al., 1999); (Kruger et al., 2000); (Tamaddon et al., 2000).
Cx40, the major connexin in the atria has been shown to be regulated by voltage
(Bruzzone R, 1993; Beblo DA, 1995), intracellular pH (Peracchia et al., 2004)
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(Stergiopoulos et al., 1999) and cAMP-dependent Protein Kinase (Van-Rijen et al.,
2000). Thus, in HeLa cells transfected with human Cx40, a single open channel
conductance of 120 pS, and 2 substates of 30 and 80 pS respectively were observed (Van
Rijen HVM, 2000). Furthermore, in oocytes transfected with mouse Cx40, CO2-induced
cytosolic acidification decreased the voltage gating sensitivity of Cx40 gap
junctions(Peracchia et al., 2004) indicating Cx40 is also regulated by intracellular pH.
Finally, van Rijen HVM et al have observed an increase in Cx40 permeability following
addition of cAMP-dependent Protein Kinase (PKA) activators (Van-Rijen et al., 2000),
indicating Cx40 regulation by this protein kinase.
Extracellular ATP is generated from different sources in the heart, being released
from cardiomyocytes during hypoxia or ischemia (Forrester and Williams, 1977), from
sympathetic nerve terminals (Burnstock and Sneddon, 1985), endothelial cells (Bodin and
Burnstock, 1996) during vascular injury, and activated platelets during aggregation (Mills
et al., 1968). There is little information about any changes which accompany purinergic
receptor activation (effected by extracellular ATP) of cardiomyocytes, even under normal
physiologic conditions. In the heart, purinergic receptor activation results in the
activation of Protein Kinase C, and increases intracellular Ca2+ concentration (Kusakari et
al., 2002; Scamps and Vassort, 1994). The regulation of Cx40 following purinergic
receptor activation is not known; therefore this study is the first to examine whether
Cx40-mediated cell-to-cell dye transfer can be regulated via purinergic receptordependent activation of Protein Kinase C as would occur in the intact heart.
Catecholamines play an important role in cardiac physiology and
pathophysiology. Sympathetic nerve activation is known to release the catecholamines
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epinephrine and norepinephrine into the blood stream affecting both contraction and
relaxation of the heart through α- and β- adrenergic receptors. Human heart expresses
both α- and β- adrenergic receptors and Cx40 is the major connexin in the atria of the
heart where the action potential initially originates. Previous investigators have shown
that cell-permeant analogs of cAMP caused an increase in Cx40-mediated cell-to-cell dye
transfer in Cx40-transfected SkHep cells. This study is the first to examine whether
Cx40-mediated cell-to-cell dye transfer can be regulated via β-adrenergic receptordependent activation of Protein Kinase A as would occur in the intact heart. Because
cardiomyocytes express at least three different connexins, namely Cx40, Cx43 and Cx45,
they are not optimal for determining how the functional properties of individual cardiac
connexins are regulated in this cell type. Thus, to study the regulation of gap junctions
comprised of Cx40 alone, studies were conducted using this connexin that was stably
transfected into communication-deficient human cervix carcinoma (HeLa) cells. These
HeLa cells also contain most of the regulatory systems (second messenger systems)
present in cardiomyocytes.
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Methods
HeLa cell culture
Untransfected or stably Cx40-transfected HeLa cells generously provided by Dr.
Richard Veenstra were grown on 25 mm coverslips in 35 mm culture dishes until
confluent (single monolayer). Cells were grown in DMEM supplemented with 10% v/v
fetal bovine serum and Pen-Strep (100 U/ml Penicillin and 0.1 mg/ml Streptomycin) with
or without 0.025 mg/ml (G418) geneticin, and were grown at 37ºC in a 5% CO2
atmosphere maintained with nearly 100% relative humidity.
Membrane isolation
Cells were harvested from 100 mm or 150 mm culture dishes by adding 500 µl of
ice-cold Buffer 1 (in mM: 25 Tris base, 100 NaCl, 10 EDTA, 50 NaF, 0.5 Na3VO4, pH
8.0), supplemented with protease inhibitors: 2 mM PMSF, 1 mg/L each: aprotinin,
leupeptin, and pepstatin) to each culture dish, removing the cells from the coverslip with
a cell scraper (Sarstedt, Newton, NC), and transferring the suspended cells to a thickwalled 1.5 ml microfuge tube (Beckman/Coulter, Fullerton, CA). Culture dishes were
washed twice with 200 µl of ice-cold Buffer 1 and the final volume in each sample
brought to 1 ml. Cells were centrifuged (5 min at 1260 x g at 4ºC) in a Beckman
TLA100.3 centrifuge, the supernatant was removed, and the cell pellet resuspended in
500 µl ice-cold Buffer 1 and incubated on ice 30 min. Cells were homogenized with a 1
ml glass-on-glass Potter-Elvehjem tissue homogenizer (Bellco Glass Inc., Vineland, NJ,
USA). Homogenates were centrifuged at 100,000 x g at 4ºC for 30 min in a Beckman
TLA 100.3 centrifuge. The supernatant was removed and discarded, and the membrane
pellet resuspended in 65 µl of ice-cold Buffer 2 (10 mM HEPES, pH 7.2) by drawing the
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membranes through a Hamilton GASTIGHT 1700 syringe (Sigma-Aldrich, St. Louis,
MO) until the membrane suspension was homogenous (~ 30 times). The protein
concentration of each membrane preparation was determined using the micro BCA assay
using bovine serum albumin as standard (36). Membranes were either used immediately
or flash-frozen in liquid nitrogen and stored at -80ºC.
Western Imunoblotting
Following electrophoretic analysis of proteins on 10 % PAGE gels with a 5 %
stacking gel in 0.1 % SDS (Laemmli, 1970), gels were equilibrated with transfer buffer
for 15 min before electrophoretic transfer to nitrocellulose membranes (Schleicher &
Schuell Inc., Keene, NH) using a Trans-Blot Cell (Bio-Rad, Richmond, CA) according
to the manufacturer’s instructions. Nonspecific antibody binding sites on the
nitrocellulose membranes were blocked in PBS-Tween (137 mM NaCl, 2.7 mM KCl, 1.8
mM Na2HPO4 and 0.1 %v/v Tween-20, pH 7.2) containing 3 % w/v dried milk for 4-5
hr at ambient temperature, or overnight at 4ºC, with gentle agitation. After blocking of
non-specific antibody binding sites, the nitrocellulose membranes were washed 3 times
for 15 min each in fresh PBS-Tween without dried milk, before overnight incubation
(4ºC, gentle agitation) with anti Connexin40 antibody from Santa Cruz Biotechnology
(1:1000 or 1:750 dilution in PBS-Tween with 3 % dried milk) as indicated in the figure
legends. Following removal of the primary antibody solution, the nitrocellulose
membranes were washed 3 times for 15 min in fresh PBS-Tween with 3 % dried milk
before addition of the appropriate horse radish peroxidase (HRP)-conjugated secondary
antibody (1:1000 dilution, in PBS-Tween with 3 % dried milk) for 3-4 hr at ambient
temperature, or overnight at 4ºC, with gentle agitation. The nitrocellulose membranes
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were washed 3 times for 15 min each in fresh PBS-Tween without milk, and
immunoreactive components were detected on Kodak BIOMAX MS film after incubating
membranes for 1 min with ECL detection reagent (Amersham Pharmacia Biotech Inc.,
Piscataway, NJ).
To identify the β-adrenergic receptor subtypes expressed in HeLa cells, cells were
analyzed by Western Immunoblotting. β-1, β-2 (Ablad B, 1974) and β -3 adrenergic
receptor subtype antibodies were purchased from Santa Cruz Biotechnology (1:1000
dilution in PBS-Tween with 5 % dried milk). Goat anti-rabbit HRP conjugated
secondary antibody was used for the identification of both β-1 and β-2 (Ablad B, 1974)
adrenergic receptor subtypes, while donkey anti-goat HRP conjugated secondary
antibody was used for the identification of the β -3 adrenergic receptor subtype (1:1000
dilution in PBS-Tween with 5 % dried milk).
Immunofluorescence
Untransfected or Cx40-transfected HeLa cells were grown on 25 mm coverslips
in 35 mm petri-dishes until cells reached confluence. Media was removed from cells that
were fixed with 4 % paraformaldehyde for 5 minutes, gently washed with 1x PBS 2x for
2 minutes on an orbital shaker. Samples were incubated with 3 % BSA, 3 % normal
donkey serum and 1 % Triton X-100 diluted in 1X PBS (Blocking solution) for one hour
at 20ºC to block non-specific antibody binding sites. This solution was then removed and
the cells were incubated with primary antibody (1:100 Goat anti-connexin 40) in
Blocking Solution overnight at 4○C on an orbital shaker. The cells were washed 3 times
with 1x PBS for 5 min and then incubated with secondary antibodies (1:250 Donkey antigoat rhodamine) in Blocking Solution for 2 hours at room temperature in the dark. The
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cells are then washed 4 times with 1x PBS, once with deionized water, when cells were
visualized using a Nikon Epifluorescence microscope.
Microinjection of dye
Glass micropipettes were pulled from capillary glass using a Flaming/brown
micropipette puller (Sutter Instrument Co.) and confluent monolayers of cells were then
impaled with micropipette filled with 1mM Alexafluor 594 dye. Dye was
iontophoretically injected into a single cell for 1 min with a pulse protocol of 5 ms every
100 ms for 3 s total using a Duo 773 electrometer with a WPI A310 Accupulser. Cells
were visualized using a Nikon Epifluorescence microscope and digitized images were
recorded using Universal Imaging Metafluor software from which the number of cells
receiving dye (excluding the impaled cell) was counted (Fig.2.3).
Analysis of consensus phosphorylation sites in Connexin40
The potential consensus phosphorylation sites for protein kinases were
determined using the Expasy Prosite-Scan database from the following website:
http://ca.expasy.org/prosite/. The Rat Cx40 protein sequence was inserted into the prosite
tool box and a quick scan for the patterns with a high probability of occurrence for the
different phosphorylation consensus sequences was performed.
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Results
Expression of Cx40 in Cx40-transfected HeLa cells
To demonstrate that Cx40 was indeed expressed, Cx40-transfected HeLa cells
were either immunolabeled or analyzed by Western Immunoblotting as shown in Fig.2.1.
Punctate labeling of Cx40 at cell borders (arrows) as seen in Fig. 2.1B and some labeling
in the cytoplasm (intracellular) was observed in Cx40-transfected HeLa cells (Fig. 2.1A
is phase-contrast image and Fig. 2.1B is rhodamine fluorescence image). In contrast,
there was no comparable immunolabeling when Cx40-transfected HeLa cells were
incubated with secondary antibody alone [Fig. 2.1C (phase image) and D (rhodamine
fluorescence image)]. As a negative control, when wild type untransfected HeLa cells
were immunolabeled [rhodamine fluorescence image] no punctate Cx40 immunofluorescence labeling was observed in these cells.
To demonstrate the expression of Cx40 by Western Immunoblotting, whole cell
lysates from Cx40-transfected HeLa cells were solubilized in SDS and electrophoresed
on 10 % polyacrylamide gels and prepared for Western Immunoblotting as described in
Methods. Lane 1 contains whole cell lysates from untransfected HeLa cells, lane 2 and 3
contain whole cell lysates from Cx40-transfected HeLa cells. A single component of 40
kDa was observed only in Cx40-transfected HeLa cells (lanes 2 and 3 in Fig. 2.1I),
demonstrating the expression of this connexin only in Cx40-transfected HeLa cells.
Functional analysis of Cx40 in transfected HeLa cells
Functional expression of Cx40 was demonstrated as cell-to-cell transfer of
injected Alexa Fluor 594 dye. Traub et al (Traub et al., 1994) have shown that Cx40transfected HeLa cells transfer Lucifer Yellow dye from the injected cell to the
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neighboring cells. In the work reported here cell-to-cell communication was determined
using the fluorescent dye Alexa Fluor 594 because the fluorescence intensity is two-fold
greater than that of Cy3 conjugates and Lucifer Yellow, it is photostable, and its
excitation (590 nm)/emission (617 nm) wavelength allows it to be use with Fura-2 to
monitor changes in [Ca2+]i. To demonstrate that Cx40-transfected HeLa cells mediate
cell-to-cell dye transfer, a single cell in a confluent monolayer of untransfected or Cx40transfected HeLa cells was microinjected with 1mM Alexafluor 594 dye as described in
Methods, and 5 min later the number of cells receiving dye was determined. Although
Cx40 gap junctions are known to be cation selective (Beblo et al., 1995) this was not an
issue in this study because significant number of cells received dye in Cx40-transfected
HeLa cells even with the anionic dye Alexa Fluor 594 compared to untransfected HeLa
cells (Fig 2.2). In HeLa cells stably transfected with rat Cx40, Alexa Fluor 594 dye
transferred to 11.0 ± 0.7 cells (n = 8); in contrast dye transferred to 1.8 ± 0.4 cells in
untransfected HeLa cells (n=11), (Fig. 2.2). This small percentage of cell-to-cell dye
transfer in untransfected wild type HeLa cells could be due to membrane damage in the
injected cell causing Alexa Fluor 594 to leak into neighboring cells, or the small amount
of signal leakage that has been reported in untransfected HeLa cells in other laboratories
(Diestel et al., 2004). Cell-to-cell dye transfer mediated by Cx40 gap junctions was
inhibited by the gap junction blocker, carbenoxolone (CBX, 35 µM) (Goldberg et al.,
1996) [11.0 ± 0.7 (n = 8) cells in the absence and 2.3 ± 0.2 (n = 10) cells in the presence
of the inhibitor] indicating dye transfer was indeed gap junction mediated (Fig. 2.2). To
determine if Alexa fluor 594 dye transfer increased with time in Cx40-transfected HeLa
cells, dye was microinjected into a single cell for 1 min and then images were collected at
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various times. Alexa fluor594 dye transfer reached a maximum by 2 min of dye injection
as shown in Fig. 2.3.
Identification of putative Cx40 consensus phosphorylation sequences
Van Rijen HVM et al (Van-Rijen et al., 2000) have reported that Cx40 is
phosphorylated by cAMP-dependent Protein Kinase (PKA) as indicated by a mobility
shift on Western Immunoblots, indicating that Cx40 is a phospho-protein and contains
consensus phosphorylation sites for cAMP dependent Protein Kinase. To determine
which protein kinases could effect the phosphorylation of Cx40, the potential consensus
phosphorylation sites for several protein kinases was determined by analysis of the Cx40
sequence using the Expasy Prosite-Scan database from the following website:
http://ca.expasy.org/prosite/, as described in Methods. 11 predicted consensus substrate
sites for protein kinases were identified in Cx40: five putative phosphorylation sites for
casein kinase II, five for Protein Kinase C, and one for Protein Kinase A as shown in Fig.
2.4. The consensus sequence for casein kinase II requires acidic amino acid residues
gluatamate, aspartate or serine phosphate immediately C-terminal to the phosphoacceptor
serine/threonine (Kennely and Krebs, 1991). Five recognition sequences for casein
kinase II in Cx40 using the Expasy prosite scan database were identified where two were
in the first extracellular loop, one in the third transmembrane domain, one in the carboxyterminus region adjacent to the fourth transmembrane domain, and the last one in the
carboxy-terminus. The consensus sequence for Protein Kinase C requires basic amino
acids near the phosphoacceptor group; it can also be influenced by both N- and Cterminal basic residues and phosphorylates substrates containing both. Five recognition
sequences were identified for Protein Kinase C in Cx40 using the Expasy prosite scan
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database, with one in the intracellular loop, one in the second extracellular loop, and three
in the carboxy-terminus. The consensus sequence for Protein Kinase A requires basic
amino acids particularly arginine, N-terminal to the phosphoacceptor serine or threonine.
A single consensus recognition sequence for Protein Kinase A that contains the basic
amino acid arginine before the phosphoacceptor serine was identified in the carboxyterminus of Cx40 at residue 343.
Cx40 mediated cell-to-cell communication is not affected by purinergic receptor
activation
Given the presence of these several Protein Kinase C consensus sequences in
Cx40 it was important to determine whether agonists that activate Protein Kinase C are
able to regulate Cx40 gap junctions. It has been demonstrated in this study (Fig. 2.5) and
previously in our laboratory that purinergic receptor activation by ATP effects a Protein
Kinase C-dependent partial inhibition of the major cardiac connexin Cx43. The heart
contains P2X and P2Y purinergic receptors, that are classified based on the order of
agonist potency of structural analogues of ATP (Burnstock and Kennedy, 1985).
Furthermore extracellular ATP is generated from different sources in the heart, being
released from cardiomyocytes during hypoxia or ischemia (Forrester and Williams,
1977), from sympathetic nerve terminals (Burnstock and Sneddon, 1985), endothelial
cells (Bodin and Burnstock, 1996) during vascular injury, and activated platelets during
aggregation (Mills et al., 1968). There is little information about any changes which
accompany purinergic receptor activation (effected by extracellular ATP) of
cardiomyocytes, even under normal physiologic conditions. In the heart, purinergic
receptor activation by ATP results in the activation of Protein Kinase C, and increases
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intracellular Ca2+ concentration (Kusakari et al., 2002; Scamps and Vassort, 1994) as
shown in Fig. 2.5. To determine whether, like Cx43, Cx40 gap junctions are regulated
following purinergic receptor activation, the effect of ATP on cell-to-cell dye transfer
mediated by Cx40 gap junctions was studied. As shown here and previously,
extracellular addition of ATP (25 µM) resulted in a delayed, transient inhibition of Cx43
gap junctions (Fig. 2.6); it has been demonstrated previously that this concentration of
ATP activates purinergic receptors increasing [Ca2+]i in HeLa cells (Paemeleire et al.,
2000). To determine if Cx40 is regulated in a similar manner, experiments were
performed in the absence or presence of 25 µM ATP. Alexa Fluor 594 dye transferred to
9.1 ± 0.4 cells in the absence of ATP. Dye transferred to 8.5 ± 0.4 cells at 5 min, 8.5 ±
0.5 cells at 15 min and 9.1 ± 0.5 cells at 30 min following the addition of ATP (25 µM)
(Fig. 2.7A). Thus, Cx40 mediated cell-to-cell dye transfer was unchanged over a 30 min
period following ATP addition indicating Cx40 is not regulated by purinergic receptor
activation of Protein Kinase C.
It has been demonstrated previously that the Protein Kinase C activator, 12-Otetradecanoylphorbol-13-acetate (TPA) activates Protein Kinase C (Chanson et al., 1988),
and that in Cx43-containing cells this results in an inhibition of cell-to-cell dye transfer
that has been correlated with the phosphorylation of Cx43 (Bao et al., 2004a); (Richards
et al., 2004). To further determine whether Cx40 gap junctions are regulated by direct
activation of Protein Kinase C, experiments were performed in the presence or absence
of the Protein Kinase C activator, TPA (81 nM); this concentration of TPA has been
shown previously to inhibit gap junction communication in lens cells (Tenbroek et al.,
1997) and Cx43-transfected HeLa cells via the PKC pathway. Alexa Fluor 594 dye
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transferred to 9.4 ± 0.6 cells (n=7) in the absence of TPA and there was no significant
change when dye transfer was determined up to 90 min in the continuous presence of
TPA (In the presence of 81 nM TPA dye transferred to 9.0 ± 0.4 cells (n=5) at 5 min, 9.7
± 0.6 cells (n=4) at 30 min, 9.2 ± 0.6 cells (n=5) at 60 min and 10.7 ± 0.7 cells (n=4) at
90 min). Thus, TPA did not appear to affect the dye permeability of Cx40 gap junctions
(Fig. 2.7B), confirming that in HeLa cells Cx40 gap junctions do not appear to be
regulated by Protein Kinase C.
Cx40 mediated cell-to-cell communication is regulated by Protein Kinase A activation
It has been demonstrated previously that activation of Protein Kinase A by
membrane permeant cAMP analog increased the dye permeability of Cx40 gap junction
channels in Cx40-transfected SkHep 1 cells. This action of cAMP was correlated with a
mobility shift of Cx40 protein on Western Immunoblots, which was concluded to be due
to Cx40 phosphorylation by these authors (Van-Rijen et al., 2000). Analysis of the Cx40
sequence with the Expasy Prosite-Scan database identifies one Protein Kinase A
consensus phosphorylation sequence in the carboxy-terminus of Cx40 at amino acid
residues 340 – 343 as shown in Fig. 2.4. To determine whether the results obtained from
the previous study in SKHep cells (Van-Rijen et al., 2000) are reproducible in Cx40transfected HeLa cells, a monolayer of Cx40-transfected HeLa cells was incubated with
the membrane –permeant cAMP analogs dibutyryl cAMP (0.5 mM) or 8 bromo cAMP (1
mM); this concentration of dibutyryl cAMP is known to enhance gap junction
communication in lung epithelial cells (Banoub et al., 1996) and 8 bromo cAMP is
known to enhance gap junction communication in Cx40-transfected SKHep1 cells (VanRijen et al., 2000). Alexa Fluor 594 was then microinjected into one cell, and 2 min later
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the number of cells receiving dye was determined. Alexa Fluor 594 dye transferred to 8.5
± 0.3 cells (n=12) in the absence of dibutyryl cAMP, whereas in the presence of 0.5 mM
dibutyryl cAMP, dye transferred to 13.1 ± 0.5 cells (n=7) at 5 min, 13.8 ± 0.9 cells (n=6)
at 15 min and 12.1 ± 0.9 cells (n=6) at 30 min. Alexa Fluor 594 dye transferred to 8.7 ±
0.3 (n= 11) cells in the absence of 8 bromo cAMP, whereas in the presence of 1 mM 8
bromo cAMP dye transferred to 13.7 ± 0.7 cells (n=4) at 5 min, 12.0 ± 0.9 cells (n=4) at
15 min and 15.5 ± 0.5 cells (n=4) at 30 min (Fig. 2.9). Thus, both cAMP analogues,
dibutyryl cAMP and 8 bromo cAMP, increased the level of Cx40-mediated cell-to-cell
dye transfer as reported previously by van Rijen et al using 8-bromo cAMP (Van-Rijen et
al., 2000).
Protein Kinase A-dependent increase in Cx40 mediated cell-to-cell communication is
via the β-adrenergic signaling pathway
Since beta-adrenergic receptors are coupled to the adenylate cyclase/cAMP/PKA
signaling pathway as shown in Fig. 2.8, it was hypothesized that the Protein Kinase A
dependent increase in Cx40-mediated cell-to-cell dye transfer (Fig. 2.9) is coupled to the
β-adrenergic receptor pathway. To test this hypothesis, the effect of activating each step
in this signaling pathway on Cx40-mediated cell-to-cell dye transfer was studied. The
first step was to demonstrate that direct activation of adenylate cyclase resulted in an
increase in Cx40-mediated cell-to-cell dye transfer which was Protein Kinase A
dependent. To accomplish this, the effect of the adenylate cyclase activator forskolin
(Jakobs and Watanabe, 1985) on Cx40-mediated cell-to-cell dye transfer was analyzed.
Alexa Fluor 594 was microinjected into one cell after the addition of either 10 or 100 µM
forskolin, concentrations of forskolin that are known to increase cAMP levels in oocytes
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(Bornslaeger and Schultz, 1985), and 2 min later the number of cells receiving dye
determined. Alexa Fluor 594 dye transferred to 8.6 ± 0.2 cells (n=6) in the absence of
forskolin, whereas in the presence of 10 µM forskolin dye transferred to 10.0 ± 0.4 cells
(n=4) at 5 min, 10.8 ± 0.5 cells (n=6) at 30 min, 10.0 ± 0.4 cells (n=5) at 60 min and 10.0
± 0.5 cells (n=6) at 90 min. At higher forskolin concentrations Alexa Fluor 594 dye
transferred to 8.7 ± 0.1 cells (n=16) in the absence of forskolin, whereas in the presence
of 100 µM forskolin dye transferred to 11.7 ± 0.2 cells (n=8) at 5 min, 11.3 ± 0.7 cells
(n=6) at 30 min, 11.7 ± 0.1 cells (n=8) at 60 min and 11.3 ± 0.4 cells (n=11) at 90 min
Fig. 2.10A). Thus, the action of forskolin on Cx40-mediated cell-to-cell dye transfer
appears to be concentration dependent in these HeLa cells and confirms that cAMP
activates cell-to-cell dye transfer in Cx40-transfected HeLa cells.
To confirm that this forskolin-mediated increase in cell-to-cell dye transfer in
Cx40-transfected HeLa cells was mediated via the activation of cAMP-dependent Protein
Kinase, the PKA inhibitor KT-5720 (Haddad et al., 2005) was included prior to the
addition of forskolin. Thus, experiments were conducted with 0.5 µM KT-5720 given
the Ki for KT-5720 is 50 nM (Kase et al., 1987); adding a concentration 10 times the Ki
ensured the KT-5720 concentration used was sufficient to inhibit PKA in HeLa cells,.
Following addition of forskolin (100 µM), Alexa Fluor 594 dye was microinjected into
one cell and 2 min later the number of cells receiving dye determined. Alexa Fluor 594
dye transferred to 8.8 ± 0.1 cells (n=6) in the absence of KT-5720 and 8.0 ± 0.2 cells
(n=6) in the presence of KT-5720 (0.5 µM), indicating that inhibiting Protein Kinase A
alone did not affect Cx40-mediated cell-to-cell dye transfer. When forskolin was added
to cells in the presence of 0.5 µM KT-5720 (5 min pre-incubation) dye transferred to 7.1
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± 0.1 cells (n=6) at 5 min, 8.6 ± 0.4 cells (n=6) at 30 min and 9.4 ± 0.2 cells (n=5) at 60
min (Fig.2. 10B). Thus, the inhibition of Protein Kinase A with KT-5720 significantly
inhibited the forskolin-dependent increase in Cx40-mediated cell-to-cell dye transfer
indicating that the forskolin-mediated increase in cell-to-cell dye transfer was Protein
Kinase A-dependent.
It has been shown previously that in frog erythrocytes TPA can effect a Protein
Kinase C-mediated phosphorylation of one of the adenylate cyclase components (Sibley
et al., 1986), suggesting that activation of Protein Kinase C may indirectly be responsible
for activating Protein Kinase A. Therefore to confirm that the forskolin-mediated
increase in cell-to-cell dye transfer in Cx40-transfected HeLa cells was not dependent on
the activation of Protein Kinase C, the Protein Kinase C inhibitor, Bisindolylmaleimide I
(35 µM) was added to Cx40-transfected HeLa cells prior to the addition of forskolin; this
concentration of Bisindolylmaleimide I was shown previously to prevent the PKCmediated inhibition of Cx43-mediated cell-to-cell dye transfer in Cx43-transfected HeLa
cells, demonstrating that 35 µM Bisindolylmaleimide I inhibits PKC in HeLa cells. A
single cell in a confluent monolayer of Cx40-transfected HeLa cells was microinjected
with Alexa Fluor 594 dye and the number of cells receiving dye was later determined as
described in Methods. Alexa Fluor 594 dye transferred to 8.6 ± 0.2 cells (n=5) in the
absence of forskolin or KT-5720, and 8.8 ± 0.3 cells (n=5) in the presence of 35 µM
Bisindolylmaleimide I indicating that Bisindolylmaleimide I alone did not alter Cx40 gap
junction function. When cells were pre-incubated with 35 µM Bisindolylmaleimide I and
100 µM forskolin, dye transferred to 12.8 ± 0.7 cells (n=5) at 5 min and 14.0 ± 0.3 cells
(n=5) at 30 min (Fig. 2.10B). Thus, inhibition of Protein Kinase C with
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Bisindolylmaleimide I did not prevent the forskolin-dependent increase in Cx40mediated cell-to-cell dye transfer, indicating that activation of Protein Kinase C was not a
required step in this forskolin-dependent increase in Cx40-mediated cell-to-cell dye
transfer.
Cx40 mediated cell-to-cell communication is regulated by adrenergic receptor
activation
Sympathetic activation is known to release the catecholamines epinephrine and
norepinephrine into the blood circulating in the heart. Catecholamines are known to
increase heart beat and blood pressure, dilate bronchial tubes, dilate some blood vessels
while contracting others, and alter insulin secretion and sweat production. These effects
of catecholamines occur via activation of adrenergic receptors. Two distinct types of
adrenergic receptors have been identified in the heart; alpha (α) and beta (β), and each
group has several sub-types. Catecholamines activate both α and β-adrenergic receptors,
activating second messenger systems that include adenylyl cyclase and phospholipase C.
α -adrenergic receptors activate the Protein Kinase C pathway, whereas β-adrenergic
receptors activate the Protein Kinase A pathway. To determine which adrenergic
receptor subtype effects the activation of Cx40-mediated cell-to-cell dye transfer, the
effect of α and β specific agonists on Cx40-mediated cell-to-cell dye transfer was
determined.
To determine whether activation of α -adrenergic receptors affects Cx40-mediated
cell-to-cell dye transfer, Cx40-transfected HeLa cells were incubated with the αadrenergic agonist Metaraminol (100 µM) for various times. Alexa Fluor 594 was then
microinjected into one cell and 2 min later the number of cells receiving dye was
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determined. Alexa Fluor 594 dye transferred to 8.8 ± 0.2 cells (n=16) in the absence of
metaraminol, whereas in the presence of metaraminol (100 µM) dye transferred to 7.6 ±
0.4 cells (n=14) at 5 min, 7.8 ± 0.5 cells (n=16) at 30 min and 8.1 ± 0.4 cells (n=14) at 60
min (Fig. 2.11). The α-1A receptor is known to be expressed in HeLa cells (Gibson and
Gilman, 2006), but the expression of other α-adrenergic receptor subtypes in HeLa cells
is not known. Therefore this absence of α-adrenergic receptor-mediated regulation in
Cx40-transfected HeLa cells may be due either to the lack of appropriate α-adrenergic
receptors in HeLa cells, or because Cx40-mediated cell-to-cell dye transfer is not
regulated by α-adrenergic receptor activation.
To determine whether activation of β-adrenergic receptors affects Cx40-mediated
cell-to-cell dye transfer, Cx40-transfected HeLa cells were incubated with the βadrenergic agonist Isoproterenol (10 µM); this concentration of Isoproterenol has been
shown to increase cAMP concentration and enhance gap junction communication in
cultures of rabbit gastric epithelial cells which was prevented by the β-blocker,
propranolol (Ueda et al., 1994). Alexa Fluor 594 was then microinjected into one cell
and 2 min later the number of cells receiving dye was determined. In the absence of
Isoproterenol Alexa Fluor 594 dye transferred to 9.0 ± 0.5 cells (n=5) at 0 min, 8.8 ± 0.7
cells (n=4) at 5 min, 9.6 ± 0.2 cells (n=6) at 30 min, and 9.1 ± 0.3 cells (n=5) at 60 min.
Alexa Fluor 594 dye transferred to 9.1 ± 0.2 cells (n=7) prior to the addition of
Isoproterenol, whereas in the presence of Isoproterenol (10 µM) dye transferred to 12.0 ±
0.3 cells (n=6) at 5 min, 11.6 ± 0.4 cells (n=6) at 30 min, and 11.0 ± 0.8 cells (n=5) at 60
min (Fig. 2.12A), where p ≤ 0.05 when compared to the number of cells receiving dye in
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the absence of Isoproterenol (Fig 2.12). Thus, β-adrenergic receptor activation affects an
increase in Cx40-mediated cell-to-cell dye transfer.
To determine whether the Isoproterenol-mediated increase in cell-to-cell dye
transfer in Cx40-transfected HeLa cells was mediated via activation of cAMP-dependent
Protein Kinase A, Cx40-transfected HeLa cells were pre-incubated with the PKA
inhibitor, KT-5720 prior to the addition of Isoproterenol. When cells were pre-incubated
with KT-5720 (0.5 µM) prior to the addition of Isoproterenol (10 µM), dye transferred to
8.9 ± 0.3 cells (n=10) at 5 min, 9.7 ± 0.5 cells (n=7) at 30 min and 9.2 ± 0.2 cells (n=10)
at 60 min (Fig. 2.12A). Thus, inhibition of Protein Kinase A with KT-5720 significantly
inhibited the Isoproterenol-dependent increase in Cx40-mediated cell-to-cell dye transfer,
indicating that this adenylate cyclase mediated activation of Cx40 required the activation
of Protein Kinase A.
To determine whether the Isoproterenol-mediated increase in cell-to-cell dye
transfer in Cx40-transfected HeLa cells could be further amplified by preventing the
dephosphorylation of any Protein Kinase A substrate, the protein phosphatase inhibitor
okadaic acid was added prior to the addition of Isoproterenol. Alexa Fluor 594 dye
transferred to 8.6 ± 0.2 cells (n=9) in the absence of okadaic acid, whereas in the
presence of okadaic acid (250 nM) dye transferred to 9.0 ± 0.3 cells (n=5), indicating that
okadaic acid did not alter the basal level of Cx40-mediated cell-to-cell dye transfer.
When cells were pre-incubated with okadaic acid (250 nM) prior to the addition of
Isoproterenol (10 µM) dye transferred to 9.0 ± 0.7 cells (n=7) at 5 min, 11.8 ± 0.1 cells
(n=6) at 30 min and 11.4 ± 0.6 cells (n=5) at 60 min (Fig. 2.12B). Thus, inhibition of
protein phosphatases with okadaic acid did not further amplify the Isoproterenol-

64
dependent increase in Cx40-mediated cell-to-cell dye transfer, indicating that the increase
seen in these experiments was not further enhanced by preventing the dephosphorylation
of Protein Kinase A substrate.
Three β-adrenergic receptor subtypes have been cloned and pharmacologically
(Dhein, 1998) classified into β-1, β-2 (Ablad B, 1974) and β -3 subtypes. The β-1
receptor subtype is the most abundant subtype in the heart and is known to coexist with
β-2 (del Monte F, 1993). In the human heart, the β1/ β2-subtype ratio is approximately
70:30 in the atria, and about 80:20 in the ventricles (Brodde, 1991); there is controversy
regarding the expression of β-3 receptor subtype in the human heart (Chamberlain et al.,
1999). Human cardiac β-1 and β-2 receptors are coupled to Gs which activate adenylyl
cyclase, increasing intracellular levels of cAMP that in turn activate cAMP dependent
Protein Kinase.
Tallman et al, 1977 have shown using radioactive ligand (1-[3H]
dihydroalprenolol) binding studies that HeLa cells contain some β-adrenergic receptors
and that the activity of these receptors increased with butyrate treatment. However, the
β-adrenergic receptors subtypes expressed in HeLa cells are still not known. Therefore to
determine which β-adrenergic receptor subtypes are expressed in HeLa cells, cells were
analyzed by Western Immunoblotting as shown in Fig. 2.13. The molecular weight of
the β receptors have been reported to be approximately 68 kDa but is known to exhibit a
lower molecular weight (~ 55 KDa) on SDS-PAGE gels depending on the extent of its
glycolysation (Xiang and Kobilka, 2003). No components were observed in the 68 kDa
or 55 kDa region for the β-1 subtype (Fig. 2.13A) and the β-3 subtype (Fig.2.13C) in both
untransfected and Cx40-transfected HeLa cells, suggesting that β-1 and β-3 subtypes
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were not expressed in HeLa cells. 55 kDa and 68 kDa components of the β-2 subtype
were observed in both untransfected and Cx40-transfected HeLa cells as seen in Fig.
2.13B. These data demonstrate that HeLa cells express only the β-2 adrenergic receptor
subtypes.
To further confirm that the β-1 receptor subtype was absent in HeLa cells, Cx40transfected HeLa cells were incubated for various times with the β-1 agonist Dobutamine
(Steinle et al., 2005). Alexa Fluor 594 dye transferred to 8.8 ± 1.6 cells (n=4) in the
absence of the β-1 agonist Dobutamine, whereas in the presence of Dobutamine (10 µM)
dye transferred to 9.0 ± 1.0 cells (n=3) at 5 min, 8.8 ± 1.0 cells (n=4) at 30 min and 8.0 ±
0.4 cells (n=4) at 60 min (Fig. 2.14); this concentration of dobutmaine is known to
activate β-1 receptor subtype in transfected HEK 293 cells and catalyses its
phosphorylation (Steinle et al., 2005). Thus, incubation with a β-1 agonist did not
increase cell-to-cell dye transfer in Cx40-transfected HeLa cells, likely due to the absence
of β-1 receptor subtype in these cells.
To further confirm that the β-2 receptor subtype was absent in HeLa cells, Cx40transfected HeLa cells were incubated for various times with the β-2 agonist Salbutamol
(Cramb, 1986). Alexa Fluor 594 dye transferred to 8.6 ± 0. 3 cells (n=10) in the absence
of Salbutamol, whereas in the presence of Salbutamol (50 µM) dye transferred to 10.7 ±
0. 6 cells (n=10) at 5 min, 11.8 ± 0.6 cells (n=10) at 30 min and 12.4 ± 0.5 cells (n=8) at
60 min (Fig. 2.15); these concentrations of Salbutamol have been shown previously to
inhibit propranolol uptake in BC3H1 cells (Cramb, 1986). These data demonstrates that
β-2 receptor activation effects an increase in Cx40-mediated cell-to-cell dye transfer in
these cells that was indistinguishable from that effected by Isoproterenol (Fig. 2.12A).
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To further confirm that the β-3 receptor subtype was absent in HeLa cells, Cx40transfected HeLa cells were incubated for various times with the β-3 agonist BRL 37344
(Pott et al., 2006). Alexa Fluor 594 dye transferred to 9.2 ± 0. 3 cells (n=11) in the
absence of the β-3 agonist BRL 37344, whereas in the presence of BRL 37344 (10 µM),
dye transferred to 9.6 ± 0. 4 cells (n=11) at 5 min, 8.7 ± 0.3 cells (n=9) at 30 min and 9.3
± 0.3 cells (n=11) at 60 min (Fig.2.16.); this concentration of BRL 37344 is known to
activate β-3 receptor subtype in choroidal endothelial cells and is also responsible for the
phosphorylation of Akt, Src, and MAPK (Pott et al., 2006). Thus, activation by β-3
receptor agonists was without effect on Cx40-transfected HeLa cells likely due to the
absence of the receptor in these cells. These data demonstrate that in Cx40-transfected
HeLa cells, the β-2 receptor subtype appears to be responsible for the Isoproterenoldependent increase in Cx40-mediated cell-to-cell dye transfer.
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Discussion
The present study has demonstrated that β-adrenergic receptor activation is tightly
coupled to the regulation of gap junctions comprised of Cx40. Thus, Cx40-mediated
cell-to-cell dye transfer was increased following the activation of several steps in the βadrenergic receptor signaling pathway which in the intact heart would result in an
increase in both electrical communication and an increase in cell-to-cell movement of
metabolites, ions and second messengers. It has been shown previously that addition of
the cell permeant cAMP analog, 8-bromo cAMP effected an increase in cell-to-cell dye
transfer in Cx40-transfected SkHep cells (Van-Rijen et al., 2000), but the pathway by
which this cAMP analog effected this activation of Cx40 gap junctions was not
determined. The data reported here has identified the pathway by which this action of a
cAMP analog on cell communication is effected.
In the atria, catecholamines are released during psychological stress (Brodde and
Zerkowski, 1989), exercise (Kato et al., 2006) and sex (Schouwenberg et al., 2006) and
also its release is increased during a number of patho-physiological conditions associated
with arrhythmias in the heart (Lameris et al., 2000; Mackins et al., 2006). Catecholamines
are known to activate both α- and β- adrenergic receptors. β-adrenergic stimulation
mediates an increase in heart rate that is much greater than that effected via α-adrenergic
stimulation. Since electrical coupling is mediated via gap junctions in the heart, and Cx40
is abundantly expressed in the atria where the action potential originates, it was important
to understand whether catecholamines regulated Cx40-mediated cell-to-cell
communication. As shown in this study, the β-adrenergic-dependent increase in Cx40mediated cell-to-cell communication may be responsible for the origin of atrial
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fibrillation, because only the Cx40-mediated conduction is shown to be increased,
whereas the conduction mediated by the only other major connexin in the atria Cx43 has
been shown previously to not be affected by β-adrenergic agonists (Kwak et al., 1995).
To demonstrate that β-adrenergic receptor activation is tightly coupled to the
regulation of Cx40 gap junctions, β-adrenergic receptors were activated by Isoproterenol
in Cx40-transfected HeLa cells. This in turn resulted in a Cx40-mediated increase in
cell-to-cell dye transfer which was prevented by inhibiting Protein Kinase A (Fig.
2.12A). To determine whether this β- adrenergic receptor-mediated increase in Cx40mediated cell-to-cell dye transfer was mediated via the adenylate cyclase/cAMP/PKA
pathway, each step in the pathway was activated independently, and its role in Cx40mediated cell-to-cell dye transfer determined. Thus, activation of adenylate cyclase by
forskolin was associated with an increase in Cx40-mediated cell-to-cell dye transfer
(Fig.2.10B), indicating that the β- adrenergic receptor-mediated increase in Cx40mediated cell-to-cell dye transfer was likely mediated via adenylate cyclase. Cell
permeant cAMP analogs dibutyryl cAMP or 8-bromo cAMP resulted in an increase in
Cx40-mediated cell-to-cell dye transfer (Fig. 2.9) which is consistent with previous
reports (Van-Rijen et al., 2000), indicating that the β- adrenergic receptor-mediated
increase in Cx40-mediated cell-to-cell dye transfer occurred via the cAMP pathway. The
requirement for PKA was shown by using the PKA-selective inhibitor KT-5720, which
prevented the β-adrenergic receptor-mediated increase in Cx40-mediated cell-to-cell dye
transfer (Fig. 2.12A). The concentration of KT-5720 used in these experiments (0.5 µM)
is known to specifically inhibit PKA because at higher concentrations (>2 µM) KT-5720
is also known to inhibit PKC and Protein Kinase G (PKG). Although KT-5720 did not
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completely inhibit the Isoproterenol-dependent increase in Cx40-mediated cell-to-cell
dye transfer, it did significantly decrease the Isoproterenol-dependent increase in Cx40mediated cell-to-cell dye transfer. Collectively these data showed that the β- adrenergic
receptor-mediated increase in Cx40-mediated cell-to-cell dye transfer occurred via the
adenylate cyclase/cAMP/PKA signaling pathway.
Although, both Cx40 and Cx43 are expressed in the atria of the heart, it is
unresolved as to whether or not Cx40/Cx43 form functional heterotypic gap junctions.
Numerous studies have reported previously that Cx40 and Cx43 do not form functional
heterotypic gap junctions (Bruzzone et al., 1993; Elfgang et al., 1995; Haubrich et al.,
1996) suggesting that they are regulated independently in the atria. However a smaller
number of studies have shown that Cx40/Cx43 form lower amounts of heterotypic gap
junctions (Cottrell and Burt, 2001; Valiunas et al., 2000). Regulation of Cx43 by direct
β-adrenergic receptor activation is still unclear; it has been shown that PKA activation
with 8-bromo cAMP, as occurs during β-adrenergic receptor activation did not alter
Cx43-mediated cell-to-cell transfer of fluorescent dyes in Cx43-transfected SKHep1 cells
(Kwak et al., 1995) and neonatal rat cardiomyocytes (Kwak and Jongsma, 1996),
suggesting that PKA activation via the β- adrenergic receptor pathway does not modify
the permeability properties of Cx43 gap junctions. Cx45 is expressed at lower levels
compared to Cx40 or Cx43 in the atria of the human heart (Davis et al., 1995). Although
Cx40 is known to form heterotypic gap junctions with Cx45, there may be fewer of these
channels expressed in the atria due to the low expression level of Cx45 in this region of
the heart. Like Cx43, the regulation of Cx45 by direct β-adrenergic receptor activation is
still unclear. It has been shown that PKA activation with 8-bromo cAMP, as occurs

70
during β-adrenergic receptor activation decreased gap junction conductance in Cx45transfected HeLa cells (van-Veen et al., 2000). Although PKA regulated Cx45 gap
junction conductance in these cells, analyzing the potential consensus phosphorylation
sites for several protein kinases in Cx45 sequence using the Expasy Prosite-Scan database
did not yield any consensus sequences for PKA in Cx45 (Fig. 2.17).
This data reported here has demonstrated for the first time that β-adrenergic
receptor activation by Isoproterenol effected an increase in Cx40-mediated cell-to-cell
dye transfer, suggesting that the β-adrenergic receptor activation-mediated increase in
heart rate may be mediated in part via the action of this signaling pathway on Cx40containing gap junctions in the conduction pathway in the atria. Since it has been shown
previously that addition of cell permeant cAMP analog, 8-bromo cAMP effected an
increase in both Cx40-mediated cell-to-cell dye transfer and Cx40-mediation electrical
conductance in transfected SkHep cells (Van-Rijen et al., 2000), it can be assumed that βadrenergic activation may increase Cx40-mediated gap junction conductance. This
indicates differential modulation of all three atrial connexins following β-adrenergic
activation in the heart.
The three β-receptor subtypes expressed in the human heart are β-1, β-2 and β-3.
Tallman et al, 1977 have shown using radioactive ligand (1-[3H] dihydroalprenolol)
binding studies that HeLa cells contain β-adrenergic receptors. When cells were grown in
culture in the presence of butyrate, the number of β-adrenergic receptors, cyclic AMP
levels, and adenylate cyclase activation by Isoproterenol was increased (Tallman et al.,
1977). This sodium butyrate-mediated increase in β-adrenergic receptors may be due to
the synthesis of new receptor molecules, because this increase was prevented by the
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protein synthesis inhibitor cycloheximide (Schmitt et al., 1978). The β-adrenergic
receptors subtypes expressed in HeLa cells are still not known. Therefore to determine
the β-adrenergic receptor subtypes expressed in HeLa cells, cells were analyzed by
Western Immunoblotting as shown in Fig. 2.13. The molecular weight of the
glycosylated β-adrenergic receptor is 68 kDa, whereas the non-glycosylated receptor has
a mass of 55 kDa. Both the unglycosylated and glycosylated forms of β-adrenergic
receptor were observed in both untransfected and Cx40-transfected HeLa cells when
probed for the β-2 subtype as seen in Fig. 2.13B. These components were absent when
probed for β-1 or β-3 subtypes indicating that only the β-2 adrenergic receptor subtype
was expressed in the HeLa cells used in these studies. The β-2 receptor-specific agonist
Salbutamol effected an increase in Cx40-mediated cell-to-cell dye transfer, indicating
that β-2 receptor subtype was functionally responsible for the Isoproterenol-dependent
increase in Cx40-mediated cell-to-cell dye transfer in transfected HeLa cells reported
here. Although this does not directly correlate to the heart where all three β-adrenergic
receptor subtypes are expressed, it does demonstrate that activation of β-2 receptors is
coupled to an increase in Cx40-mediated increase in cell-to-cell communication.
Both α-1 and α-2 adrenergic receptors are expressed in the human heart, while in
agreement with our data reported here, the α-2 adrenergic receptor subtypes α-2a and α2b are the only ones shown previously to be expressed in HeLa cells (Gibson and
Gilman, 2006). The α-1 adrenergic receptor agonist Metaraminol did not affect Cx40mediated cell-to-cell dye transfer, indicating that α-2 adrenergic receptor activation does
not regulate Cx40-mediated cell-to-cell dye transfer in Cx40-transfected HeLa cells.
Although this does not directly correlate to the heart where all α-adrenergic receptor
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subtypes are expressed, again it does demonstrate that Cx40-mediated cell-to-cell
communication is not regulated by α-2 receptor activation in the heart.
Potential consensus phosphorylation sites for several protein kinases have been
identified following analysis of the Cx40 sequence using the Expasy Prosite-Scan
database. Together with casein kinase II and Protein Kinase A, five consensus sequences
were identified for Protein Kinase C (Table 2.1). Activation of Protein Kinase C by ATP
(Fig. 2.7A) via the purinergic receptor pathway or direct activation of Protein Kinase C
by the phorbol ester (TPA) (Fig. 2.7B) did not affect Cx40-mediated cell-to-cell dye
transfer in Cx40-transfected HeLa cells indicating that activation of PKC does not appear
to affect the permeability properties of Cx40 gap junctions. It has been shown in this
study and in previous studies in our laboratory (Lurtz et al., 2006) that Cx43-mediated
cell-to-cell dye transfer was transiently inhibited by ATP via activation of PKC (Fig. 2.6).
PKC activation by the phorbol ester PMA has been shown to increase gap junctionmediated electrical conductance in Cx45-transfected HeLa cells (van-Veen et al., 2000),
and analysis of the potential consensus phosphorylation sites for several protein kinases
in the Cx45 sequence using the Expasy Prosite-Scan database identified five consensus
sequences for PKC (Fig. 2.17). This data demonstrates that unlike Cx43 or Cx45, Cx40
gap junctions do not appear to be regulated by Protein Kinase C although consensus
phosphorylation sites for this protein kinase are present in the Cx40 sequence, suggesting
differential modulation of these atrial connexins in the heart.
In summary, our data provides evidence for the first time that β-adrenergic
receptor activation is tightly coupled to the regulation of gap junctions comprised of
Cx40 and that it is PKA-dependent. This β-adrenergic receptor-dependent increase in
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Cx40-mediated cell-to-cell permeability may be responsible for the β-adrenergic
activation-mediated increase in heart rate during physiological and pathophysiological
conditions.
Abnormal Ca2+ homeostasis is known to be responsible for cardiac contractility
dysfunction (Morgan, 1991). Changes in the expression or function of the Ca2+regulatory molecules such as sarcoplasmic reticulum Ca2+-adenosine triphosphatase
(SERCA), phospholamban, sarcolemmal Na+/Ca2+ exchanger (NCX), sarcolemmal Ltype Ca2+ channels, and ryanodine receptors are known to result in abnormal Ca2+
homeostasis in failing hearts (Hasenfuss et al., 1999; Mercadier et al., 1990; Meyer et al.,
1995; Movsesian et al., 1994). β-blockers are currently thought to decrease heart rate by
acting on the SERCA, and its regulatory protein phospholamban, in turn normalizing
intracellular Ca2+-handling in failing hearts. It has been shown that in tropomodulinoverexpressing transgenic mice that suffer from dilated cardiomyopathy, there was a
reduction of SERCA and an increase in Na+/Ca2+ exchanger (NCX) protein levels (Plank
et al., 2003). When these mice were treated with the β-blocker propranolol the alterations
in SERCA and NCX protein levels were reversed thus restoring normalized intracellular
Ca2+-handling (Plank et al., 2003). Others have shown that in patients with congestive
heart failure there was a reduction in SERCA, phospholamban, and Na+/Ca2+ exchanger
protein levels, when these patients were treated with the β-blockers the alterations in
SERCA, phospholamban, and NCX protein levels were reversed thus restoring
normalized intracellular Ca2+-handling (Kubo et al., 2001). Collectively these studies
indicate that β-blockers normalize intracellular Ca2+-handling in failing hearts by acting
on Ca2+-regulatory proteins.
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Although drugs such as β-blockers have had success in the treatment of atrial
fibrillation by suppressing β-adrenergic receptor signaling and by intracellular Ca2+handling, the downstream target of their action is still not fully understood. This study
clarifies that β-adrenergic receptors are likely tightly coupled to the regulation of atrial
gap junctions suggesting that the use of β-blockers may prevent the β-adrenergic
receptor-dependent increase in gap junction-mediated coupling thus decreasing electrical
conduction in the heart. Since atrial fibrillation is associated with alterations in atrial
conduction mediated by gap junctions, gap junctions present an interesting alternative
potential therapeutic target. In this case drugs that specifically inhibit or close Cx40 gap
junctions might be of value when used together with β-blockers to decrease electrical
conduction thus assisting in the treatment of atrial fibrillation.
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Table 2.1: Several putative Cx40 consensus phosphorylation sequences were identified
for casein kinase II, Protein Kinase C and Protein Kinase A using Expasy prosite scan
database.
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Table 2.1
Protein Kinase

Amino acid

Casein kinase II

39-42
44-47
160-163
221-224
272-275
99-101
201-203
287-289
337-339
346-348
340-343

Protein Kinase C

Protein Kinase A

Consensus
phosphorylation sites
taae
swgd
tame
slae
spde
tvr
tek
srk
sdk
ssk
rrls

83

Table 2.2: Several receptors, receptor ligands, activators and inhibitors of various protein
kinases/phosphatases.
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Table 2.2
Receptors
Purinergic receptor
α – adrenergic
receptor
β – adrenergic
receptor
β –1 adrenergic
receptor
β –2 adrenergic
receptor
β –3 adrenergic
receptor

Agonists
ATP
Metaraminol
Isoproterenol
Dobutamine
Salbutamol
BRL-37344

Protein
Kinases/
phosphatases
PKC

Activators

Inhibitors

TPA

Adenylate
cyclase
PKA
Protein
phosphatases 1
and 2A

forskolin

Bisindolylmaleim
ide I
-

-

KT-5720
Okadaic acid
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Fig. 2.1: Expression of Cx40 in HeLa cells transfected with rat Cx40. Immunolabeling
of Cx40 in Cx40 transfected HeLa cells. Panels A, C and E show phase images while
Panels B, D and F show Rhodamine fluorescence images. (A) & (B) Cx40-transfected
HeLa cells immunolabeled with both primary and secondary antibodies for Cx40.
Punctate labeling of Cx40 is seen in panel B (arrows) after incubation with anti-Cx40
primary antibody and rhodamine-conjugated secondary antibody. (C) & (D) Cx40transfected HeLa cells labeled with secondary antibody only. (E) & (F) untransfected
HeLa cells immunolabeled with both anti-Cx40 primary antibody plus rhodamineconjugated secondary antibody. No punctuate labeling of Cx40 was observed in panels D
& F. Panel I: Western blot of Cx40. Lane 1 contains cell lysate from wild type
untransfected HeLa cells, lanes 2 and 3 contain cell lysates from Cx40-transfected HeLa
cells. 50 µg of protein was loaded per lane. A 40 kDa band was seen in Cx40-transfected
HeLa cells (lanes 2 and 3) which was absent in untransfected HeLa cells (lane 1).
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Fig. 2.2: Cell-to-cell dye transfer in Cx40-transfected HeLa cells. Cell-to-cell dye
transfer mediated by untransfected (bar 1) or Cx40-transfected HeLa cells (bar 2). Alexa
Fluor 594 (1 mM) was microinjected into one cell and 2 min later the number of cells
receiving dye was determined. Pre-incubation with the gap junction blocker,
carbonexolone (35 µM CBX) inhibited the Cx40-mediated cell-to-cell dye transfer (bar
3). * p ≤ 0.05 significantly different from Cx40 transfected HeLa cells.
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Fig. 2.3: Cell-to-cell transfer of Alexa Fluor 594 dye in Cx40-transfected HeLa cells.
Alexa Fluor 594 (1 mM) was microinjected into one cell and the number of cells
receiving dye was determined at various times after dye injection.
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Fig. 2.4: Cx40 amino acid sequence with the putative transmembrane regions (TM1TM4) and several putative consensus phosphorylation sequences for casein kinase II,
Protein Kinase C and Protein Kinase A.
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Figure 2.4

TM 1
mgdwsflgef leevhkhstv igkvwltvlf ifrmlvlgta aesswgdeqa dfrcdtiqpg
TM 2
cqnvcydqaf pishirywvl qiifvstpsl vymghamhtv rmqekqklre aekakeaggt
TM 3
gtyeylaeka elscwkevng kivlqgtlln tyvctilirt amevafmvgq yllygifldt
TM 4
lhvcrrspcp hpvncyvsrp teknvfivfm mavaglslfl slaelyhlgw kkirqrlaks

rqgdkhqllg pstslvqglt pppdfnqclk nspdekffsd fsnnmgsrkn pdplateevp

nqeqipeegf ihtqygqkpe qpsgasaghr fpqgyhsdkr rlskasskar sddlsv
CKII in pink, PKC in green, PKA in blue
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Fig. 2.5: Schematic diagram of the Purinergic receptor pathway. ATP binds to the
purinergic receptor and activates phospholipase C (PLC) which hydrolyzes
phosphatidylinositol 4,5-bisphosphate (PIP2) to inositol 1,4,5-triphosphate (IP3) and
diacylglycerol (DAG). DAG activates Protein Kinase C (PKC) which in turn
phosphorylates various residues in connexins thus altering gap junction function, while
IP3 binds to ER receptors to effect the release of Ca2+ from this intracellular organelle.
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Fig. 2.6: Effect of the purinergic receptor agonist ATP on Cx43 mediated cell-to-cell dye
transfer. ATP (25 µM ATP ) was added to a monolayer Cx40-transfected HeLa cells
when Alexa Fluor 594 (1mM) was microinjected into one cell prior to (Control) or at 5,
15 or 30 min after ATP addition; 2 min after each microinjection the number of cells
receiving dye were counted. * p ≤ 0.05 significantly different from Control.

97

Figure 2.6

Number of cells receiving dye

18
16
14
12
10

*
*

8
6
4
2
0
Control

5 min
ATP

15 min
ATP

Time in min

30 min
ATP

98

Fig. 2.7: Effect of the purinergic receptor agonist ATP on Cx40 mediated cell-to-cell dye
transfer. Effect of (A) ATP or (B) TPA on Cx40 mediated cell-to-cell dye transfer in
HeLa cells. A monolayer of Cx40-transfected HeLa cells was incubated with either ATP
(25 µM) or TPA (81 nM). At various intervals following the addition or ATP or TPA,
Alexa Fluor 594 was microinjected into one cell and 2 min later the number of cells
receiving dye was counted.
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Fig. 2.8: Schematic diagram of the β-adrenergic receptor pathway. Beta-adrenergic
receptor agonists bind to β -adrenergic receptors resulting in the activation of adenylate
cyclase (AC) which catalyzes the conversion of ATP to cAMP. Subsequently, cAMP
activates Protein Kinase A (PKA) which in turn catalyzes the phosphorylation of various
residues in connexins that may or may not affect gap junction function.
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Fig. 2.9: Effect of cAMP analogs on Cx40 mediated cell-to-cell dye transfer. A
monolayer of Cx40-transfected HeLa cells were either incubated with 0.5 mM dibutyryl
cAMP or 1 mM 8-bromo cAMP. At various intervals following the addition of the cAMP
analog, Alexa Fluor 594 was microinjected into one cell and 2 min later number of cells
receiving dye was counted. * p ≤ 0.05 from control.
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Fig. 2.10: Effect of forskolin on Cx40 mediated cell-to-cell dye transfer. (A) Monolayer
of Cx40-transfected HeLa cells were incubated with forskolin (10 or 100 µM). (B) Cells
were pre-incubated with KT-5720 (500 nM) or Bisindolylmaleimide I (35 µM) prior to
the addition of forskolin. At various intervals following the addition of forskolin, Alexa
Fluor 594 was microinjected into one cell and 2 min later the number of cells receiving
dye was counted. * p ≤ 0.05 significantly different from cells receiving dye at zero time
(i.e. prior to the addition of forskolin). ** p ≤ 0.05 significantly from cells receiving dye
in the presence of forskolin.
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Fig. 2.11: Effect of the α-adrenergic agonist metaraminol on Cx40 mediated cell-to-cell
dye transfer. Cx40-transfected HeLa cells were incubated with metaraminol (100 µM)
for various times. At various intervals following the addition of metaraminol, Alexa
Fluor 594 was microinjected into one cell and 2 min later the number of cells receiving
dye was counted.
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Fig. 2.12: Effect of the β-adrenergic agonist Isoproterenol on Cx40 mediated cell-to-cell
dye transfer. Cx40-transfected HeLa cells were pre-incubated with the (A) PKA inhibitor
KT-5720 (500 nM), or (B) phosphatase inhibitor Okadiac acid (250 nM) before addition
of Isoproterenol (10 µM). At various intervals following the addition of Isoproterenol,
Alexa Fluor 594 was microinjected into one cell and 2 min later the number of cells
receiving dye was counted. * p ≤ 0.05 significantly different from cells receiving dye at
zero time.
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Fig. 2.13: Western blots of β-adrenergic receptor subtypes in untransfected or Cx40transfected HeLa cells. (A) No bands at 55 or 68 kDa were observed in either
untransfected (lane 1) or Cx40-transfected HeLa cells (lanes 2) when incubated with β-1
adrenergic receptor antibody and goat anti-rabbit HRP conjugated secondary antibody.
(B) 55 kDa and 68 kDa bands were observed in both untransfected (lane 1) and Cx40transfected HeLa cells (lanes 2) when incubated with β-2 adrenergic receptor antibody
and goat anti-rabbit HRP conjugated secondary antibody. (C) No bands at 55 or 68 kDa
were observed in either untransfected (lane 1) or Cx40-transfected HeLa cells (lanes 2)
when incubated with β-3 adrenergic receptor antibody and donkey anti-goat HRP
conjugated secondary antibody.
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Fig. 2.14: Effect of the the β-1 adrenergic agonist Dobutamine on Cx40 mediated cell-tocell dye transfer. Cx40-transfected HeLa cells were incubated with the β-1 adrenergic
receptor agonist Dobutamine (10 µM) for various times. At various intervals following
the addition of Dobutamine, Alexa Fluor 594 was microinjected into one cell and 2 min
later the number of cells receiving dye was counted.
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Fig. 2.15: Effect of the β-2 adrenergic receptor agonist Salbutamol on Cx40 mediated
cell-to-cell dye transfer. Cx40-transfected HeLa cells were incubated with the β-2
adrenergic receptor agonist Salbutamol (50 µM) for various times. At various intervals
following the addition of Salbutamol, Alexa Fluor 594 was microinjected into one cell
and 2 min later the number of cells receiving dye was counted. * p ≤ 0.05 significantly
different from control (i.e. prior to the addition of Salbutamol).
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Fig. 2.16: Effect of the β-3 adrenergic agonist BRL 37344 on Cx40 mediated cell-to-cell
dye transfer. Cx40-transfected HeLa cells were incubated with the β-3 adrenergic
receptor agonist BRL 37344 (10 µM). At various intervals following the addition of BRL
37344, Alexa Fluor 594 was microinjected into one cell and 2 min later the number of
cells receiving dye was counted.
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Fig. 2.17: Cx45 amino acid sequence with the putative transmembrane regions (TM1TM4) and several concensus sequences for casein kinase II (highlighted in green) and
Protein Kinase C are highlighted in pink while concensus sequences for both Protein
Kinase C and casein kinase II are highlighted in yellow.
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Figure 2.17
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CHAPTER 3

Regulation of Connexin40 Gap junctions by Intracellular Calcium
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Introduction
Electrical and intercellular communication in the heart is mediated by gap
junctions, non-specific plasma membrane channels that connect the cytoplasm of
adjacent cells (Uehara and Burnstock, 1970). Alterations in gap junction function has
been implicated in various diseases of the heart that are associated with altered electrical
communication such as arrhythmias, myocardial infarction, atrial fibrillation,
hypertension, valvular dysfunction, heart failure and hyperthyroidism (Cooklin et al,
1997; Kaprielian et al, 1998) indicating the importance of functional gap junctions for
maintaining normal cardiac function. Gap junctions are comprised of proteins called
connexins that form intercellular channels (Laird, 1996; Musil and Goodenough, 1993).
Each connexin consists of four transmembrane domains with the amino (N-) and carboxy
(C-) termini in the cytoplasm. Twenty highly related human connexin genes have been
identified with their nomenclature based on their expected molecular weight in
kilodaltons (kDa). Gap junctions are known to be regulated by voltage, intracellular pH,
phosphorylation state, intracellular calcium ([Ca2+]i) and more recently it is recognized
that associated proteins may also play an important role in regulating gap junctions. The
major connexins expressed in the atria of the heart include connexin 40 (Cx40) and
connexin 43 (Cx43).
Gap junctions are regulated by [Ca2+]i, one of the most important intracellular
signaling molecules (Burt, 1987a; Peracchia, 2004; Peracchia and Girsch, 1985). In the
heart, maintaining Ca2+ homeostasis (influx and efflux equilibrium) is important for
excitation-contraction coupling of cardiac muscle (Zhang et al., 2001), activating various
signaling pathways (El-Armouche et al., 2006), enzymes (Guo et al., 2006), genes
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(Weissgerber et al., 2006), and regulating a number of important ion channels in both the
plasma membrane and sacroplasmic reticulum (Kockskamper and Pieske, 2006). As in all
other cell types, there is a 104 gradient of Ca2+ across the plasma membrane, with
extracellular [Ca2+] ([Ca2+]o) in the range of ~ 1-2 mM while [Ca2+]i is in the range of ~
100 – 200 nM. Most of the intracellular Ca2+ is stored in the sacroplasmic reticulum
(SR); release of this Ca2+ into the cytoplasm during excitation-contraction coupling
occurs via SR Ca2+ release channels termed ryanodine receptors and to a smaller extent
via IP3 receptors (Berridge, 1993).
During ischemia there is an increase in [Ca2+]i in cardiomyocytes (Watts et al.,
1980) which may be due to the influx of Ca2+ from the extracellular space via the
Na+/Ca2+ exchanger [during ischemia there is increase in intracellular [H+] and [Ca2+]
(Lazdunski et al., 1985)], so removal of [H+] by the plasma membrane Na+/ H+
exchanger would lead to Na+ influx which would in turn trigger Ca2+ influx via the
Na+/Ca2+ exchanger). Increased [Ca2+]i can also result from an influence of Ca2+
mediated by plasma membrane store-operated Ca2+ channels, or a decreased rate of
removal of cytosolic Ca2+ by the sarcoplasmic reticulum during ischemia (Chen et al.,
1998; Moreau et al., 2005). This increased [Ca2+]i is known to result in a decrease in gap
junction-mediated electrical (gap junction conductance) and biochemical communication
(gap junction permeability) in cardiomyocytes (Burt, 1987a; White et al., 1990).
The major connexins present in cardiomyocytes are Cx40, Cx43 and Cx45. Cx43,
the major connexin in the heart is known be to inhibited by elevated [Ca2+]i (Crow et al.,
1994). Previously our laboratory has demonstrated that Cx43-mediated cell-to-cell dye
transfer is inhibited by elevated [Ca2+]i with an IC50 of approximately 350 nM in Cx43-

123
transfected HeLa cells. Although Cx40 is most abundantly expressed in the atria, its
possible regulation by [Ca2+]i is unknown. Therefore we have examined the effect of
[Ca2+]i on Cx40 gap junctions and the mechanisms underlying any action of [Ca2+]i on
Cx40 gap junction permeability. Because cardiomyocytes express at least three different
connexins, namely Cx40, Cx43 and Cx45 they do not provide an optimal system for
determining how the functional properties of individual cardiac connexins are regulated.
Thus, to study the regulation of gap junctions comprised of Cx40 alone, studies were
conducted using this connexin that was stably transfected in a communication-deficient
HeLa cell line. This study, which is the first to examine the effect of [Ca2+]i on Cx40 gap
junction-mediated cell-to-cell dye transfer, reveals that a sustained elevation in [Ca2+]i
caused a partial inhibition of Cx40 gap junction-mediated cell-to-cell dye transfer with an
IC50 ~ 500 nM that appears to be Calmodulin-dependent.
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Methods
Materials
Dulbecco’s Modified Eagles Medium (DMEM), Hank’s balanced salt solution
without divalent cations (HBSS--) or with divalent cations (HBSS++), ATP, CaCl2,
Calmidazolium, Ionomycin and Thapsigargin were purchased from Sigma-Aldrich
Chemical Co. (St. Louis, MO). Fetal bovine serum (FBS) was purchased from Hyclone
(Logan, UT). G418 (Geneticin) and Hygromycin B were obtained from Invitrogen
(Carlsbad, CA). Fura-2 AM, and Alexa Fluor 594 were from Molecular Probes (Eugene,
OR). Connexin40 and Donkey anti-goat IgG-HRP antibodies were from Santa Cruz
Biotechnology, Inc., (Santa Cruz, CA). KT-5720 was from Tocris Bioscience (Ellisville,
MI). Bisindolymaleimide I and Lavendustin C were from EMD Biosciences (San Diego,
CA).
HeLa cell culture
Cx40 stably transfected HeLa cells generously provided by Dr. Richard Veenstra
(SUNY Upstate Medical University, Syracuse, NY) were grown as a single monolayer on
25 mm coverslips in 35 mm culture dishes until confluent. Cells were grown in DMEM
supplemented with 10% v/v fetal bovine serum and Pen-Strep (100 U/ml Penicillin and
0.1 mg/ml Streptomycin) with or without 0.025 mg/ml (G418) geneticin, and were kept at
37ºC in a 5% CO2 atmosphere maintained with nearly 100% relative humidity.
Membrane isolation and Western Immunoblotting
Membranes were isolated from untransfected of Cx40-transfected HeLa cells as
described previously in Chapter 2.
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Microinjection
Cell-to-cell communication was detected by measuring the extent of cell-to-cell
transfer of Alexa Fluor 594 dye as described previously in Chapter 2.
Intracellular Ca2+ measurements
Cx40-transfected HeLa cells were loaded with Fura-2-AM (1 mM) in the dark for 45
min at room temperature. The buffer containing Fura-2 was then removed; the cells were
rinsed with fresh HBSS++ buffer, then incubated an additional 30 min in 2 ml HBSS++
buffer to allow for complete hydrolysis of the intracellularly loaded Fura-2 AM.
Intracellular Ca2+ was measured ratiometrically (340 nm /380 nm) with Fura-2
throughout the experiment. Ca2+ concentrations were determined as described previously
by Grynkiewicz et al, 1984. The Ca2+ concentration was calculated using the equation:

[Ca2+] = Kd

Where:

(R-Rmin) (Fmin)
(Rmax-R)(Fmax)

Kd = 0.224 µM (Kd is the Ca2+ dissociation constant of Fura-2)
R = fluorescence intensity ratio Fλ1/F λ2, in which λ1 (340 nm) and λ2
(380 nm) are the fluorescence detection wavelengths for the ion-bound and
ion-free indicator, respectively
Rmin = fluorescence intensity ratio at 10 nM Ca2+;
Rmax = fluorescence intensity ratio at 39 µM Ca2+;
Fmin = fluorescence intensity λ 380 10 nM Ca2+;
Fmax = fluorescence intensity λ 380 at 39 µM Ca2+;
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Raising intracellular Ca2+
Intracellular Ca2+ concentration ([Ca2+]i) was elevated in Cx40-transfected HeLa cells
by adding ionomycin (2 µM) and then increasing extracellular Ca2+ concentration
2+

([Ca ]o) from 1.8 to 21.8 mM by adding CaCl2 to the bathing buffer (Hank’s balanced

salt solution with divalent cations (HBSS++).
Data analysis
The data are expressed as Mean ± SEM. In cell-to-cell dye transfer assays, n reflects
the number of times the experiments were performed. Differences between groups were
analyzed by ANOVA. Student’s paired t-test was used to calculate levels of significance,
with p-value below 0.05 indicating significance. Statistical significance is indicated in the
graphs with a ‘*’ for p ≤ 0.05.
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Results
Expression of Cx40 in transfected HeLa cells
To demonstrate the expression of Cx40 by Western Immunoblotting, membranes
were isolated from Cx40-transfected HeLa cells, proteins were separated on SDS-PAGE
gels and immunolabeled with Cx40 antibodies as described in Methods (Fig.3.1). A
single component of 40 kDa was observed only in Cx40-transfected HeLa cells as shown
previously (Vozzi et al., 1999b) (Fig.3.1 lane 2 compared with lane 1), demonstrating the
expression of this connexin in the Cx40-transfected HeLa cells used in this study. There
was a non-specifically immunolabeled band at 52 kDa in both untransfected wild type
and Cx40-transfected HeLa cells.
A sustained increase in intracellular Ca2+ causes a decrease in Cx40-mediated cell-tocell dye transfer
In the heart, a sustained increase in [Ca2+]i occurs during myocardial ischemia
where [Ca2+]i increases from ~ 300 nM (resting) to ~ 900 nM (20 min ischemia) in
perfused rat hearts (Marban et al., 1990). An ischemia-mediated increase in [Ca2+]i is
known to decrease gap junction-mediated electrical (gap junction conductance) and
biochemical communication (gap junction permeability) in cardiomyocytes (Burt, 1987a;
White et al., 1990). Cardiomyocytes express at least 3 different connexins, namely Cx40,
Cx43 and Cx45. The question addressed here is whether inhibition of these connexins are
responsible for this elevated [Ca2+]i -mediated inhibition of gap junctions in
cardiomyocytes during ischemia. Cx43, the major connexin in the heart is known be to
inhibited by elevated [Ca2+]i (Crow et al., 1994) but the possible regulation of the major
connexin in the atria Cx40 by [Ca2+]i is unknown, and was the focus of this study. To
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determine whether like Cx43 cell-to-cell dye transfer mediated by Cx40 was inhibited by
a sustained increase in [Ca2+]i, Cx40-transfected HeLa cells were incubated with the Ca2+
ionophore ionomycin and extracellular Ca2+ was then increased from 1.8 mM
(physiological [Ca2+]o) to 21.8 mM (this [Ca2+]o was required to increase [Ca2+]i to micromolar levels as occurs during ischemia in the heart). This high calcium gradient across
the plasma membrane was likely required due to the presence of numerous plasma
membrane Ca2+ pumps which pump intracellular Ca2+ out of cells (Negulescu and
Machen, 1993). Under physiological conditions ([Ca2+]o = 1.8 mM), [Ca2+]i was ~ 0.1
µM and dye transferred to 9.6 ± 0.3 cells (n=13). When cells where incubated with the
Ca2+ ionophore ionomycin (2 µM) (Churchill et al., 2001) and [Ca2+]o was increased to
21.8 mM, [Ca2+]i increased to micromolar levels and dye transfer decreased to 4.0 ± 0.8
cells (n=10) (Fig.3.2). The number of cells receiving dye at different [Ca2+]i is shown in
Fig.3.2. Given the Kd for Fura-2 of 224 nM (Grynkiewicz et al., 1985), intracellular Ca2+
concentrations greater than approximately 1 µM cannot be estimated accurately in these
experiments. Elevating [Ca2+]i to greater than 2 µM resulted in cell shrinkage and death
of the Cx40-transfected HeLa cells (data not shown). Thus, these data demonstrate a ~
50% inhibition in Cx40-mediated cell-to-cell dye transfer when [Ca2+]i ≥ 0.5 µM. A
sustained elevation in [Ca2+]i caused a partial inhibition of Cx40 gap junction-mediated
cell-to-cell dye transfer with an IC50 = 500 ± 0.72 nM.

The [Ca2+]i-dependent decrease in Cx40-mediated cell-to-cell dye transfer does not
require the activation of Protein Kinase A
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Elevating [Ca2+]i levels to higher that 0.5 µM partially inhibited Cx40 gap
junction-mediated cell-to-cell dye transfer (Fig.3.2). This [Ca2+]i-mediated inhibition of
Cx40 may be effected by at least three different mechanisms: 1) Ca2+ activates a Ca2+dependent Protein Kinase 2) direct binding of Ca2+ to Cx40 protein or 3) via a Ca2+binding protein such as Calmodulin.
Analysis of the Cx40 sequence for putative phosphorylation sites as described in
Methods (Chapter 2) using the Expasy Prosite-Scan database predicted substrate sites for
Protein Kinase A and Protein Kinase C. Therefore, to determine whether the [Ca2+]imediated decrease in Cx40 gap junction-mediated cell-to-cell dye transfer was dependent
on the activation of Protein Kinase A, Cx40-transfected HeLa cells were pre-incubated
with the PKA inhibitor, KT-5720 (0.5 µM) (RM Fried, 1986) before adding the Ca2+
ionophore ionomycin, and [Ca2+]i was then increased to micro molar levels by increasing
[Ca2+]o to 21.8 mM as described above. Alexa Fluor 594 dye transferred to 9.5 ± 0.6 cells
(n=13) under physiological [Ca2+]o (1.8 mM) when [Ca2+]i was < 0.1 µM. In the presence
of the PKA inhibitor alone dye transferred to 9.3 ± 0.9 cells (n=9), indicating that the
PKA inhibitor alone did not alter [Ca2+]i (0.16 ± 0.005 µM) or the number of cells
receiving dye from control levels [absence of PKA inhibitor]. When [Ca2+]i was elevated
to micromolar levels in the presence of the PKA inhibitor, dye transferred to 4.5 ± 0.4
cells (n=6) as shown in Fig.3.3 indicating that inhibition of Protein Kinase A had no
effect on the [Ca2+]i-dependent inhibition of Cx40-mediated cell-to-cell dye transfer.
Thus, the Ca2+-dependent inhibition of Cx40 does not appear to require the activation of
PKA.
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The [Ca2+]i-dependent decrease in Cx40-mediated cell-to-cell dye transfer does not
require the activation of Protein Kinase C
It has been demonstrated previously in our laboratory that purinergic receptor
activation by ATP effects a Protein Kinase C-dependent inhibition of the major cardiac
connexin Cx43. To determine whether, like Cx43, the [Ca2+]i-dependent decrease in
Cx40 gap junction-mediated cell-to-cell dye transfer was effected by activating the Ca2+dependent enzyme Protein Kinase C (PKC), Cx40-transfected HeLa cells were preincubated with the PKC inhibitor bisindolylmaleimide I (2 µM) before the addition of
the Ca2+ ionophore ionomycin (Fried and Tashjian, 1986); [Ca2+]i was then increased to
micro molar levels by increasing [Ca2+]o to 21.8 mM as described above (Fig 3.4). Alexa
Fluor 594 dye transferred to 9.5 ± 0.2 cells (n=10) in physiological [Ca2+]o (1.8 mM)
when [Ca2+]i was ~ 0.1 µM. In the presence of the PKC inhibitor bisindolylmaleimide I
alone dye transferred to 8.9 ± 0.2 cells (n=23); [Ca2+]i was unchanged from control levels
in the presence of the PKC inhibitor. Thus, PKC inhibitor alone did not alter either
[Ca2+]i (0.21 ± 0.008 µM) or the number of cells receiving dye. When [Ca2+]i was
elevated to micromolar levels in the absence of PKC inhibitor, dye transferred to 4.0 ±
0.2 cells (n=5) whereas in the presence of the PKC inhibitor dye transferred to 5.5 ± 0.6
cells (n=17) (Fig.3.4) indicating that inhibition of Protein Kinase C had minimal effect
on the [Ca2+]i-dependent inhibition of Cx40-mediated cell-to-cell dye transfer. Thus, the
Ca2+-dependent inhibition of Cx40 does not appear to require the activation of PKC.
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The [Ca2+]i-dependent decrease in Cx40-mediated cell-to-cell dye transfer does not
require the activation of Calmodulin Kinase II
To determine whether the [Ca2+]i-dependent inhibition of Cx40-mediated cell-tocell dye transfer was dependent on the activation of Calmodulin-dependent Protein
Kinase II (CaMK II), experiments were performed in the presence or absence of an
inhibitor of this Protein Kinase (Fig 3.5). Alexa Fluor 594 dye transferred to 9.9 ± 0.5
cells (n=12) in physiololgical [Ca2+]o conditions in Cx40-transfected HeLa cells. When
Cx40-transfected HeLa cells were incubated with the CaMK II inhibitor, lavendustin C (2
µM) (Watanabe et al., 1999) alone dye transferred to 9.0 ± 0.2 cells (n=31) and [Ca2+]i
was unchanged from control levels in the presence of this CaMK II inhibitor (Fig.3.5).
This suggests that CaMK II inhibitor alone did not alter either [Ca2+]i (0.18 ± 0.008 µM)
or the number of cells receiving dye when compared to control levels (in the absence of
CaMK II inhibitor). When [Ca2+]i was elevated to micromolar levels in the absence of
CaMK II inhibitor dye transferred to 4.4 ± 0.8 cells (n=4) whereas in the presence of the
CaMK II inhibitor dye transferred to 4.0 ± 1.0 cells (n=3) (Fig.3.5) indicating that
inhibition of CaMK II had no effect on the [Ca2+]i-dependent inhibition of Cx40mediated cell-to-cell dye transfer. Thus, the Ca2+-dependent inhibition of Cx40 does not
appear to require the activation of CaMK II.

The [Ca2+]i-dependent decrease in Cx40-mediated cell-to-cell dye transfer does not
appear to be due to direct binding of Ca2+ to Cx40
To determine whether the [Ca2+]i-dependent inhibition of Cx40 gap junctionmediated cell-to-cell dye transfer was due to a direct binding of Ca2+ to Cx40 protein, the
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Cx40 protein sequence was scanned for EF hand Ca2+ binding domains using the EF-hand
prediction server (Zhou et al., 2006). No Ca2+ binding domains were found in the Cx40
protein sequence suggesting that the [Ca2+]i-dependent inhibition of Cx40 gap junctionmediated cell-to-cell dye transfer is unlikely due to a direct binding of Ca2+ to Cx40
protein.
Collectively these data suggest that the elevated [Ca2+]i-dependent inhibition of
Cx40 gap junctions was not due to the activation of Ca2+-activated proteins kinases or
from direct binding of Ca2+ to Cx40 protein.
The [Ca2+]i-dependent inhibition of Cx40-mediated cell-to-cell dye transfer appears to
be Calmodulin-dependent
When the Cx40 protein sequence was examined using the Calmodulin target database
for identifying Calmodulin binding sites obtained from Ikura Lab, Ontario Cancer
Institute (Zhou et al., 2006), one site was identified in the C-terminus just distal to the
fourth transmembrane domain of Cx40 as shown in Fig.3.6. Scores range from 0-9 for
protein sequences based on the probability for a Calmodulin binding site, 9 being the
highest probability for the Calmodulin binding site. These normalized scores ranging
from 0 to 9 are shown below the amino acid sequence indicating the highest affinity for
Calmodulin within the given protein sequence. This scoring is based on a consecutive
string of high values indicates the location of a putative binding site, the higher the score,
the higher the predicted affinity for Calmodulin. Criteria for determining putative CaMbinding sites is based on hydropathy, alpha-helical propensity, residue weight, residue
charge, hydrophobic residue content, helical class and occurrence of particular residues.
Furthermore, a second scoring system also ranging from 0-9 is shown above the protein
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sequence when they are scanned for Calmodulin binding affinity. This scoring system is
based on the Calmodulin binding affinity of Cx40 to the Calmodulin binding affinity of
other proteins in the data base. When the Cx40 protein sequence was examined using
the Calmodulin target database a maximum score of 2 was obtained; although there was a
probable site in Cx40 it may have a low predicted affinity for Calmodulin albeit the
predictive scores do not always reflect the actual affinity of such sites for Calmodulin.
Since a Calmodulin binding site was predicted in a region of Cx40 that the membrane
spanning domain algorithms would indicate to be in a cytosolic region of Cx40,
Calmodulin may bind directly to Cx40 thus altering the conformation of the connexin and
closing the channel.
To determine whether the [Ca2+]i-dependent inhibition of Cx40 gap junctions was
effected via the Ca2+-binding protein Calmodulin (CaM), Cx40-transfected HeLa cells
were incubated with a Calmodulin inhibitor and [Ca2+]i was elevated as described
previously. Dye transferred to 9.0 ± 0.3 cells (n=12) in physiololgical [Ca2+]o in Cx40transfected HeLa cells. When Cx40-transfected HeLa cells were incubated with the CaM
inhibitor Calmidazolium alone dye transferred to 9.0 ± 0.3 cells (n=19) and [Ca2+]i was
unchanged from control levels indicating that addition of this Calmodulin inhibitor alone
did not alter either [Ca2+]i (0.15 ± 0.04 µM) or the number of cells receiving dye when
compared to control levels (in the absence of Calmodulin inhibitor). When [Ca2+]i was
elevated to micromolar levels in the absence of CaM inhibitor, dye transferred to 4.1 ±
0.3 cells (n=5) whereas in the presence of the CaM inhibitor, dye transferred to 9.0 ± 0.4
cells (n=4) indicating that the inhibition of Calmodulin prevented the [Ca2+]i-dependent
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inhibition of Cx40 gap junctions (Fig.3.7). Thus, the Ca2+-dependent inhibition of Cx40
appears to be Calmodulin-dependent.
A transient increase in intracellular calcium did not affect Cx40-mediated cell-to-cell
dye transfer
A number of physiological agonists such as ATP (Niedergerke and Page, 1981),
phenylephrine (α-1 adrenergic receptor activation) (Zhang et al., 2005), histamine
(Hardwick et al., 2006), and acetylcholine (Weber et al., 2005) are also known to cause a
transient increases in [Ca2+]i concentration which returns to basal levels within tens of
seconds, unlike the ionomycin-induced increase in [Ca2+]i described here where the
increase in [Ca2+]i is sustained. The [Ca2+]i increase during an agonist-mediated Ca2+
release, and the ionomycin-induced increase in [Ca2+]i are all in the micromolar range, the
difference being that the agonist-mediated increase is transient whereas the ionomycininduced increase is sustained. The goal of these experiments was to determine whether
an agonist-dependent transient elevation in [Ca2+]i similar to the ionomycin-induced
sustained increase in [Ca2+]i, inhibited Cx40-mediated cell-to-cell dye transfer. This was
accomplished by incubating Cx40-transfected HeLa cells with ATP (25 µM) as ATP has
been shown to transiently increase [Ca2+]i via purinergic receptor activation (Muscella et
al., 2003) in HeLa cells. This same signaling system is also present in the heart, where
purinergic receptor activation is coupled to an IP3-dependent increase in [Ca2+]i (Kusakari
et al., 2002; Scamps and Vassort, 1994). To confirm that extracellular ATP increases
[Ca2+]i in Cx40-transfected HeLa cells, these cells were incubated with ATP (25 µM) and
changes in [Ca2+]i was measured ratiometrically using Fura-2 as described in Methods.
Addition of ATP to the media transiently increased [Ca2+]i in Cx40-transfected HeLa
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cells from ~ 0.1 µM to ~0.5 µM within 1 min of adding ATP and this declined to control
levels by about 4 min after the addition of ATP as shown in Fig. 3.8A.
To determine whether this ATP-dependent increase in [Ca2+]i modulated Cx40mediated cell-to-cell dye transfer, cells were incubated with ATP (25 µM) for various
times prior to microinjection of dye. Alexa Fluor 594 dye transferred to 9.1 ± 0.5 cells
(n=22) prior to addition of ATP, whereas following the addition of ATP (25 µM) during
the period when there was a transient increase in [Ca2+]I, dye transferred to 8.8 ± 0.4 cells
at 1 min (n=5) ([Ca2+]i maximum was ~ 0.5 µM), 8.6 ± 0.3 cells at 5 min (n=7) when
[Ca2+]i had returned back to basal levels, 8.6 ± 0.6 cells (n=7) at 15 min, and 9.1 ± 0.6
cells (n=7) at 30 min (Fig.3.8B). Thus, addition of extracellular ATP did not appear to
affect Cx40-mediated cell-to-cell dye transfer suggesting that the ATP-dependent
increase in [Ca2+]i does not affect Cx40 gap junction permeability. This data
demonstrates that an agonist-dependent, transient increase in [Ca2+]i does not appear to
affect cell-to-cell dye transfer in Cx40-transfected HeLa cells.
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Discussion
The present study demonstrates for the first time that a sustained elevation in
[Ca2+]i, such as occurs during myocardial ischemia, causes a partial inhibition of Cx40mediated cell-to-cell dye transfer which appears to be Calmodulin-mediated.
[Ca2+]i is elevated by physiological agonists such as ATP, catecholamines, and
also during pathophysiological conditions such as during arrhythmias. The absolute
[Ca2+]i increase following addition of agonists or during ischemia is similar, except that
during ischemia there is a sustained increase in [Ca2+]i whereas agonist-mediated
increases in [Ca2+]i are transient. [Ca2+]i, one of the most important intracellular signaling
molecules in the heart, is required for maintaining the contraction-relaxation function of
the heart muscle (Zhang et al., 2001), activating various signaling pathways (ElArmouche et al., 2006), enzymes (Guo et al., 2006), gene expression (Weissgerber et al.,
2006) and regulating a number of ion channels including gap junctions in the plasma
membrane (Kockskamper and Pieske, 2006). In the heart, electrical and intercellular
communication is mediated by gap junctions, and alterations in gap junction function
have been implicated in various pathologic conditions in the heart (Cooklin et al., 1997;
Kaprielian et al., 1998).
Myocardial ischemia is known to cause arrhythmias, and during myocardial
ischemia there is an elevation in [Ca2+]i (Watts et al., 1980). This increase in intracellular
[Ca2+] is known to be associated with a decreased gap junction-mediated electrical (gap
junction conductance) and biochemical communication (gap junction permeability) in
cardiomyocytes (Burt, 1987a; White et al., 1990). In the atria, gap junctions are mainly
comprised of Cx40 and Cx43 proteins. Thus, examining the regulation of gap junctions
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comprised of individual connexins by elevated [Ca2+]i would help us better understand
the role of gap junctions in various pathological conditions such as arrhythmias that are
associated with elevated [Ca2+]i. Indeed, that the modulation of gap junction function can
directly regulate electrical conduction in the heart makes gap junctions an ideal
therapeutic target in the treatment of these pathologic conditions.
In the atria, gap junctions are comprised mainly of Cx40 and Cx43 proteins.
However, several studies have demonstrated that Cx40 and Cx43 do not form heterotypic
gap junctions (Bruzzone et al., 1993; Elfgang et al., 1995; Haubrich et al., 1996),
suggesting that gap junctions formed by these two connexins are regulated independently
of each other in this region of the heart.
It has been shown previously that elevation of [Ca2+]i inhibits Cx43-mediated
cell-to-cell dye transfer (Crow et al., 1994), while the role of [Ca2+]i in regulating Cx40
gap junctions has not been examined previously. Therefore it was hypothesized that like
Cx43, Cx40-mediated cell-to-cell dye transfer would be inhibited by increased [Ca2+]i.
This was accomplished by raising [Ca2+]i by 2 different methods in these cells 1) a
sustained elevation in [Ca2+]i using the Ca2+ ionophore ionomycin and then raising
[Ca2+]o and, 2) a transient increase in [Ca2+]i using agonists such as ATP.
During the myocardial ischemia that may cause arrhythmias, [Ca2+]i has been
shown to increase up to micromolar levels (Marban et al., 1990). A sustained elevation
in [Ca2+]i accomplished by addition of ionomycin increased [Ca2+]i to micromolar levels
when the [Ca2+]o was elevated from 1.8 mM to 21.8 mM (Fig.3.2). This increase in
[Ca2+]i resulted in > 50% inhibition of Cx40-mediated cell-to-cell dye transfer which was
prevented by prior addition of an inhibitor of the Ca2+ binding protein Calmodulin.
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Whether this action of Ca2+ + Calmodulin results from the direct interaction of
Calmodulin with Cx40 is not known, but it can be speculated that like other gap junction
proteins [for example Calmodulin directly binds to Cx32 resulting in channel closure
(Peracchia et al., 2000)], Calmodulin may directly bind to Cx40 protein. When the Cx40
protein sequence was examined using the Calmodulin target database obtained from
Ikura Lab, Ontario Cancer Institute for identifying Calmodulin binding sites, there was
one site identified in the C-terminus just outside the fourth transmembrane domain as
shown in Fig.3.6. Since this shows that a Calmodulin binding site was found in the Cx40
C-terminus, we can speculate that Calmodulin may directly bind to Cx40 thus altering the
conformation of the connexin and closing the channel.
In the myocardium, Ca2+ transients result when various agonists such as ATP,
histamine, and acetylcholine are released during sympathetic nerve stimulation. The
question is whether this transient increase in [Ca2+]i alters electrical coupling-mediated by
gap junctions in the heart. Among the three major connexins expressed in
cardiomyocytes Cx43 [fully open single channel conductance of 220 pS (Contreras et al.,
2003)] and Cx40 [fully open single channel conductance of 120 pS (Van-Rijen et al.,
2000)] gap junctions have large conductances and are also expressed at much higher
levels compared to Cx45 [fully open single channel conductance of 40 pS (van-Veen et
al., 2000)], thus these three major cardiac connexins play an important role in
maintaining electrical conduction in the heart. However, the data reported here indicate
that a transient elevation of [Ca2+]i by ATP did not affect cell-to-cell dye transfer in
Cx40-transfected HeLa cells, indicating that Cx40-mediated cell-to-cell communication
is not affected by an agonist-dependent transient increase in [Ca2+]i.
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A sustained increase in [Ca2+]i as occurs during myocardial ischemia, would
likely result in the inhibition of Cx40-mediated cell-to-cell dye transfer, whereas a
transient increase in [Ca2+]i effected by ATP mediated purinergic receptor activation to ~
0.5 µM did not result in an inhibition of Cx40-mediated cell-to-cell dye transfer. The
possible explanation for this could be as described by Dakin et al (Dakin et al., 2005),
when there is an influx of Ca2+ from the extracellular space [Ca2+]i is likely higher in
close proximity to the gap junctions in the plasma membranes rather than in the
cytoplasm. When Ca2+ is released from intracellular stores, the cytosolic [Ca2+] increases
to ≥ 0.5 µM but the [Ca2+] in the vicinity of gap junctions may be lower than that reported
by Fura-2 for the average cytoplasmic [Ca2+] because the distance when Ca2+ enters cells
from the extracellular space in the vicinity of gap junctions.
Taken together with previous studies in our laboratory it is possible to conclude
that under physiological conditions [Ca2+]i transients induced by agonists in the heart
would likely not result in a Ca2+-dependent inhibition of gap junction-mediated electrical
conduction mediated by either Cx40 or Cx43. However, a sustained increase in [Ca2+]i as
occurs during myocardial ischemia might be expected to inhibit gap junction coupling
mediated by either of these connexins. Such an inhibition may be both beneficial and
detrimental to cardiomyocytes, this phenomenon is described by Andrade-Rozental et al
(Andrade-Rozental et al., 2000) as “kiss to life” and “kiss of death”. Inhibiting gap
junction-mediated biochemical communication in the heart during ischemia protects
neighboring cardiomyocytes from the movement of toxic metabolites such as free
radicals which causes cell injury and death described as “kiss to life” thus being
beneficial. Reduction or inhibition of gap junction-mediated electrical coupling in the
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heart during arrhythmias may slow or stop heart rate described as “kiss of death” thus
being detrimental eventually leading to heart failure and death. Although various antiarrhythmic drugs such as β-blockers have been used with moderate success for the
treatment of arrhythmias, most have significant side effects. Since arrhythmias result
from an inhibition in gap junction-mediated electrical coupling in the heart leading to
abnormal heart rhythms, gap junctions may be valuable therapeutic targets for the
treatment of this condition. Our data reported here could suggest that this ischemiamediated inhibition of cardiac gap junction function may be due in part to the increase in
[Ca2+]i as occurs during myocardial ischemia (Burt, 1987b). Drugs that specifically
open/enhance gap junction function may be of value in the treatment of arrhythmias, thus
preventing the myocardial ischemia-mediated inhibition in gap junction-mediated
electrical conduction in the heart.
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Figures
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Fig. 3.1: Expression of Cx40 in rat Cx40 transfected-HeLa cells. Western Immunoblot
of Cx40. Lane 1 contains whole cell lysates from untransfected HeLa cells, and lane 2
contains whole cell lysates from Cx40-transfected HeLa cells (50 µg of protein per lane).
A 40 kDa band was seen in Cx40-transfected HeLa cells (lane 2) which was absent in
untransfected HeLa cells (lane 1).
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Figure 3.1
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Fig. 3.2: Effect of a sustained increase in [Ca2+]i on Cx40-mediated cell-to-cell dye
transfer. Cx40-transfected HeLa cells were incubated with ionomycin (2 µM), [Ca2+]o
was increased from 1.8 mM to 21.8 mM and at various subsequent times Alexa Fluor 594
was microinjected into one cell and 2 min later the number of cells receiving dye was
counted. Inhibition curve is shown in dashed line.
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Fig.3.3: Effect of Protein Kinase A inhibition on the Ca2+-mediated inhibition of Cx40mediated cell-to-cell dye transfer. Cx40-transfected HeLa cells were pre-incubated with
the PKA inhibitor KT-5720 (0.5 µM) for 15 min and then incubated with ionomycin (2
µM), [Ca2+]o was increased from 1.8 mM to 21.8 mM and at various times subsequently
Alexa Fluor 594 was microinjected into one cell and 2 min later the number of cells
receiving dye was counted. * p ≤ 0.05 from control (1.8 mM [Ca2+]o) .
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Fig. 3.4: Effect of Protein Kinase C inhibition on the Ca2+-dependent inhibition of Cx40mediated cell-to-cell dye transfer. Cx40-transfected HeLa cells were pre-incubated with
the PKC inhibitor, bisindolylmaleimide I (2 µM) for 15 min and then incubated with
ionomycin (2 µM); [Ca2+]o was increased from 1.8 mM to 21.8 mM. At various times
subsequently Alexa Fluor 594 was microinjected into one cell and 2 min later the number
of cells receiving dye was counted. * p ≤ 0.05 from control (1.8 mM [Ca2+]o).
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Fig.3.5: Effect of CaMK II inhibition on the Ca2+-dependent inhibition of Cx40-mediated
cell-to-cell dye transfer. Cx40-transfected HeLa cells were pre-incubated with CaMK II
inhibitor, Lavendustin C (2 µM) for 15 min and then incubated with 2 µM ionomycin,
extracellular Ca2+ was then raised from 1.8 mM to 21.8 mM. At various times following
the elevation of [Ca2+]o to 21.8 mM, Alexa Fluor 594 was microinjected into one cell and
2 min later the number of cells receiving dye was counted. * p ≤ 0.05 from control (1.8
mM [Ca2+]o).
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Fig.3.6: Cx40 amino acid sequence with the putative transmembrane regions (TM1- TM4
in gray) and the possible Calmodulin binding region (highlighted in pink) in the Cterminus when examined for Calmodulin binding sites using the Calmodulin target
database obtained from Ikura Lab, Ontario Cancer Institute (Zhou et al., 2006).
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Fig. 3.7: Effect of a Calmodulin inhibitor on the Ca2+-dependent inhibition of Cx40mediated cell-to-cell dye transfer. Cx40-transfected HeLa cells were pre-incubated with
Calmodulin inhibitor, Calmidazolim (2 µM) for 15 min and then incubated with
ionomycin (2 µM), [Ca2+]o was then increased from 1.8 mM to 21.8 mM and at various
times subsequently Alexa Fluor 594 was microinjected into one cell and 2 min later the
number of cells receiving dye was counted. * p ≤ 0.05 from control (1.8 mM [Ca2+]o).
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Fig. 3.8: Effect of a transient increase in [Ca2+]i on Cx40-mediated cell-to-cell dye
transfer. A. Effect of ATP on [Ca2+]i in Cx40-transfected HeLa cells. B. Effect of ATPinduced increase in [Ca2+]i on Cx40-mediated cell-to-cell dye transfer. Cx40-transfected
HeLa cells were incubated with ATP (25 µM) for various times when Alexa Fluor 594
was microinjected into one cell and 2 min later the number of cells receiving dye was
counted.
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CHAPTER 4

Regulation of Connexin40 Gap Junctions during Ischemia
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Introduction
Intercellular communication in the heart occurs through gap junctions, which mediate
both electrical and biochemical cell-to-cell communication in cardiomyocytes. Gap junctions are
composed of connexin proteins that form intercellular channels that are important determinants
of action potential propagation in the heart. The major connexins expressed in cardiomyocytes
are Cx40, Cx43, and Cx45 and alterations in gap junction function, expression and distribution
have been implicated in various cardiac pathological conditions (Kirchhoff et al., 1998; Kleber et
al., 1987; Simon et al., 1998) such as myocardial ischemia (Peters et al., 1993; Smith et al.,
1991b), indicating the importance of functional gap junctions for maintaining normal cardiac
function.
Ischemia is associated with various pathological conditions including arrhythmia which
leads to sudden cardiac death (Janse and Wit, 1989), as well as atrial and ventricular fibrillation
in the heart. Several changes that occur in cardiomyocytes during myocardial ischemia include a
reduction in [ATP]i and [Mg2+]i (Kirkels et al., 1989), accumulation of various ions such as [H+]i,
[Ca2+]i (Kihara et al., 1989), [Na+]i (Malloy et al., 1990), [K+]o (Wilde and Aksnes, 1995),
accumulation of fatty acids (Vusse et al., 1994), catecholamines (Newton et al., 1997), and free
radicals (Kukreja and Hess, 1992).
One of the important mechanisms responsible for the myocardial ischemia-induced origin
of arrhythmias is the uncoupling of gap junctions (Groot and Coronel, 2004). During ischemia
there is a significant decrease in cellular ATP and oxygen concentrations that is known to be
associated with inhibition in cardiac gap junction-mediated electrical conduction (Beardslee et
al., 2000). Cardiomyocytes express at least three different connexins, namely Cx40, Cx43 and
Cx45. Whether this ischemia-induced inhibition of gap junction-mediated electrical conduction
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is due to the inhibition of all three connexins or one or more connexins is still not clear. Cx43,
the major connexin in the heart is known to be inhibited in ischemia (Li and Nagy, 2000).
Although Cx40 is most abundantly expressed in the atria, its permeability in ischemia is still not
known. Therefore we have examined the effect of ischemia on Cx40 gap junctions and the
mechanisms underlying any action of ischemia on Cx40 gap junction permeability. Because
cardiomyocytes express at least three different connexins, namely Cx40, Cx43 and Cx45, they do
not provide an optimal system for determining how the functional properties of individual
cardiac connexins are regulated. Thus, to study the regulation of gap junctions comprised of
Cx40 alone, studies were conducted using this connexin that was stably transfected in a
communication-deficient HeLa cell line. In these cells ischemia was induced chemically by
inhibiting the electron transport chain with sodium cyanide, and inhibiting glycolysis with
iodoacetate and 2-deoxyglucose. This study, which is the first to examine the effect of chemical
ischemia on Cx40 gap junction-mediated cell-to-cell dye transfer, revealed that there was a
partial inhibition of Cx40 gap junction-mediated cell-to-cell dye transfer after 3 hours of
chemical ischemia. This ischemia-mediated inhibition in Cx40-mediated cell-to-cell dye transfer
appears to be Calmodulin-dependent.
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Methods
Materials
Dulbecco’s Modified Eagles Medium (DMEM), Hank’s balanced salt solution
with divalent cations (HBSS++), ATP, and all other chemicals were purchased from
Sigma Chemical Co. (St. Louis, MO). Fetal bovine serum (FBS) was purchased from
Hyclone (Logan, UT). G418 (Geneticin) and Hygromycin B were obtained from
Invitrogen (Carlsbad, CA). Fura-2 AM, and Alexa Fluor 594 were from Molecular
Probes (Eugene, OR). Cell Titer-Glo Luminescent Cell Viability Assay kit was from
Promega (Madison, WI).
HeLa cell culture
A single monolayer of untransfected or Cx40-transfected HeLa cells generously
provided by Dr. Richard Veenstra were grown on 25 mm coverslips in 35 mm culture
dishes until they reached confluency. Cells were grown in DMEM supplemented with
10% v/v fetal bovine serum and Pen-Strep (100 U/ml Penicillin and 0.1 mg/ml
Streptomycin) with or without 0.025 mg/ml (G418) geneticin, and were kept at 37ºC in a
5% CO2 atmosphere maintained at nearly 100% relative humidity.
Normoxia and Chemical ischemia
Cx40-transfected HeLa cells were subjected to normoxia or chemical ischemia for
various times at 37ºC (Rodriguez-Sinovas et al., 2006). Chemical ischemia was induced
by inhibiting the electron transport chain with NaCN and inhibiting glycolysis with
iodoacetate and 2-deoxyglucose. Cells were washed with normoxic buffer [40 NaCl, 3.6
KCl, 2 CaCl2, 1.2 MgSO4, 20 HEPES, and 5 glucose(in mM), pH 7.4] and then subjected
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to chemical ischemia in the same buffer lacking glucose and containing NaCN (2 mM)
and 2-deoxyglucose (20 mM).
Intracellular Ca2+ measurements
Cx40-transfected HeLa cells were loaded with Fura-2-AM (1 mM) in the dark for
45 min at room temperature. The buffer containing Fura-2 was then removed; the cells
were rinsed with fresh HBSS++ buffer, then incubated an additional 30 min in 2 ml
HBSS++ buffer to allow for complete hydrolysis of the intracellularly loaded Fura-2 AM.
Intracellular Ca2+ was measured ratiometrically (340 nm /380 nm) with Fura-2
throughout the experiment. Intracellular Ca2+ concentrations were determined as
described previously by Grynkiewicz et al, 1984. The Ca2+ concentration was calculated
using the equation:

[Ca2+] = Kd

Where:

(R-Rmin)
(Rmax-R)(Fmax)

Kd = 0.224 µM [Kd is the Ca2+ dissociation constant of the

indicator (Grynkiewicz et al., 1985)]
R = fluorescence intensity ratio Fλ1/F λ2, in which λ1 (340 nm) and λ2
(380 nm) are the fluorescence detection wavelengths for the ion-bound and
ion-free indicator, respectively
Rmin = fluorescence intensity ratio at 10 nM Ca2+;
Rmax = fluorescence intensity ratio at 39 µM Ca2+;
Fmin = fluorescence intensity λ 380 at 10 nM Ca2+;
Fmax = fluorescence intensity λ 380 at 39 µM Ca2+;
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ATP assay
The amount of ATP in Cx40-transfected HeLa cells treated with normoxic or
hypoxic buffer was measured using the CellTiter-Glo luminescent cell viability assay
(Promega, Madison, Wis., USA). This assay quantifies the amount of ATP and is based
on the luciferase-catalyzed reaction of luciferin and ATP. In particular, monooxygenation of luciferin is catalyzed by luciferase in the presence of Mg2+, ATP, and
molecular oxygen. Cx40-transfected HeLa cells were plated at the appropriate density
(1.25 x 104 cells/well) in an opaque-walled 96-well plate. Twenty-four hours after
plating, cells were exposed to either normoxic or hypoxic buffer for various times.
CellTiter-Glo® Reagent was then added to each well and the contents were mixed for 2
minutes on an orbital shaker to induce cell lysis. The plates were then allowed to incubate
at room temperature for 10 minutes to stabilize luminescent signal. The Luminescent
signal was recorded for 1 second per well using a BMG-Lumistar luminometer. At least
four independent experiments were performed for each condition.
Data analysis
The data are expressed as Mean ± SEM. In cell-to-cell dye transfer assays, n
reflects the number of times the experiments were performed. Differences between
groups were analyzed by ANOVA. Student’s paired t-test was used to calculate levels of
significance, with p-value less than 0.05 indicating significance. Statistical significance is
indicated in the graphs with a ‘*’ for p ≤ 0.05.
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Results
Chemical ischemia causes a decrease in [ATP]i in Cx40-transfected HeLa cells
One of the several changes that occur in cardiomyocytes during myocardial
ischemia is a reduction in intracellularATP concentration ([ATP]i) (Kirkels et al., 1989).
To determine whether chemical ischemia indeed effected a decrease in [ATP]i, changes
in [ATP]i were measured at various times during cell cultures maintained in normoxic
conditions, or following chemical ischemia. Cx40-transfected HeLa cells were exposed
to either maintained in normoxic or chemical ischemic buffer for various times, and total
ATP concentration in the HeLa cells was determined using the CellTiter-Glo luminescent
cell viability assay kit (Promega, Madison, Wis., USA) as described in Methods. ATP
concentration was ~ 2 µM/ 104 cells (n=4) prior to the onset of normoxia and ~ 1.8 µM/
104 cells (n=4) 15 min following normoxia. In contrast [ATP] was ~ 2 µM/ 104 cells
(n=4) prior to the onset of chemical ischemia and decreased to less than ~ 0.4 µM/ 104
cells (n=4) within 15 min of chemical ischemia (Fig. 4.1). Thus, these data indicate that
chemical ischemia resulted in a rapid decrease in ATP concentration within 15 minutes in
Cx40-transfected HeLa cells confirming that chemical ischemia induced an inhibition of
glycolysis and the electron transport chain in these cells, and thus caused a decrease in
[ATP]i.
Chemical ischemia causes a decrease in Cx40-mediated cell-to-cell dye transfer
Ischemia is known to decrease gap junction-mediated electrical (gap junction
conductance) and biochemical communication (gap junction permeability) in
cardiomyocytes (Burt, 1987a; White et al., 1990). Cardiomyocytes express at least 3
different connexins, namely Cx40, Cx43 and Cx45. To determine whether like Cx43,
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Cx40-mediated cell-to-cell dye transfer was inhibited by ischemia (Li and Nagy, 2000),
Cx40-transfected HeLa cells were incubated in either normoxic or ischemic buffer at
20ºC for various times. Dye transferred initially to 8.2 ± 0.5 cells (n=7) and to 8.8 ± 0.5
cells (n=5) 3 hours in normoxic media at 20ºC. Whereas dye transferred to 8.0 ± 0.4 cells
(n=5) prior to the onset of chemical ischemia, it transferred to 8.8 ± 0.6 cells (n=9) 3
hours following chemical ischemia at 20ºC (Fig. 4.5). Thus, this data suggests that
chemical ischemia induced at 20ºC did not affect Cx40-mediated cell-to-cell dye transfer
for up to 3 hours; therefore experiments were performed at 37oC as this more accurately
reflects the physiologic state of cells in the heart. When cells were maintained at 37oC
dye initially transferred to 8.4 ± 0.3 cells (n=9) and to 8.8 ± 0.9 cells (n=6) 3 hours in
normoxic media at 37oC. In contrast, whereas dye transferred to 8.0 ± 0.7 cells (n=5)
prior to the onset of chemical ischemia, it decreased to 5.3 ± 1.5 cells (n=8) 3 hours
following the onset of chemical ischemia at 37oC (Fig.4.2). Thus, these data
demonstrates that chemical ischemia ≥ 3 hours caused ~ 40% inhibition in Cx40mediated cell-to-cell dye transfer at 37oC.
Changes in [Ca2+]i following the onset of chemical ischemia in Cx40-transfected HeLa
cells
In the heart, a sustained increase in [Ca2+]i occurs during myocardial ischemia
where [Ca2+]i increases from ~ 300 nM (resting) to ~ 900 nM (20 min ischemia) in
perfused rat hearts (Marban et al., 1990). An ischemia-dependent increase in [Ca2+]i is
known to decrease gap junction-mediated electrical (gap junction conductance) and
biochemical communication (gap junction permeability) in cardiomyocytes (Burt, 1987a;
White et al., 1990). The question addressed here is whether inhibition of Cx40-mediated
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cell-to-cell dye transfer (Fig.4.2) correlated with ischemia-mediated changes in [Ca2+]i.
To determine whether [Ca2+]i changed in HeLa cells following the onset of chemical
ischemia, Cx40-transfected HeLa cells were loaded with Fura-2 and then exposed to
either normoxic or hypoxic buffer for various times at 37ºC. It was discovered that
changes in [Ca2+]i could not be measured during chemical ischemia at 37oC due to the
loss of Fura-2 fluorescence at this elevated temperature (37ºC) as indicated by the
decrease in absolute fluorescence signals measured at either 340 nm or 380 nm (Fig.
4.3B). Therefore it could be speculated that at 37ºC, the loss of Fura-2 fluorescence may
be due to its release from the cells or that this fluorescent dye is hydrolyzed to a nonfluorescent product.
To determine whether inducing chemical ischemia at 20ºC affected Fura-2
fluorescence, Cx40-transfected HeLa cells were incubated with the Ca2+-sensitive dye
Fura-2 AM and then exposed to either normoxic or ischemic buffer for various times at
20ºC. In contrast to measurements at 37oC, this absolute fura-2 fluorescence signal did
not significantly decrease at 20oC (Fig. 4.3A). Thus, ischemia-mediated changes in
[Ca2+]i were measured using Fura-2 at 20oC as this temperature was used in all previous
experiments. To determine whether [Ca2+]i in HeLa cells was modified following
chemical ischemia at 20ºC, Cx40-transfected HeLa cells were incubated with the Ca2+sensitive dye Fura-2 AM and then exposed to either normoxic or hypoxic buffer for
various times at 20ºC. [Ca2+]i was initially 0.03 ± 0.002 µM (n=10), and 0.07 ± 0.002
µM (n=12) at 15 min, 0.10 ± 0.003 µM (n=11) at 30 min, 0.10 ± 0.002 µM (n=10) at 45
min, 0.13 ± 0.002 µM (n=10) at 1 hour, 0.12 ± 0.001 µM (n=10) 2 hours and 0.11 ±
0.008 µM (n=7) 3 hours incubation in normoxic buffer at 20ºC. Thus, there was a
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modest increase in [Ca2+]i following 3 hours incubation at 20ºC. In contrast, [Ca2+]i was
0.03 ± 0.001 µM (n=12) prior to the onset of chemical ischemia, 0.05 ± 0.001 µM (n=15)
at 15 min, 0.05 ± 0.002 µM (n=11) at 30 min, 0.12 ± 0.006 µM (n=10) at 45 min, 0.26 ±
0.01 µM (n=10) at 1 hour, 2.0 ± 0.17 µM (n=11) 2 hours and to 1.9 ± 0.08 µM (n=15) 3
hour following onset of chemical ischemia (Fig. 4.4), indicating that chemical ischemia
induced a significant increase in [Ca2+]i at 20ºC.
The chemical ischemia-dependent inhibition of Cx40-mediated cell-to-cell dye transfer
appears to be Calmodulin-dependent
Although changes in [Ca2+]i could not be measured using Fura-2 at 37oC, based
on the data at 20oC there likely was an increase in [Ca2+]i in these HeLa cells at 37oC
which could have been responsible for the ischemia-mediated decrease in Cx40-mediated
cell-to-cell dye transfer. It has been shown in the previous chapter that the Ca2+dependent inhibition of Cx40-mediated cell-to-cell dye transfer is Calmodulin-dependent.
Therefore, to determine whether the ischemia-mediated decrease in Cx40-mediated cellto-cell dye transfer was Calmodulin-dependent, Cx40-transfected HeLa cells were preincubated with the Calmodulin inhibitor, calmidazolium prior to incubation in either
normoxic or chemical ischemic media at 37oC. Dye transferred initially to 9.6 ± 0.3 cells
(n=3), and to 8.6 ± 0.3 cells (n=3) after 3 hours following incubation in normoxic media
(Fig. 4.6A) in agreement with the data in Fig. 4.3. In contrast, whereas dye transferred to
9.5 ± 0.6 cells (n=4) prior to the onset of chemical ischemia (Fig. 4.2), it decreased to 4.8
± 0.3 cells (n=4) 3 hours following chemical ischemia in the absence of calmidazolium
(Fig. 4.6B) in agreement with the data in Fig. 4.3. In the presence of the Calmodulin
inhibitor calmidazolium, dye transferred to 9.3 ± 0.7 cells (n=3) and to 8.5 ± 0.5 cells
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(n=2) 3 hours following incubation in normoxic buffer plus calmidazolium (Fig. 4.6A),
indicating no nonspecific action of this inhibitor on gap junctions in normoxic media. In
contrast, whereas dye transferred to 8.6 ± 0.7 cells (n=3) prior to the onset of chemical
ischemia, it transferred to 9.0± 0.4 cells (n=5) 3 hours following chemical ischemia in the
presence of the Calmodulin inhibitor calmidazolium (Fig. 4.6B). Thus, pre-treating cells
with the Calmodulin inhibitor calmidazolium prevented the ischemia-mediated decrease
in Cx40-mediated cell-to-cell dye transfer indicating that the ischemia-dependent
decrease in Cx40-mediated cell-to-cell dye transfer at 37oC appears to be Calmodulindependent.
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Discussion
The present study demonstrates for the first time that chemical ischemia causes a
partial inhibition of cell-to-cell dye transfer in Cx40-transfected HeLa cells that appears
to be Calmodulin-dependent.
During ischemia there is a significant decrease in intracellular ATP concentration
that is known to be associated with the inhibition of cardiac gap junction-mediated
electrical conduction (Beardslee et al., 2000). To confirm that similar changes in
intracellular ATP levels occurred in HeLa cells, ATP was measured, and was shown to be
significantly decreased within 15 minutes of the onset of ischemia (Fig. 4.1), indicating
that the chemical ischemia described here was indeed induced by iodoacetate, cyanide
and 2-deoxyglucose treatment of HeLa cells.
In the heart, a sustained increase in [Ca2+]i occurs during myocardial ischemia
where [Ca2+]i increases from ~ 300 nM (resting) to ~ 900 nM (20 min ischemia) in
perfused rat hearts (Marban et al., 1990). Burt et al (1987) have demonstrated that
ischemia caused an increase in [Ca2+]I(Burt, 1987a; White et al., 1990), there also
observed an ischemia-dependent decrease in gap junction-mediated electrical (gap
junction conductance) and biochemical communication (gap junction permeability) in
cardiomyocytes, whether this increase in [Ca2+]i was responsible for the ischemiamediated decrease in gap junction is not known. Since there was an increase in [Ca2+]i
during ischemia in cardiomyocytes, an increase in [Ca2+]i was expected in Cx40transfected HeLa cells. However, the chemical ischemia-mediated changes in [Ca2+]i
could not be measured using Fura-2 (Fig. 4.3B) at 37oC due to the loss of Fura-2
fluorescence at this temperature due either to the Fura-2 being released by HeLa cells, or
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hydrolyzed by the cells thus making it impossible to measure [Ca2+]i using Fura-2 at this
temperature.
When chemical ischemia-mediated changes in [Ca2+]i were determined with Fura2 at 20ºC, an increase in [Ca2+]i was observed, confirming many other studies (Churchill
et al., 1996; Yashiro and Duling, 2000) that the fluorescence intensity of Fura-2 was not
affected at this temperature (Fig.4.3A). To determine if this ischemia-mediated change in
[Ca2+]i correlated with the inhibition of Cx40-mediated cell-to-cell dye transfer, dye
transfer was measured during normoxia or ischemia for various times at 20ºC. Inducing
chemical ischemia at 20ºC did not affect Cx40-mediated cell-to-cell dye transfer even by
2 or 3 hours by which time [Ca2+]i had increased (Fig. 4.5). Thus, although chemical
ischemia effected a significant increase in [Ca2+]i as early as 2 hours (Fig. 4.4), this
change in [Ca2+]i did not correlate with decrease in Cx40-mediated cell-to-cell dye
transfer.
Rodriguez-Sinovas et al. (2006) have demonstrated an increase in [Ca2+]i in rat
cardiomyocytes using the same ischemia protocol as used in this study (RodriguezSinovas et al., 2006), so an increase in [Ca2+]i was expected in Cx40-transfected HeLa
cells. Although changes in [Ca2+]i could not be measured using Fura-2 at 37oC, there was
an ischemia-dependent increase in [Ca2+]i observed at 20ºC that did not affect Cx40mediated cell-to-cell dye transfer.
It could be speculated that if there is an increase in [Ca2+]i at 37oC which may be
in part responsible for the chemical ischemia-dependent decrease in Cx40-mediated cellto-cell dye transfer at this temperature, it may be Calmodulin-dependent as shown in
Chapter 3. To determine if the chemical ischemia dependent decrease in Cx40-mediated
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cell-to-cell dye transfer was Calmodulin-dependent, cells were pre-incubated with the
Calmodulin inhibitor calmidazolium and cell-to-cell dye transfer was subsequently
measured during normoxia or ischemia for various times at 37oC. The data reported here
demonstrated that calmidazolium prevented the chemical ischemia-dependent decrease in
Cx40-mediated cell-to-cell dye transfer at 37oC (Fig. 4.6B), indicating that the ischemiamediated decrease in Cx40-mediated cell-to-cell dye transfer at 37oC appears to be
Calmodulin and therefore likely Ca2+-dependent.
A possible explanation for this slow onset of gap junction closure at 37oC may be
that there are confounding changes in intracellular pH ([pH]i) or changes in Cx40
phosphorylation state. Although changes in [pH]i were not measured during chemical
ischemia in this study, it could be speculated that there may be a decrease in [pH]i during
chemical ischemia. An increase in [H+]i as occurs during chemical ischemia may
decrease the Ca2+ sensitivity of proteins due to H+ ions binding to the Ca2+ binding sites
thus decreasing their affinity for Ca2+ ions. Thus an increase in [Ca2+]i may not now
affect Cx40 gap junctions because of its inability to bind to its receptor that our data
would indicate is likely Calmodulin.
In Cx40-transfected HeLa cells [Ca2+]i increased within 1 min after ATP addition
as demonstrated in chapter 2 and within 15 min of chemical ischemia at 20ºC, yet neither
of these increases in [Ca2+]i were associated with a decrease in Cx40-mediated cell-to-cell
dye transfer. That both ATP and chemical ischemia-mediated increase in [Ca2+]I at 20ºC
did not correlate with a decrease in Cx40-mediated cell-to-cell dye transfer may be due
the protocol/method used to raise [Ca2+]i. As described by Dakin et al (2005) and
discussed in Chapter 3 (Dakin et al., 2005), a sustained elevation in [Ca2+]i using
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ionomycin increased [Ca2+]i to micromolar levels when the [Ca2+]o was elevated from 1.8
mM to 21.8 mM. This increase in [Ca2+]i resulted in > 50% inhibition of Cx40-mediated
cell-to-cell dye transfer, whereas a transient increase in [Ca2+]i using agonists such as
ATP also increased [Ca2+]i to micromolar levels but did not affect Cx40-mediated cell-tocell dye transfer. The possible explanation for this is described by the same group (Dakin
et al., 2005), where [Ca2+] is likely higher in the close proximity of gap junctions than in
the cytoplasm following an influx of Ca2+ from the extracellular space. When Ca2+ is
released from intracellular stores, the cytosolic [Ca2+] increases to ≥ 0.5 µM but the
[Ca2+] in the vicinity of gap junctions may be lower than that reported by Fura-2 for the
average cytoplasmic [Ca2+] because the distance traveled by Ca2+ from the intracellular
stores to the plasma membrane is greater than the distance Ca2+ traveled from the
extracellular space to the vicinity of gap junctions.
Acute cardiac ischemia is known to be associated with ventricular arrhythmia and
fibrillation. One of the major factors responsible for the impaired action potential
propagation during arrhythmias and fibrillation is uncoupling of gap junctions (Dhein,
2006). This gap junction uncoupling is known to lead to predominant transverse
(myocardial end-to-end) uncoupling. Complete gap junction uncoupling would initiate
arrhythmia (Kojodjojo et al., 2006), while intermediate uncoupling has been shown to
enhance the safety factor of propagation, limiting the current loss to non-depolarized
areas. Therefore, as demonstrated in this study, an ischemia-dependent decrease in Cx40mediated cell-to-cell dye transfer would enhance the safety factor of propagation
therefore preventing the complete block of electrical conduction to the infarct areas of the
heart.
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Figures
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Fig. 4.1: Effect of chemical ischemia on intracellular ATP concentration in Cx40transfected HeLa cells. Cx40-transfected HeLa cells were incubated with either
normoxic or ischemic buffer (see Methods) for various times at 37oC and [ATP] was
measured using the CellTiter-Glo luminescent cell viability assay. The Luminescent
signal was recorded using a BMG-Lumistar luminometer. * p ≤ 0.05 from [ATP] prior to
ischemia or maintenance in normoxic buffer.
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Fig. 4.2: Effect of chemical ischemia on Cx40-mediated cell-to-cell dye transfer at 37oC.
Cx40-transfected HeLa cells were incubated in either normoxic or chemical ischemic
buffer for various times at 37oC. At various times subsequently Alexa Fluor 594 was
microinjected into one cell and 2 min later the number of cells receiving dye was
counted. * p ≤ 0.05 from number of cells receiving dye prior to further incubation in
normoxic or chemical ischemia media.
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Fig. 4.3: Effect of temperature on Fura-2 fluorescence. Cx40-transfected HeLa cells were
loaded with Fura-2 AM as described in "Methods". Cells were then maintained in (A)
20 oC or (B) 37oC for various times when the fluorescence at 340 nm and 380 nm was
captured using the Metafluor software from which the average number of fluorescence
pixels in each cell was later determined. * p ≤ 0.05 from average number of fluorescence
pixels in each cell prior to further incubation in normoxic or chemical ischemia media.
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Fig. 4.4: Effect of chemical ischemia on [Ca2+]i in Cx40-transfected HeLa cells at 20οC.
Cx40-transfected HeLa cells were incubated with either normoxic or ischemic buffer for
various times at 20ºC and then intracellular Ca2+ was measured with Fura-2. * p ≤ 0.05
from [Ca2+]i prior to further incubation in normoxic or chemical ischemia media.
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Fig. 4.5: Effect of chemical ischemia on Cx40-mediated cell-to-cell dye transfer at 20ºC.
Cx40-transfected HeLa cells were incubated with in either normoxic media or chemical
ischemic buffer for various times at 20ºC. At various times subsequently Alexa Fluor
594 was microinjected into one cell and 2 min later the number of cells receiving dye was
counted.
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Fig. 4.6: Effect of the Calmodulin inhibitor calmidazolium on the chemical ischemiadependent decrease in Cx40-mediated cell-to-cell dye transfer at 37oC. Cx40-transfected
HeLa cells were pre-incubated with calmidazolium (2 µM) before incubation in either
(A) normoxic media or (B) chemical ischemia. At various times subsequently , Alexa
Fluor 594 was microinjected into one cell and 2 min later the number of cells receiving
dye were counted. * p ≤ 0.05 from number of cells receiving dye at prior to further
incubation in normoxic or chemical ischemia media.

190

Figure 4.6

Number of cells receiving dye

A. Normoxia

Normoxia
CDZ + Normoxia
10

8

6

4
0.0

0.5

1.0

1.5

2.0

Time in hours

2.5

3.0

3.5

191

Figure 4.6
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CHAPTER 5

Regulation of Connexin43 Hemichannels
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Introduction
Evidence for the existence of non-junctional gap junction connexon hemichannels
in the plasma membrane was first provided by electrical studies on horizontal cells of fish
retina (Malchow, 1993; De Vries, 1992). Since then, many different connexins have
been shown to form functional hemichannels including all three of the cardiac connexins,
Cx40, Cx43 and Cx45 (Beyer et al, 1990; Hagendorff and Plum, 2000; Kondo et al,
2000; John et al, 1999).
Hemichannels are half gap junctions, composed of 6 protein subunits called
connexins. Like any plasma membrane channel, hemichannels connect the interior of the
cell to the exterior space. Each connexin has 4 transmembrane domains with the aminoand carboxyl-termini in the cytoplasm. Cardiomyocytes are known to express functional
hemichannels (Kondo et al., 2000). Thus, John, Kondo et al. (1999) and Kondo, Wang et
al (2000) have examined the properties of functional hemichannels in isolated
cardiomyocytes demonstrating hemichannel-mediated conductance and calcein dye
uptake that was increased in the presence of reduced extracellular Ca2+ or metabolic
inhibition in the presence of normal extracellular Ca2+ (John et al., 1999) indicating the
presence of functional hemichannels in the heart (Kondo et al., 2000). The presence of
endogenous hemichannels in cardiac myocytes may have both physiological and
pathophysiological significance, since their activation during ischemia is known to enable
a non-selective current to exchange [K+]i for [Na+]o and [Ca2+]o.
The physiological function of these hemichannels is unclear, although
hemichannel activity has been reported to be gated by [Ca2+]o (Valiunas, 2000; Ebihara,
1993; Pfahnl, 1998), metabolic state (Contreras, 2002; John, 1999), membrane potential
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(Valiunas, 2000; Trexler, 1996; Ebihara, 1993; De Vries, 1992), Protein Kinase C (Li,
1996), and Ca2+ (Quist, 2000). Many of the properties of these hemichannels are similar
to those of the corresponding gap junction channels (Francis, 1999; Trexler, 1996).
Cx43 is ubiquitously expressed through out the body and is the major connexin in
the heart. The existence of functional hemichannels has been demonstrated in a number
of cell types such as astrocytes (Ye et al., 2003), monocytes, macrophages (Wong et al.,
2006), osteocytes in the bone (Cherian et al., 2005), outer hair cell in the cochlea (Zhao
and Fleming, 2005) including cardiomyocytes in the heart (Kondo et al., 2000).
Hemichannels provide a direct link between the extracellular space and the cytoplasm,
and have been proposed to open under both physiological and pathophysiological
conditions allowing movement of molecules, ions, and second messengers (< 1000 Da)
from the cytoplasm to the extracellular space and vice versa. Hemichannels have been
shown to open when [Ca2+]o is reduced to nano molar concentrations, when the plasma
membrane is depolarized (Gomez-Hernandez et al., 2003; Pfahnl et al., 1997; White et
al., 1999), by metabolic inhibition, and by mechanical stimulation (Stout et al., 2002).
Hemichannels have been shown to close in the presence of millimolar [Ca2+]o, by plasma
membrane hyperpolarization (Trexler et al., 1996), by reduced [pH]o (Trexler et al.,
1999) and by gap junction blockers (John et al., 1999). Cx43 has been shown to form
functional hemichannels when exogenously expressed in HEK293 cells (John et al.,
1999), decreasing [Ca2+]o from 1.8 mM to nanomolar concentrations opened
hemichannels and made them permeable to large fluorescent dyes such as Lucifer
Yellow, and were reversibly blocked by halothane and irreversibly blocked by lanthanum,
indicating that the dye uptake was through Cx43 hemichannels in Cx43-transfected
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HEK293 cells. Metabolic inhibition in the presence of [Ca2+]o also opened Cx43
hemichannels in these Cx43-transfected HEK293 cells (John et al., 1999).
ATP is released with norepinephrine from sympathetic nerve terminals
(Burnstock, 1995), from endothelial cells during vascular injury (Born and Kratzer,
1984), and from cardiomyocytes during hypoxia (Forrester and Williams, 1977). A close
association between elevated extracellular ATP concentration and ischemia has also been
reported (Kuzmin et al., 1998). The increased premature ventricular contraction and
increased frequency of ventricular tachycardias in ischemic rat hearts corresponded to the
peak levels of interstitial ATP concentration (Kuzmin et al., 1998). Little information is
known about the subcellular ionic changes which accompany purinergic receptor
activation (caused by ATP) of cardiac myocytes, even under physiological conditions.
Since cardiomyocytes are known to express Cx43 hemichannels (Kondo et al., 2000) it is
important to understand the effect of agonists such as ATP on Cx43 hemichannels.
Therefore it was important to understand whether cardiac Cx43 hemichannel activity was
regulated by agonists such as ATP that are released during cardiovascular ischemia. To
study the regulation of Cx43 hemichannels alone, studies were conducted using Cx43transfected HeLa cells and measuring the uptake of fluorescent dye via functional Cx43
hemichannels.
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Methods
Materials
Dulbecco’s Modified Eagles Medium (DMEM), Hank’s balanced salt solution
without divalent cations (HBSS--) or with divalent cations (HBSS++), ATP, Staurosporine
and Lucifer Yellow were purchased from Sigma Chemical Co. (St. Louis, MO). Fetal
bovine serum (FBS) was purchased from Hyclone (Logan, UT). G418 (Geneticin) and
Hygromycin B were obtained from Invitrogen (Carlsbad, CA).
HeLa cell culture
Untransfected or stably Cx43-transfected HeLa cells were grown overnight on 25
mm coverslips in 35 mm culture dishes. Cells were grown in DMEM supplemented with
10% v/v fetal bovine serum and Pen-Strep (100 U/ml Penicillin and 0.1 mg/ml
Streptomycin) with or without 0.4 mg/ml (G418) geneticin, and were kept at 37ºC in a
5% CO2 atmosphere maintained with nearly 100% relative humidity.
Dye Uptake measurements
Visual method:
Untransfected wild type and Cx43-transfected HeLa cells were grown on 18 mm
glass coverslips overnight for all hemichannel experiments. Glass coverslips with
adherent cells were transferred to an experimental microincubation chamber and washed
with bath solution (1.8mM Ca2+ or Ca2+ free HBSS buffer) once. Cells were then
incubated in bath solution containing 1.8mM Ca2+ or Ca2+ free HBSS buffer and 1mM
Lucifer Yellow CH dilithium salt solution for 20 min at 20ºC. The cells were then
washed ten times with bath solution containing 1.8 mM Ca2+. Cells were imaged using
Nikon Epi-fluorescence microscope and images were captured using the Metafluor
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software to permit visual determination of the number of Lucifer Yellow positive cells in
a given field of cells. Cells were considered Lucifer Yellow positive when the
fluorescence intensity in the cell was greater than that of the the background fluorescence
of neighboring cells that had not taken up dye. Data is reported as the percentage of cells
that took up Lucifer Yellow dye relative to the total number of cells in the image.
Measuring dye uptake by this “visual method” was used as the initial standard assay for
determining hemichannel activity.
Quantitative method:
Metafluor software was used to capture images from which the number of Lucifer
Yellow positive cells was determined in each image. The fluorescence intensity of each
cell in the field was calculated by subtracting a threshold value (background) from the
mean of the fluorescence intensity of each cell [i.e., the number of fluorescence pixels in
each cell = Mean of the fluorescence pixels in each cell – number of fluorescence pixels
in an identically sized area that was cell-free (background)].
Data Analysis and Statistical Procedures
Data for each experimental set was pooled, averaged, and expressed as the Mean
± SE for identical treatments and time points. For each treatment a minimum of five
observations were made. Statistical differences were tested for multiple treatments
against the control using the One-Way ANOVA, and differences between two samples
were conducted using a t-test. Differences were considered significant when p≤0.05.
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Results
Expression of Cx43 in Cx43-transfected HeLa cells
To demonstrate that Cx43 was indeed expressed in these cells, Cx43-transfected
HeLa cells were analyzed by Western Immunoblotting. Membranes from Cx43transfected HeLa cells were isolated, solubilized in SDS, electrophoresed on 10% PAGE
and prepared for Western Immunoblotting as described in Methods (Fig. 5.1). A single
component of 43 kDa was observed only in Cx43-transfected HeLa cells (Fig. 5.1 lane 1)
which was absent in untransfected HeLa cells (Fig. 5.1 lane 2), confirming the expression
of this connexin in Cx43-transfected HeLa cells.
Functional analysis of Cx43 hemichannels in transfected HeLa cells
Uptake of Lucifer Yellow (LY) dye from the bath solution was used as a measure
of hemichannel functional activity. To examine the existence of functional Cx43
hemichannels, transfected HeLa cells were treated with reduced extracellular calcium
([Ca2+]o) (~ 10 nM) by incubation in 1 mM EGTA. It has been demonstrated previously
that reduced [Ca2+]o resulted in an increased open probability of Cx43 hemichannels
(DeVries and Schwartz, 1992). When non-confluent Cx43-transfected HeLa cells were
incubated in low Ca2+ buffer (HBSS--) [[Ca2+] ~ 10 nM] Lucifer Yellow (1 mM) uptake
from the bathing solution occurred in a significant percentage of cells (~ 40 %) (Fig.
5.2B) compared to cells incubated in 1.8 mM [Ca2+]o. A series of experiments was
carried out to determine what influenced dye uptake levels. In this study the effect of
Lucifer Yellow dye concentration, incubation time and temperature were examined.
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To determine whether dye uptake varied with dye concentration, Cx43-transfected
HeLa cells were incubated in buffer containing different concentrations of Lucifer
Yellow (e.g., 0.25, 0.5, 0.75 or 1mM ) for 20 min at 20ºC. The cells were then washed
with bath solution containing 1.8 mM Ca2+ fifteen times. Experiments were performed in
both physiological Ca2+ (1.8 mM) and reduced [Ca2+]o (10 nM) (1 mM EGTA) buffer.
Reducing the [Ca2+]o from 1.8 mM to ~10 nM Ca2+ resulted in an increased uptake of dye
such that 6.9 ± 2.8% cells took up dye in the presence of 0.25 mM LY, 25.1 ± 8.4% cells
took up dye in 0.5 mM LY, 39.1 ± 13.7% cells took up dye in 0.75 mM LY, and 44.0 ±
13.5% cells took up dye in 1.0 mM LY (Fig.5.1). In contrast, in 1.8 mM [Ca2+]o only
1.23 ± 1.23 % cells took up dye in the presence of 0.25 mM LY, 1.46 ± 0.9 % cells took
up dye in 0.5 mM LY, 3.0 ± 1.9 % cells took up dye in 0.75 mM LY and 1.6 ± 1.1 %
cells took up dye in 1.0 mM LY (Fig.5.3). Thus, there was no significant dye uptake
when cells were incubated in varying concentrations of Lucifer Yellow in 1.8 mM
[Ca2+]o.
To determine whether Lucifer Yellow dye uptake varied with time of incubation
with dye, Cx43-transfected HeLa cells were incubated in 1 mM Lucifer Yellow in low
[Ca2+]o ~10 nM [Ca2+]o buffer for various times at 20˚C. The cells were then washed
fifteen times with media containing 1.8 mM [Ca2+]o. The number of cells taking up dye
increased with time with 8.2 ± 1.38 % cells taking up dye at 5 min, 10.9 ±1.5 % cells
taking up dye at 10 min, 15.3 ± 4.2 % cells taking up dye at 15 min and 20.8 ± 2.6 %
cells taking up dye at 20 min (Fig. 5.4). No significant dye uptake was observed when
cells were incubated with Lucifer Yellow in media containing 1.8 mm [Ca2+]o.
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To determine whether Lucifer Yellow dye uptake varied with temperature, Cx43transfected HeLa cells were incubated at different temperatures in media containing 1
mM Lucifer Yellow in either ~10 nM or 1.8 mM [Ca2+]o. The cells were then washed
fifteen times with media containing 1.8 mM [Ca2+]o. The percentage of cells taking up
dye increased with increasing temperature such that in ~10 nM [Ca2+]o 7.7 ± 1.8 % cells
took up dye at 15oC, 28.9 ± 3.3 % cells at 20oC, 48.3 ± 1.7 % cells at 25oC, 60.7 ± 5.3 %
cells at 30oC, and 62.6 ± 2.6 % cells took up dye at 35oC (Fig.5.5). In the presence of 1.8
mM [Ca2+]o, 3.8 ± 1.5 % cells took up dye at 15oC, 3.6 ± 2.0 % cells took up dye at 20oC,
10.7 ± 2.2 % cells took up dye at 25oC, 17.6 ± 4.7 % cells took up dye at 30oC, and 37.2
± 4.7 % cells took up dye at 35oC indicating Lucifer Yellow dye uptake increased with
increasing temperature at both ~10 nM and 1.8 mM [Ca2+]o, although the percentage of
cells taking up dye was very much lower when cells were incubated in 1.8 mM [Ca2+]o
(Fig. 5.5).

Cx43 hemichannel permeability is inhibited by purinergic receptor activation
Extracellular ATP levels are known to be elevated during myocardial ischemia
(Zhang et al, 2001). Li et al. (1996) and others have shown that like intact gap junctions,
connexin hemichannels are also regulated by 2nd messenger-activated protein kinases.
Given the presence of these several Protein Kinase C (PKC) consensus sequences in
Cx43 it was important to determine whether agonists that activate PKC are also able to
regulate Cx43 hemichannels. The heart contains P2X and P2Y purinergic receptors that
are classified based on the order of agonist potency of structural analogues of ATP
(Burnstock and Kennedy, 1985). There is little information about any changes which
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accompany purinergic receptor activation of cardiomyocytes even under normal
physiologic conditions. Purinergic receptor activation results in the activation of PKC,
and a transient increase in intracellular [Ca2+] in cardiomyocytes (Kusakari et al., 2002;
Scamps and Vassort, 1994). It has been shown previously in this laboratory that
extracellular addition of ATP resulted in a delayed, transient inhibition of Cx43 gap
junctions that was Protein Kinase C-dependent. To determine whether like Cx43 gap
junctions, Cx43 hemichannels are also regulated following purinergic receptor activation,
the effect of ATP on Cx43 hemichannel-mediated Lucifer Yellow dye uptake was
studied. Cx43-transfected HeLa cells were grown overnight on glass coverslips as
described in Methods, then incubated with 1 mM Lucifer Yellow in the presence or
absence of ATP (25 µM) in ~10 nM [Ca2+]o HBSS buffer for 20 min. Cells were then
washed with 1.8 mM [Ca2+] HBSS buffer and digitized images were recorded from which
the number of cells taking up dye was determined. 19.8 ± 2.0 % cells took up dye in the
absence of ATP, whereas in the presence of ATP 9.1 ± 0.9 % cells took up dye in 10 nM
[Ca2+]o (Fig. 5.6). Thus, Cx43 hemichannels appear to be partially inhibited in the
presence of ATP (25 µM) in ~ 10 nM [Ca2+]o indicating that purinergic receptor
activation by ATP effected an inhibition of Cx43 hemichannel permeability.
In the heart, purinergic receptor activation results in the activation of Protein
Kinase C (Kusakari et al., 2002; Scamps and Vassort, 1994). To determine whether the
purinergic receptor activation-mediated inhibition in Cx43 hemichannel permeability was
mediated by the activation of Protein Kinase C, experiments were performed in the
presence or absence of Protein Kinase C inhibitor, Staurosporin. Cells were incubated
with the PKC-inhibitor Staurosporin (10 nM) prior to addition of ATP. In the presence of
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1.8 mM [Ca2+]o, 8.1 ± 3.0 % cells took up dye, while in the presence of ~ 10 nM [Ca2+]o
28.2 ± 2.9 % cells took up dye. When cells were incubated with ATP (25 µM) alone in ~
10 nM [Ca2+]o 11.1 ± 1.5 % cells took up dye, while 27.7 ± 3.1 % cells took up dye when
incubated with Staurosporin only. When cells were incubated with the PKC-inhibitor
Staurosporin (10 nM) prior to the addition of ATP 28.6 ± 3.3 % cells took up dye
indicating that staurosporin appeared to prevent the ATP-mediated inhibition of Cx43
hemichannel-mediated dye uptake (Fig. 5.7). Thus, inhibition of Protein Kinase C
prevented the ATP-mediated inhibition of Cx43 hemichannel-mediated Lucifer Yellow
dye uptake, suggesting that purinergic receptor activation mediated inhibition of Cx43
hemichannels required the activation of Protein Kinase C.
Reliability of the Hemichannel dye uptake Assay
All the above data was collected using the “visual method” as described in
Methods, since this has been the most commonly used method to analyze hemichannel
functional activity along with measuring single channel currents (Alves et al., 1996;
Kondo et al., 2000). Subsequent to the completion of the ATP experiments (Fig. 5.7), the
visual method for assaying hemichannel activity did not produce results that were
consistent with our previous data (where Cx43 hemichannel-mediated dye uptake should
have been ~ 40% in ~ 10 nM [Ca2+]o and < 2% in 1.8 mM [Ca2+]o), so a quantitative
method for assaying hemichannel activity was examined. In this method the fluorescence
intensity of each cell (i.e., the number of fluorescent pixels in each cell) was calculated
by subtracting background fluorescence (i.e., the number of fluorescent pixels in an
identical sized cell-free area) from the mean of the fluorescence intensity of each cell
(Fluorescence intensity of cell = Mean fluorescence of cell – background fluorescence).
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The data was then analyzed using different measures of variation or difference from the
mean values. The goal was to determine whether it was possible to identify whether a
defined level of variation could reproducibly demonstrate significant differences in ±
Ca2+, ± ATP experiments as had been observed using the “visual method” for assaying
hemichannel activity.
The variations tested statistically were:
1.

Mean value ± 1 Standard deviation

2.

Mean value ± 2 Standard deviations

3.

Mean value ± 10% of Mean value

4.

Mean value ± 20% of Mean value

5.

Mean value ± 30% of Mean value

Since standard deviation is the most common measure of statistical dispersion, it
was used to measure the widely spread values in this data set. Therefore it was important
to use this alternative threshold levels to measure variation about the mean fluorescence
of each cell. Mean + 10, 20 or 30% of the mean was also used to measure variability
within this distribution because of the data spread.
To measure the percentage of cells taking up dye using this quantitative approach
non-confluent wild type HeLa cells were incubated in either low Ca2+ buffer ([Ca2+]o was
~ 10 nM) or physiological Ca2+ buffer ([Ca2+]o was 1.8 mM) containing Lucifer Yellow
(1 mM). A significant percentage of cells appeared to take up dye from the bathing
solution in both low and normal Ca2+ buffers when analyzed using the 5 different levels
of variation of the mean (Fig. 5.9A).
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To measure the percentage of Cx43-transfected HeLa cells taking up dye using
this quantitative approach, cells were incubated in either low Ca2+ buffer ([Ca2+]o was ~
10 nM) or physiological Ca2+ buffer ([Ca2+]o was 1.8 mM) containing Lucifer Yellow (1
mM). However, similar to wild type HeLa cells, a significant percentage of cells
appeared to take up dye from the bathing solution in both low and normal Ca2+ buffers
when analyzed using the five different levels of variation of the mean (Fig. 5.9B). These
high percentages of cells taking up dye in both wild type and Cx43-transfected HeLa
cells in the presence of normal [Ca2+ ]o (1.8 mM) is not consistent with our “visual
method” data or that published by other laboratories (Alves et al., 1996; Kondo et al.,
2000). Data analyzed using the quantitative method for both untransfected and Cx43transfected HeLa cells in low or normal [Ca2+]o buffer demonstrated a high percentage of
cells appeared to take up dye irrespective of the way threshold levels were calculated
indicating that the dye uptake approach could not be used as a reliable assay for
measuring Cx43 hemichannel activity.
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Discussion
Are Cx43 hemichannels regulated by the purinergic receptor agonist ATP?
Using the “visual method” for analyzing hemichannel-mediated dye uptake, this
data appeared to demonstrate that ATP, a purinergic receptor agonist that is released from
sympathetic nerves during myocardial ischemia (Sesti et al., 2003) and injury, effected a
decrease in the Lucifer Yellow permeability of Cx43 hemichannels. Furthermore, this
purinergic receptor-mediated inhibition of Cx43 hemichannels appeared to be dependent
on the activation of Protein Kinase C.
In this study the presence of functional Cx43 hemichannels were demonstrated by
determining the uptake of dye into Cx43-transfected HeLa cells from the medium. To
optimize experimental conditions dye uptake assays were analyzed with varying dye
concentrations, time of incubation with the dye, and temperature. As determined using
the “visual method”, Cx43 hemichannel-mediated dye uptake increased with increasing
Lucifer Yellow concentration (Fig. 5.3), time of incubation of dye (Fig. 5.4) and
temperature (Fig. 5.5), indicating that hemichannel-mediated dye uptake appeared
saturable as would be expected to a gap junction mediated process.
Cx43 is a phospho-protein (Crow et al., 1990) and potential consensus
phosphorylation sites for Protein Kinase C have been identified. Since ATP is an
important potential regulating molecule in the heart, it was important to determine the
effect of purinergic receptor activation by ATP on Cx43 hemichannel-mediated dye
uptake. Extracellular addition of ATP (25 µM) resulted in an apparent ~ 50% decrease in
dye uptake through Cx43 hemichannels using the “visual method” for assaying dye
uptake (Fig. 5.6). Pre-inhibition with Staurosporin to inhibit PKC prevented the ATP-
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dependent inhibition of dye uptake by Cx43 hemichannels in Cx43-transfected HeLa
cells. This data demonstrates that Cx43 hemichannels are regulated by purinergic
receptors via the activation of Protein Kinase C (Fig.5.7). This data complements the
data published by Bao et al (2004) that phosphorylation of the Cx43 hemichannels by
Protein Kinase C decreases dye coupling in oocytes, and that this appears to be via
purinergic receptor activation as shown in this study.
The data collected up to this point was accomplished using the “visual method” as
described in Methods, since this has been used previously to analyze hemichannel
permeability. After the ATP ± Staurosporin experiments, the “visual method” for
assaying hemichannel activity did not produce consistent results as shown previously in
Fig. 3, where < 2% of cells received dye in 1.8 mM [Ca2+]o, whereas now a high
percentage of cells took up dye in 1.8 mM [Ca2+]o (~ 12.7%) in Cx43-transfected HeLa
cells (Fig. 5.9), so a quantitative method was developed where the fluorescence intensity
of each cell in the field was calculated by subtracting various threshold values
(background) from the mean of the fluorescence intensity of each cell. Like the “visual
method”, quantitative analysis of data with various threshold values also provided
variable results as shown in Fig. 5.9 in both untransfected and Cx43-transfected HeLa
cells in both low (~10 nM) and normal (1.8 mM) [Ca2+]o buffer; this was not consistent
with the previous data collected in this study and other data published in the literature
(Alves et al., 1996; Kondo et al., 2000).
Although dye uptake in the above experiments has been attributed to functional
hemichannels, it is important to realize that there are other nonjunctional channels that
have permeability properties that are also consistent with the data presented in favor of
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hemichannel involvement, since there was also an apparent significant percentage of dye
uptake in connexin-deficient wild type HeLa cells (Fig. 5.9A). A major limitation in the
hemichannel field is the absence of selective hemichannel inhibitors, thereby
compromising attempts to identify connexin hemichannels through their blockade.
There are several reagents that are known to block gap junctions and hemichannels,
including 18 -glycyrrhetinic acid and its derivative carbenoxolone, fenamates, certain
lipophiles such as heptanol, octanol and arachidonic acid, and quinine and its derivatives.
These gap junction blockers are also known to block P2X7-induced dye uptake at similar
concentrations (Suadicani et al., 2006) and some are also known to block other potential
hemichannel flux pathways, suggesting that these gap junction blockers should be used
along with other channels blockers that mimic hemichannel behavior, further making it
challenging to unambiguously measure hemichannel function. This ambiguity is due to
the observations in this study that apparent hemichannel-mediated dye uptake was
detected in the presence and absence of divalent cations, occurs in cells in the presence or
absence of connexins as shown in this study, and is blocked by one or more non-specific
gap-junction blockers as shown in several studies in the literature (Contreras et al., 2003;
Contreras et al., 2002; Eskandari et al., 2002; Srinivas et al., 2005a).
Even though hemichannel currents have been measured successfully in several
studies, there is still controversy in the literature regarding hemichannel opening under
low [Ca2+]o, for example the lack of expression of functional Cx43 hemichannels in
Xenopus oocytes (where carboxyfluorescein uptake and enhancement by Protein Kinase
C inhibitors have been reported in the absence of measurable hemichannel currents (Bao
et al., 2004b), lack of opening of Cx43 hemichannels at potentials below 0 mV in HeLa
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transfectants (Contreras et al., 2003), and by variable activation of Cx43 hemichannels by
reduced Ca2+ (Contreras et al., 2003).
One main conclusion that can be deduced from this study is that studying
hemichannels is technically challenging, due to the lack of specific hemichannel blockers
and similar channel properties of hemichannels to other channels such as pannexins,
P2X7, and voltage dependent anion conductance. Furthermore, it is clear that the use of
dye uptake to measure hemichannels is problematic because of its lack of consistency.
In contrast to the dye uptake method to measure hemichannel function, studies using
single channel current of connexin hemichannels expressed in oocytes have proved to be a
reliable method to measure hemichannel function in other laboratories and could be used to
determine the effect of ATP on Cx43 hemichannels in future experiments (Srinivas et al.,
2006; Srinivas et al., 2005b; Tong and Ebihara, 2006; Tong et al., 2004).
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Figures

213

Fig. 5.1: Expression of Cx43 in HeLa cells transfected with Cx43. Western Immunoblot
of Cx43. Lane 1 contains membrane isolates from Cx43-transfected HeLa cells and lane
2 contains membrane isolates from untransfected HeLa cells; 50 µg of protein per lane
was loaded. A 40 kDa band of Cx43 was seen in Cx43-transfected HeLa cells (lanes 1)
which was absent in untransfected HeLa cells (lane 2).
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Figure 5.1
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Fig. 5.2: Effect of reduced extracellular [Ca2+] on Cx43 hemichannel-mediated dye
uptake. Cx43 transfected HeLa cells were incubated with Lucifer Yellow (1 mM) for 20
min in ~10 nM Ca2+ buffer. A. Phase contrast view of a typical field of cells B. Lucifer
Yellow fluorescence image showing cells which have taken up dye.
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Figure 5.2
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Fig. 5.3: Effect of dye concentration on Cx43 hemichannel-mediated dye uptake. Cx43transfected HeLa cells were incubated with varying Lucifer Yellow concentrations (0.25,
0.5, 0.75 and 1.0 mM) in either 1.8 mM (grey bars) or 10 nM (black bars) [Ca2+]o for 20
min at 20ºC. Cells were then washed and the number of cells taking up dye determined.
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Fig. 5.4: Effect of time of incubation with dye on Cx43 hemichannel-mediated dye
uptake. Cx43-transfected HeLa cells were incubated with Lucifer Yellow (1 mM) in ~10
nM [Ca2+]o for various times at 20oC; cells were then washed and the number of cells
taking up dye determined.
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Fig. 5.5: Effect of temperature on Cx43 hemichannel-mediated dye uptake. Cx43transfected HeLa cells were incubated with Lucifer Yellow (1mM) in either 1.8 mM or
10 nM [Ca2+]o for 20 min at various temperatures (15, 20, 25, 30, 35˚C). Cells were then
washed and the number of cells taking up dye determined.
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Fig. 5.6: Effect of ATP on Cx43 hemichannel-mediated dye uptake. Cx43-transfected
HeLa cells were incubated with ATP (25 µM) and Lucifer Yellow (1mM) in the
presence 1.8 mM [Ca2+]o for 20 min at 20ºC. Cells were then washed and the number of
cells taking up dye determined. ** p ≤ 0.05 from number of cells taking up dye in the
absence of ATP.
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Fig. 5.7: Effect of a PKC inhibitor on the ATP-dependent inhibition of Cx43
hemichannels. Cx43-transfected HeLa cells were pre-incubated with Protein Kinase C
inhibitor, Staurosporin (10 nM) for 15 min and then incubated with ATP (25 µM) and
Lucifer Yellow (1mM) in the presence 1.8 mM [Ca2+]o for 20 min at 20ºC. Cells were
then washed and the number of cells taking up dye determined.
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Fig. 5.8: Effect of reduced [Ca2+]o on Cx43 hemichannel-mediated dye uptake. Cx43transfected HeLa cells were incubated with Lucifer Yellow (1 mM) for 20 min in ~10 nM
[Ca2+] buffer. A. Phase contrast view of a typical field of cells B. Lucifer Yellow
fluorescence image showing cells which have taken up dye. Data was analyzed using the
visual method as described in “Methods”.
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Fig. 5.9: Effect of reduced extracellular [Ca2+] on hemichannel-mediated dye uptake
analyzed using the quantitative method. A. untransfected HeLa cells B. Cx43-transfected
HeLa cells were incubated with Lucifer Yellow (1 mM) for 20 min in either 1.8 mM or
~10 nM [Ca2+]o buffer.
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Conclusions and Future Research
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At the onset of this research little was known regarding the regulation of Cx40.
Thus, the goal was to better understand the regulation of Cx40, an atrial cardiac
connexin, in both physiological and pathophysiological conditions. The four main
conclusions from this research are: (1) β-adrenergic receptor activation increases Cx40mediated cell-to-cell dye transfer which requires the activation of PKA; (2) A sustained
elevation in [Ca2+]i causes a partial inhibition of Cx40 gap junction-mediated cell-to-cell
dye transfer which appeared to be Calmodulin-dependent; (3) Chemical ischemia causes
a partial inhibition of Cx40 gap junction-mediated cell-to-cell dye transfer which
appeared to be Calmodulin-dependent; (4) Dye uptake assays are an unreliable method
for measuring gap junction hemichannel function.
The first objective of this thesis was to determine whether Cx40 gap junctions
were regulated by β-adrenergic receptor activation and the pathway/s involved in the βadrenergic receptor signaling. Previous investigators have shown that the cell permeant
cAMP analog, 8-bromo cAMP effected an increase in cell-to-cell dye transfer in Cx40transfected SkHep cells (Van-Rijen et al., 2000), but the pathway by which this cAMP
analog effected this activation of Cx40 gap junctions was not determined. This was
accomplished by activating several steps in the β-adrenergic receptor signaling pathway
and then Cx40 gap junction permeability was determined by measuring the cell-to-cell
transfer of Alexa Fluor 594 dye. The data reported here has demonstrated for the first
time that a β-adrenergic receptor-mediated increase in Cx40-mediated cell-to-cell dye
transfer occurred via the adenylate cyclase/cAMP/PKA signaling pathway. It was further
demonstrated that the β-2 receptor subtype was functionally responsible for the β-
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adrenergic receptor-dependent increase in Cx40-mediated cell-to-cell dye transfer in
Cx40-transfected HeLa cells.
In this study it has been demonstrated that the β-adrenergic receptor-mediated
increase in Cx40-mediated cell-to-cell dye transfer is affected by the adenylate
cyclase/cAMP/PKA signaling pathway. Further insight into the regulation of Cx40 by
PKA-dependent β-adrenergic receptor activation, could be derived by identifying the
Cx40 amino acid substrate responsible for the β-adrenergic receptor-mediated increase in
Cx40-mediated cell-to-cell dye transfer. When the potential consensus phosphorylation
sites for protein kinases in Cx40 were determined by analysis of the Cx40 sequence using
the Expasy Prosite-Scan database, only one substrate site for Protein Kinase A was
identified at amino acid 343. To determine if this residue is indeed critical for Cx40
regulation by β-adrenergic receptor activation, a Cx40 mutant could be developed in
which this candidate serine 343 residue for the Protein Kinase A pathway is mutated to
alanine residue. This construct could then be transfected into communication-deficient
HeLa cells that are treated with β-adrenergic receptor agonists to determine if this residue
is indeed critical for this regulation of Cx40.
In the heart, the action potential is generated in the sino-atrial node (SA node) and
it is regulated by the modulation of various ion channels in the cardiac membrane
(DiFrancesco, 1993). The mechanisms responsible for action potential propagation in the
SA node are the delayed rectifier current IK, the L-type calcium currents ICa, and the
hyperpolarization-activated cation channel If. The spontaneous activity of the pacemaker
cells of the SA node results from slow diastolic depolarization. The cardiac membrane
slowly depolarizes following termination of an action potential, until threshold for a new
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action potential is reached. Thus, the diastolic depolarization is responsible for initiating
rhythmic behavior and characterizes action potentials of SA node and other
spontaneously active cardiomyocytes. This diastolic depolarization is associated with a
decaying K+ current due to decreased K+ permeability (Noble and Tsien, 1968). During
this phase there is a slow increase in [Na+]i and [Ca2+]i. This depolarization is mainly due
to the slow influx of Ca2+ by the L-type Ca2+ channels which open when threshold is
achieved (between -40mV and -50mV) (Noma et al., 1980). These L-type Ca2+ channels
close soon after they open thus decreasing [Ca2+]i, during this phase there is also a
decrease in [Na+]i, thus increasing the influx of K+ which repolarizes the cell.
Beta-adrenergic stimulation is known to have several actions on the ionic currents
in the generation of electrical activity of SA node cells. β-adrenergic stimulation is
known to increase IK resulting in rate dependent shortening of action potentials and
increase in the amplitude of the [Ca2+]i transient thus increasing heart rate. Activation of
β-adrenergic receptors regulates the activity of ion channel proteins via a cAMPdependent Protein Kinase A (PKA) or by direct binding of cAMP to channel subunits.
Thus beta-adrenergic stimulation increases the firing rate of action potential initiation in
the SA. Since Cx40 gap junctions are present in the AV node, AV bundle branches, atria,
Purkinje fibers and low levels in the ventricles. This action potential propagation from
the SA node to the AV node, atria and ventricles by Cx40 gap junctions by β-adrenergic
agonists would increase electrical conduction thus having a positive dromotropic effect.
The ability of β-adrenergic agonists to increase Cx40 conduction provides a mechanistic
explanation for this beta-adrenergic stimulation-mediated increase in heart rate.
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The second objective of this thesis was to examine the effect of [Ca2+]i on Cx40
gap junctions and the mechanisms underlying any action of [Ca2+]i on Cx40 gap junction
permeability. This was achieved by elevating [Ca2+]i in Cx40-transfected HeLa cells by
adding ionomycin to permeabilze the plasma membrane to Ca2+, and then elevating
[Ca2+]o from 1.8 to 21.8 mM by adding CaCl2 to the bathing buffer which elevated [Ca2+]i
from nano molar to micro molar. The data reported here demonstrated for the first time
that a sustained elevation in [Ca2+]i, caused a partial inhibition of Cx40-mediated cell-tocell dye transfer which appeared to be Calmodulin-dependent.
To obtain more insight into the regulation of Cx40 by [Ca2+]i, the Cx40 region
responsible for the elevated [Ca2+]i-mediated decrease in Cx40-mediated cell-to-cell dye
transfer could be identified. This increase in [Ca2+]i resulted in > 50% inhibition of Cx40mediated cell-to-cell dye transfer which was prevented by prior addition of an inhibitor of
the Ca2+ binding protein Calmodulin. Whether this action of Ca2+ + Calmodulin results
from the direct interaction of Calmodulin with Cx40 is not known, but it can be
speculated that like other gap junction proteins [for example Calmodulin directly binds to
Cx32 resulting in channel closure (Peracchia et al., 2000)], Calmodulin may bind directly
to Cx40 protein. When the Cx40 protein sequence was examined using the Calmodulin
target database for identifying Calmodulin binding sites, there was one site identified in
the C-terminus just outside the fourth transmembrane domain (Fig. 6.1). That a
Calmodulin binding site was identified in the Cx40 C-terminus indicates that Calmodulin
may bind directly to Cx40 thus altering the conformation of the connexin and closing the
channel. To determine if this region is critical for Cx40 regulation by [Ca2+]i, a Cx40
mutant could be developed in which this Calmodulin binding site is either deleted or
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mutated to abolish its high Calmodulin binding affinity. This construct could then be
transfected into communication-deficient HeLa cells that can then be exposed to elevated
[Ca2+]i to determine if this region is critical for this regulation of Cx40 by Ca2+. An
alternative method would be by constructing peptides corresponding to the candidate
Calmodulin-binding region in Cx40. To determine if this region is critical for this
regulation of Cx40 by Ca2+, biophysical approaches such as circular dichroism or
fluorescence spectroscopy could be performed to determine if the peptide binds to
Calmodulin in a Ca2+-dependent manner. If this calmodulin binding peptide displays
high affinity for Calmodulin in the presence of Ca2+ this would indicate that this
Calmodulin binding region of Cx40 would be saturated with Calmodulin when [Ca2+]i is
elevated providing a mechanistic explanation for the ability of Ca2+ to inhibit Cx40 gap
junctions.
The third objective of this thesis was to examine the effect of chemical ischemia
on Cx40 gap junction permeability. This was achieved by inducing ischemia chemically
by inhibiting the electron transport chain with sodium cyanide and glycolysis with 2deoxyglucose and iodoacetate, when Cx40 gap junction permeability was determined by
measuring cell-to-cell transfer of Alexa Fluor 594 dye. This study, which is the first to
examine the effect of chemical ischemia on Cx40 gap junction-mediated cell-to-cell dye
transfer, revealed that there was a partial inhibition of Cx40 gap junction-mediated cellto-cell dye transfer when measured at 37oC. This ischemia-mediated inhibition in Cx40mediated cell-to-cell dye transfer appeared to be Calmodulin-dependent. Changes in
[Ca2+]i could not be measured using Fura-2 at 37oC due to the loss of Fura-2 fluorescence
at this temperature due either to the Fura-2 being released by HeLa cells, or hydrolyzed
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by the cells thus making it impossible to measure [Ca2+]i using Fura-2 at this temperature.
When chemical ischemia-mediated changes in [Ca2+]i were determined with Fura-2 at
20ºC, there was an increase in [Ca2+]i, but Cx40-mediated cell-to-cell dye transfer was
not affected. Thus, an increase in [Ca2+]i did not appear to correlate with a decrease in
Cx40-mediated cell-to-cell dye transfer at 20oC.
Several intracellular changes occur during myocardial ischemia including a
reduction in [ATP]i and [Mg2+]i (Kirkels et al., 1989), accumulation of various ions such
as [H+]i, [Ca2+]i (Kihara et al., 1989), [Na+]i (Malloy et al., 1990), [K+]o (Wilde and
Aksnes, 1995), accumulation of fatty acids (Vusse et al., 1994), catecholamines (Newton
et al., 1997) and free radicals (Kukreja and Hess, 1992). This study has demonstrated
that chemical ischemia-mediated a slow onset partial inhibition of Cx40-mediated cell-tocell dye transfer. There was an elevation in [Ca2+]i which could be measured at 20ºC
with Fura-2 but could not be determined at 37oC due to the loss of Fura-2 fluorescence at
this elevated temperature. This inhibition of Cx40-mediated cell-to-cell dye transfer
following chemical ischemia at 37oC was prevented by the Calmodulin inhibitor
calmidazolium, indicating that the ischemia-mediated inhibition in Cx40-mediated cellto-cell dye transfer appeared to be Calmodulin-dependent and thus Ca2+-dependent.
Resolving these contradictory data will be an important future study. It could be
that a decrease in [pH]i during ischemia affects the Ca2+ dependency so that at 20oC,
[Ca2+]i increases but it now cannot inhibit Cx40-mediated cell-to-cell dye transfer as the
affinity of Cx40 for Calmodulin is altered. At 37oC the chemical ischemia-dependent
decrease in Cx40-mediated cell-to-cell dye transfer appeared to be Calmodulin-dependent
indicating the role of Ca2+. To determine if Ca2+ plays a role in this chemical ischemia-
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dependent decrease in Cx40-mediated cell-to-cell dye transfer, cells could be loaded with
the cell permeant Ca2+chelator BAPTA-AM to prevent an increase in [Ca2+]i. Chemical
ischemia could then be induced to determine if pre-loading cells with the [Ca2+]i chelator
BAPTA prevented the chemical ischemia-dependent decrease in Cx40-mediated cell-tocell dye transfer.
It would be important to further determine the time point at which [ATP]i
decreases significantly being so much sooner than the time of onset of an increase in
[Ca2+]i, and the decrease in gap junction permeability. However, it would also be
important to measure other changes such as intracellular pH and how increased this
affects Cx40 regulation during ischemia. The chemical ischemia-mediated slow decrease
in gap junction closure at 37oC may be due to a decrease in intracellular pH or changes in
Cx40 phosphorylation state. A decrease in intracellular pH as occurs during chemical
ischemia may decrease the Ca2+ sensitivity of intracellular Ca2+ binding proteins due to
H+ binding to the Ca2+ binding sites on these proteins thus decreasing their affinity for
Ca2+. In such circumstances, an increase in [Ca2+]i may not affect Cx40 gap junction
function. Therefore it would be important to accurately monitor changes in [pH]i
following chemical ischemia. This could be accomplished by using the pH sensitive dye
BCECF to measure changes in intracellular pH to determine whether the decrease in Cx40
gap junction permeability was more closely tied to a decrease in intracellular pH than
changes in [Ca2+]i.
The chemical ischemia-mediated decrease in gap junction closure at 37oC may be
due to changes in Cx40 phosphorylation states. Therefore it would be important to
determine whether the level of Cx40 phosphorylation changes following chemical
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ischemia. To determine alterations in Cx40 phosphorylation, Western Immunoblot
analysis could be performed and a phosphorylation-dependent mobility shift assay could
be used to determine whether chemical ischemia results in changes in Cx40
phosphorylation. Densitometry could be used to determine the relative amounts of the
nonphosphorylated and phosphorylated forms of Cx40 following chemical ischemia.
Should there be no change in Cx40 mobility in Western blots two alternative approaches
could be used. In the first, Cx40 could be immunoprecipitated from crude membranes
isolated from Cx40 transfected HeLa cells prior to and subsequent to chemical ischemia.
Following SDS-PAGE and Western blotting, any changes in the level of Cx40
phoshophorylation could be determined by probing the Western blots with phosphoserine, phospho-threonine or phosphotyrosine antibodies as described by Saleh et al
(Saleh et al., 2001). Subsequent incubation with secondary antibodies could be used to
determine the changes in relative levels of phosphate incorporated into Cx40. In the
second alternative approach, cells could be metabolically labeled with 1-2 mCi/ml [32P]
PO3- in phosphate-free basal minimal medium. A plasma membrane preparation could be
subsequently isolated from cells after each treatment and Cx40 could be
immunoprecipitated from these membranes, fractionated on SDS -PAGE, transferred to
nitrocellulose membranes, and the relative levels of incorporation of 32Pi into the
connexins evaluated by auto radiography.
The fourth objective of this thesis was to examine the effect of agonists such as
ATP on Cx43 hemichannel function. This was accomplished by measuring the uptake of
fluorescent dye via functional Cx43 hemichannels in Cx43-transfected HeLa cells using
the “visual method”. Cells were considered Lucifer Yellow positive when the
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fluorescence intensity in the cell was greater than the background fluorescence. After the
ATP experiments, the “visual method” did not continue to produce consistent results as
previously shown in this study and other hemichannel studies in the literature (Alves et
al., 1996; Kondo et al., 2000), where there should have been minimal dye uptake in the
presence of 1.8 mM [Ca2+]o (< 2%), yet a high percentage of cells took up dye (~ 12.7%),
so a quantitative method was developed. In this, the fluorescence intensity of each cell
(i.e., the fluorescent pixels in each cell) in the field was calculated by subtracting
background fluorescence from the mean of the absolute dye fluorescence intensity of
each cell (Fluorescence intensity of cell = Mean fluorescence of cell – background
fluorescence). The fluorescence intensity increase of a given cell was calculated by
subtracting the fluorescence intensity of the cell from various alternative threshold levels
from the experimental levels. Five different thresholding criteria were used to either
narrow or broadened the spread of data and to determine which method would provide
the greatest consistency with data collected previously in our laboratory and with data
published by other laboratories (Alves et al., 1996; Kondo et al., 2000) using the “visual
method”. Analyzing data using the quantitative method for both untransfected and Cx43transfected HeLa cells in either low or normal [Ca2+]o buffer demonstrated a high
percentage of cells appeared to take up dye irrespective of the way threshold levels were
calculated. No significant difference could be determined between the untransfected and
connexin-transfected HeLa cells and the quantitative data was unable to confirm the data
collected previously using the “visual method”. Therefore, these hemichannel
experiments were terminated because the dye uptake assay is not a reliable measure of
hemichannel function. Studies using single channel current of hemichannels expressed in
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oocytes have proved to be a reliable method to measure hemichannel function in other
laboratories and would be a more reliable approach for examining the effects of ATP on
Cx43 hemichannels (Srinivas et al., 2006; Srinivas et al., 2005b; Tong and Ebihara, 2006;
Tong et al., 2004).
Taken together, the results reported here demonstrate for the first time that Cx40 but
not Cx43 gap junctions are regulated by β-adrenergic receptor activation in a PKAdependent manner, suggesting differential regulation of these two cardiac connexins.
Furthermore, Cx40 gap junctions can be regulated by elevated [Ca2+]i in a Calmodulindependent manner. Finally chemical ischemia results in a decrease in Cx40-mediated cell-tocell dye transfer that is Calmodulin-dependent, although the exact role that Ca2+ plays in this
inhibition remains to be defined.
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Figure

261

Fig. 6.1: Cx40 amino acid sequence with the putative transmembrane regions (TM1TM4 highlighted in grey) and the possible Calmodulin binding region (highlighted in
pink) in the C-terminus as identified using the Calmodulin target database (Zhou et al.,
2006) obtained from Ikura Lab, Ontario Cancer Institute.
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